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Abstract 
 
Background: Disease-specific questionnaires are increasingly being used 
to evaluate treatment outcomes from the perspective of patients.  There are 
currently no validated questionnaires that measure patient-reported 
outcomes after proximal thoracic aortic aneurysm surgery. 
 
Objectives: To develop and pilot a newly formulated patient focussed 
questionnaire that measures the patient’s health status and health-related 
quality of life before and after proximal thoracic aortic aneurysm surgery.   
 
Methods: Based on a literature review, a thematic analysis of audio 
recorded patient interviews and expert clinical testimony, a pool of items 
was generated to form a new questionnaire instrument. Suitable patients 
who were scheduled for elective aortic surgery at Liverpool Heart and 
Chest Hospital were identified and invited to participate in the pilot study. 
Patients were asked to complete the questionnaire prior to surgery and 
then at 6 weeks and 3 months after their operation. The newly developed 
instrument underwent preliminary testing for its appropriateness, 
acceptability, feasibility, interpretability, precision, reliability and 
responsiveness. 
 
Results: Several items from the CROQ (Coronary Revascularisation 
Outcomes Questionnaire) formed the basis of the instrument, with the 
addition of 10 items derived from a newly formulated conceptual model of 
proximal thoracic aortic disease. The items were arranged into four 
domains (symptoms, physical, psychosocial and cognitive). Initial testing 
showed that the newly developed instrument performed to acceptable 
standards. It showed good internal consistency (Cronbach’s alpha results 
for all domains >0.85), and test-retest reliability (intraclass correlation 
coefficient for all domains >0.85). In paired sample tests, the values in each 
domain led to statistically significant differences from baseline at either 6 
weeks or 3 months (p<0.05), supporting the construct validity and 
responsiveness of the instrument.  
 
Conclusions: The new instrument demonstrated satisfactory validity as 
well as good internal reliability and test retest reliability for each item across 
all four domains. The initial findings suggest that the measure is sensitive 
and responsive to the effects of surgical treatment for proximal thoracic 
aortic aneurysms. 
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Chapter 1 
Introduction 
 
1.1  General introduction 
The aim of this thesis is to contribute to the understanding, recording and 
reporting of health-related quality of life (HRQoL) and health status in 
patients undergoing an elective surgical repair of a proximal thoracic aortic 
aneurysm (TAA).  
 
This is addressed, initially, with a literature review that focusses on aortic 
aneurysms, the measurement of health outcomes and the development and 
use of questionnaire instruments designed to evaluate patients’ HRQoL, 
these questionnaires are known as Patient Reported Outcome Measures 
(PROMs).  
 
Subsequently, qualitative research in the form of in-depth interviews was 
used to develop of a conceptual model of proximal TAA patient’s perceptions 
of their diagnosis, treatment and recovery. The results of this analysis 
included a set of themes that were used to support the composition of a 
PROM instrument.  
 
Finally, the proximal TAA PROM itself was piloted and the validity, reliability 
and sensitivity of the tool were assessed. Before providing details of the 
aims, objective and structure of this thesis, a brief introduction to thoracic 
aortic aneurysms, HRQoL and PROMs is given, and the scope of the thesis 
is clarified. 
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1.2  Background 
1.2.1  Thoracic aortic aneurysms 
Diseases of the thoracic aorta are increasing in prevalence worldwide 
(Benchimol, 2015; NHS National Statistics, 2017). In the United States, The 
Centers for Disease Control and Prevention reports that aortic aneurysms 
(both thoracic and abdominal)  
are the 15th leading cause of death in individuals aged over 55 years and the 
19th leading cause of death overall (CDC, 2007). Although the prevalence of 
TAAs is likely lower than the reported prevalence of abdominal aortic 
aneurysms (AAAs), TAAs represent an important component of vascular 
disease due to their particularly lethal nature (Elefteriades, 2007; Kuzmik, 
2012) 
 
In the United Kingdom (UK), between 1999 and 2010, hospital admissions 
for thoracic aortic dissection increased from 7.2 to 8.8 and for TAA from 4.4 
to 9.0 per 100,000 inhabitants (Bridgewater et al, 2009). These diseases 
have a high mortality; in the UK, mortality rates for thoracic aortic dissection 
and aneurysm are 3.2 and 7.5 per 100,000 inhabitants, respectively 
(Bridgewater et al, 2009; Bottle et al, 2017).  
 
Mean annual admission rates for proximal aortic surgery in England and 
Wales have been reported at over 1440 cases per annum between 2007 and 
2013 (National Institute for Cardiovascular Outcomes Research (NICOR) 
dataset results, 2007-2013), with an associated mortality rate of 9.0% (95% 
confidence intervals: 8.4% to 9.6%) (NICOR dataset results, 2007-2013). 
Thus, as the incidence of TAA is increasing, mortality rates are high and 
methods of detection are improving, further research within this area is 
justified. This leads to a compelling argument for the development of 
appropriate outcome measures that allow evaluations of the impact of 
hospital treatment from the patient’s perspective. 
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Figure 1.1 shows the position of the heart and its major anatomical 
components, including the origin of the aorta, in a person’s chest. A healthy, 
adult heart is about the size of a clenched fist (Shier, 2015). 
 
 
 
Figure 1.1: The human heart and its major anatomical components (adapted 
from Blausen, 2014a and 2014b) 
 
 
Figure 1.2 then illustrates the difference between a normally sized aortic root 
and an aortic root that has been enlarged, or dilated, with aneurysmal 
disease. The affected section of the diseased aorta begins to bulge out “like 
a weak spot in a tire” (sic. as US spelling. Siwek, 1993). 
4 
 
 
Figure 1.2: A normal heart and aorta, and a heart with an aortic root 
aneurysm (Mayo Clinic, 2019, used with permission of Mayo Foundation for 
Medical Education and Research, all rights reserved). 
 
 
Figure 1.3 shows the basic anatomy of the thoracic aorta. The aorta is 
divided into two main sections; the proximal and distal. The proximal thoracic 
aorta consists of the aortic root, the ascending aorta and the aortic arch. The 
longer descending aorta segment is categorised as the distal thoracic aorta, 
and the abdominal aorta segment begins further down the vessel, below the 
abdomen. Proximal TAA surgery therefore includes procedures that address 
the proximal aorta up to and including the aortic arch via a sternotomy 
incision, without the need for a more invasive thoracotomy incision (these 
procedures upon the distal aorta are described in more detail by Safi (1998)). 
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Figure 1.3: Basic anatomy of a normal thoracic aorta, adapted from 
OpenStax College (2013). (The heart is not shown in this diagram, but would 
appear below the aortic root). 
 
As an aortic aneurysm increases in size, so the risk that the artery may 
rupture and cause a catastrophic injury also increases. The average 
diameter of a normal ascending aorta in a 75 year old woman is 
approximately 3.6–3.7cm and 4.1–4.2cm in a man of the same age (Hager, 
2002). Current guidelines state that a typical patient with a proximal aortic 
aneurysm measured at or above 5.5cm should be considered a candidate for 
surgical intervention, although this generalised threshold can be lowered 
based on each individual patient’s risk profile (Saliba, 2015).  
 
Unruptured TAA’s are found in the International Statistical Classification of 
Diseases and Related Health Problems 10th Revision (ICD-10), at ‘Chapter 
IX: Diseases of the circulatory system’, in the block ‘I70-I79: Diseases of 
arteries, arterioles and capillaries’. The code and description for this 
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condition is ‘I71.2: Thoracic aortic aneurysm, without mention of rupture’ 
(ICD-10, 2019). 
 
1.2.2  Health-related quality of life 
The World Health Organisation (WHO) define quality of life (QoL) as “an 
individual’s perception of their position in life in the context of the culture and 
value systems in which they live and in relation to their goals, expectations, 
standards and concerns” (The WHOQoL Group, 1995).   
 
The ultimate goal of health care is to maintain or improve a patient’s QoL. 
Health is an important determinant of a person’s QoL although, as the WHO 
definition above makes clear, it is not the only one. QoL is comprised of a 
range of perceptions related to a patient’s well-being, based on their 
subjective experiences (Revicki, 2000). Many variables, both objective and 
subjective, interact to define QoL (Higginson and Carr, 2003), but it is 
dependent upon individual patient experiences, states, and perceptions of 
their illness. QoL can vary as a result of life events or changes in functional 
health status, with each area of QoL impacting the others (Revicki, 2000).  
 
Factors such as culture, religion, environment, education, social status and 
income also affect QoL but they are often neglected in the context of health 
care interventions. Patient HRQoL is one of the main concerns of health care 
professionals and over recent decades has become an important health 
outcome indicator (Greenfield and Nelson, 1992; Wilson and Cleary, 1995; 
Lam, 1997). One possible reason for this is that advances in medical science 
and technology have resulted in an increasing number of people living with 
chronic diseases and disabilities. This change in our population’s morbidity 
pattern has called for a paradigm shift in how we should evaluate outcomes 
of illness and care. This raises questions around decision making such as: Is 
it worthwhile to keep a comatose person alive on a respirator? Is renal 
transplant a better treatment than haemodialysis for patients with renal 
failure? Is one particular health care delivery system better for patients with 
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chronic diseases than another? Traditional methods that focus on outcomes 
such as mortality rates, stroke rates and objective clinical parameters are no 
longer viewed as adequate to answer these questions (Tian-hui, 2005). 
There has been a concurrent change in public health discourse away from 
life expectancy and towards Healthy Life Years (HLY), with health outcomes 
becoming less focused on the quantity of years lived and more directed 
towards the quantity and quality of life (Hyder, 1998; Murray, 2012). 
 
Although the term is used regularly in relation to patient care, there is no 
single, established definition of HRQoL. There is, however, general 
agreement that HRQoL focuses on the functional outcome associated with a 
medical condition and/or any subsequent treatment upon a patient (Cella, 
1995; Schipper et al, 1996). This definition reflects a broad view of well-being 
encompassing the person’s satisfaction, HRQoL is therefore subjective and 
multidimensional, comprising not only the basic property of disease 
‘symptoms’ but also physical and occupational performance, psychological 
wellbeing, depth of social interaction and cognitive functioning (Schipper et 
al, 1996). 
 
The measurement of HRQoL allows clinicians and researchers to further 
their understanding of the impact of diseases such as TAAs on the lives of 
patients (Guyatt, 1993). The results of these studies also allow patients to 
have a better grasp of their clinical situation. Patients who are familiar with 
relevant HRQoL results may have an increased ability to manage their own 
expectations of disease and the impact of possible treatments. In the case of 
patients with proximal TAA disease, comorbidities and complications such as 
concomitant cardiovascular or valvular disease, peripheral vascular disease, 
diabetes, renal insufficiencies or contributing congenital malformations could 
all play a part in influencing HRQoL. Equally, as TAA disease is often 
asymptomatic, the diagnosis of aneurysmal disease and the knowledge that 
this unwanted, potentially life-threatening abnormality is present may mean 
that the patient feels under increased psychological pressure, which could 
also in turn influence HRQoL. 
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Several different views exist on how to use PROMs to measure HRQoL, in 
large part due the subjective nature of HRQoL, but also due to the lack of 
distinction between independent and dependent variables, as well as 
mediating variables (Higginson and Carr, 2003). Other barriers identified that 
could limit the routine use of PROMs to gather HRQoL data are cost, 
feasibility and clinical relevance. For a measure to have clinical usefulness it 
must not only be valid, appropriate, reliable, responsive, and able to be 
interpreted, but it must also be simple, quick to complete, easy to score, and 
provide useful clinical data (Tian-hui, 2005). Introducing a PROM into general 
practice is not necessarily a straightforward undertaking, especially in 
healthcare systems which have limited resources. By way of an introduction 
to how a PROM programme may be carried out, Higginson and Carr (2001) 
provide a simple step-by-step method of firstly: Questions to ask when 
choosing a PROM (Table 1.1) and secondly: Stages to follow when 
integrating a PROM into regular clinical procedures (Table 1.2):   
 
Table 1.1: Step 1. Questions to ask when choosing a PROM to measure 
HRQoL for use in clinical practice (from Higginson and Carr, 2001). 
Order Questions to ask when choosing a PROM 
1 Are the domains covered relevant? 
2 
In what population and setting was it developed and tested, and are these similar to 
those situations in which it is planned to be used? 
3 Is the measure valid, reliable, responsive, and appropriate? 
4 What were the assumptions of the assessors when determining validity? 
5 
Are there floor and ceiling effect–that is, does the measure fail to identify 
deterioration in patients who already have a poor QoL or improvement in patients 
who already have a good QoL? 
6 Will it measure differences between patients or over time and to what extent? 
7 
Who completes the measure: patients, their family, or a professional? What effect 
will this have–that is, will they complete it? 
8 How long does the measure take to complete? 
9 Do staff and patients find it easy to use? 
10 Who will need to be trained and informed about the measure? 
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Table 1.2: Step 2. Introducing a PROM to measure HRQoL into clinical 
practice (from Higginson and Carr, 2001). 
 
Order Stages of PROM implementation 
1 Review who is using which measures internally and externally 
2 Choose a measure 
3 Decide whether other outcomes also need to be monitored 
4 Involve staff and patients 
5 Adapt the measure for local use and requirements 
6 Identify a leader of the project 
7 Assign responsibilities (decide who will be doing what) 
8 Agree on a timetable 
9 Test when and where the measure will be completed 
10 Prepare and test paperwork 
11 
Plan and begin training in both the use of the measure and associated clinical 
skills 
12 Agree on start date and review period 
13 Begin using the measure 
14 Review its use in the first week and month and then at regular intervals 
15 Review individual patients’ results and group results to improve care 
16 
Modify measure as patients and staff feel appropriate for improving the use of 
the measure or make other changes 
 
These checklists were particularly useful for the current study, as they 
provided a structured reference for timeline planning and involvement of key 
stakeholders during the PROM development and pilot.  
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1.2.3  Patient reported outcome measures  
PROMs are a means of collecting information on the effectiveness of care 
delivered to patients, as perceived by the patients themselves (NHS Digital, 
2017). Clinical interventions no longer aim only to treat specific medical 
problems in physical terms but to improve QoL as well, these instruments are 
designed to evaluate aspects of a patient’s QoL. The intention is for PROM 
data to supplement and enrich any routinely collected clinical data for a 
particular disease and treatment, thus producing a more detailed and 
balanced information set regarding the quality of clinical interventions, and 
the success of the treatment from the patient’s point of view. 
 
Over recent years, clinicians and researchers have given greater recognition 
and academic attention to these subjective patient experiences. This 
increase in attention aims at a more holistic understanding of the patient and 
how hospital procedures which aim to treat specific diseases affect physical 
and psychosocial functioning in everyday life (Baiardini, 2010). 
 
The term ‘PROM’ covers a group of outcomes used to measure a wide 
variety of aspects of care including: HRQoL, patient illness perceptions, 
treatment satisfaction and adherence. PROMs can be distinguished from 
other outcomes such as laboratory results and clinician or caregiver ratings 
because the data collected is from the patient's perspective, usually without 
interpretation by another individual (Patrick, 2007). Furthermore, PROMs are 
designed to focus on specific disease-related dimensions, such as the 
degree of chest pain caused by a TAA. Researchers are more frequently 
including PROMs in randomised control trials (RCTs) as they help 
demonstrate benefit, patient feelings regarding treatments and even survival 
(insofar as patients who respond can be assumed to still be alive) (Patrick, 
2007). However, PROMs tend to be evaluated as a secondary measure, and 
are rarely the primary outcome of an RCT (Baiardini, 2010). 
 
In the UK National Health Service (NHS), providers of four key elective 
interventions (unilateral hip and knee replacements, groin hernia and 
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varicose vein surgeries) were required to collect and report PROMs from 1st 
April 2009, under the terms of the Standard NHS Contract for Acute 
Services. In practice, this meant that all NHS hospitals were expected to 
invite patients undergoing one of these four relevant NHS-funded procedures 
to complete a specified pre-operative PROM questionnaire in accordance 
with the relevant guidance (Department of Health, 2008). Post-operative 
questionnaires were then sent to patients at a specified point in time after 
their operation.  
 
The UK Government White Paper, ‘Equity and excellence: Liberating the 
NHS’, envisaged an increase in the scope and coverage of PROMs in future, 
starting from April 2011: 
 
“Information generated by patients themselves will be critical to 
this process, and will include much wider use of effective tools 
like Patient Reported Outcome Measures (PROMs), patient 
experience data, and real-time feedback. At present, PROMs, 
other outcome measures, patient experience surveys and 
national clinical audit are not used widely enough. We will 
expand their validity, collection and use. The Department will 
extend national clinical audit to support clinicians across a much 
wider range of treatments and conditions, and it will extend 
PROMs across the NHS wherever practicable.” (paragraph 2.7) 
 
In early 2016 the NHS performed a consultation on the national PROM 
programme, asking patients, clinicians, healthcare managers and academics 
about how they used PROM data. The results were subsequently published 
by the NHS England Insight & Feedback Team (2017). This report found a 
range of views towards PROMs, with many potential uses being identified for 
patients, clinicians and commissioners. The two main purposes of the NHS 
PROM programme were identified as:  
 
“1.  Demonstrating the effectiveness of treatments; and 
 2.  Providing information to reduce variation in care” 
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The consultation report found that where engagement from care providers, 
commissioners and patient representation groups was high, the utility gained 
from PROM results had value. However, the report also notes that in many 
cases the potential of PROMs was not being realised, with the financial and 
staffing costs of administering the programme being most keenly felt in these 
areas (the annual cost of collecting the four nationally mandated PROMs 
was estimated to be £825,000). The response of NHS England to the report 
findings was to discontinue the mandatory groin hernia and varicose vein 
PROM collections, as the results from these were found to be limited in 
scope. NHS England further resolved to explore digital collection of PROM 
data (whilst stressing the importance of appropriate models of patient 
consent), with the intention of increasing the timeliness of useful results and 
reducing the burden of data collection on front-line staff. They also indicated 
their intention to open up the supply of PROMs data to companies and other 
healthcare organisations in an effort to encourage innovation and new ideas. 
 
In addition, the consultation report found that there was an appetite among 
respondents for PROM collection in other clinical areas, the most frequent 
being Cancer care and Long-Term Conditions. The need for robust, 
substantiated, dedicated tools for different disease types is also emphasised, 
as only PROMs with a high level of relevance will provide the necessary 
insights for patients, clinicians and other stakeholders (Insight & Feedback 
Team, 2017).  
 
As focussed, patient-centred healthcare grows in importance, clinicians and 
researchers need a way to make health care decisions that meet the needs 
of patients. It is a key objective to ensure that treatment decisions meet 
patient and societal values, and to recognise that perceptions of treatment 
success may vary between the patient and clinicians (Revicki, 2000; Milne, 
2012). Furthermore, investigations into public perceptions of PROM data 
suggest that areas judged important by the general public have not been 
included in some commonly used measurement tools (Higginson and Carr, 
2003).  
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Collecting well designed and validated PROMs allows clinicians and 
researchers to take into account a wider array of information that cannot be 
obtained through laboratory or physical measures, and permit a subjective 
description of functioning alongside objective findings (McDowell, 2006). 
Through the collection of patient perceptions of interventions used to treat 
proximal TAAs, health care providers will be able to have a better 
understanding of which aspects of health patients value most highly and 
therefore what types of treatment may provide the greatest benefit from their 
perspectives. 
 
The tools used for evaluating PROMs can vary significantly. Evaluation tools 
may be as simple as a single question asking the patient to state their QoL; 
however, they are more likely to take the form of a questionnaire with 
multiple items, which investigate several different domains that are related to 
HRQoL (Guyatt, 1993). The common thread that exists among measurement 
tools is that they attempt to summarise the judgments patients make about 
their health and illness experiences (Higginson and Carr, 2003). PROM tools 
can be placed into two broad categories: instruments that assess general 
health and instruments that are disease-specific. 
 
Generic PROM tools investigate all important aspects of HRQoL and allow 
broad comparisons, but they do not necessarily investigate a specific aspect 
of a disease. Typically generic tools include questions relating to the four 
main domains of HRQoL: physical, functional, social and psychological 
health (de Boer et al, 2004). These tools may be less responsive to change 
as they provide an overall summary score of HRQoL, rather than a score on 
a specific area of health (Guyatt, 1993; Milne, 2012).  
 
Specific HRQoL instruments are designed to target a disease, population, or 
an outcome. Where generic tools allow broad comparisons, specific tools 
may be more responsive to HRQoL changes in the specific patient 
population under investigation (Guyatt, 1993). 
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1.3  Scope of this thesis 
This research focusses on people who have developed aneurysmal disease 
positioned somewhere in the proximal segments of their aorta, namely the 
aortic root, ascending aorta or the aortic arch. Patients who have aneurysmal 
disease in more distal areas (the descending or thoracoabdominal aorta) are 
not included within the scope of this work. Aneurysmal disease in these more 
distal aortic areas has a different natural history, aetiology and pathology to 
their proximal counterparts, along with considerably divergent treatment 
options. Proximal TAA patients are more likely to have concomitant coronary 
heart disease or heart valve insufficiencies. This could be either as a 
consequence of their aneurysmal disease, or a contributing factor towards it.  
 
The cohorts of patients who took part in the qualitative interviews and the 
PROM pilot study were all elective attendees at a single tertiary NHS 
institution located in the North-West of England – Liverpool Heart and Chest 
Hospital (LHCH). 
 
All emergency presentations were excluded, along with any patients who had 
diagnoses of chronic or acute aortic dissection, or indeed any other acute 
aortic syndrome (AAS) such as an aortic ulcer or an intramural haematoma 
(Vilacosta, 2001). The reason for the exclusion of acute presentations was 
the impossibility of delivering a pre-operative PROM, in order to have a 
baseline measure to compare post-operative PROMs against. Chronic 
dissection patients are sometimes well enough to be placed on the surgical 
waiting list and present electively, however they were considered to have a 
significantly dissimilar pathology to proximal TAA patients, hence their 
exclusion. 
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1.4  Overview of the thesis 
1.4.1  Objectives 
The main objectives for this thesis are to develop an item suite of key themes 
which describe the lived experience of proximal TAA patients, and from this 
develop a PROM tool to measure HRQoL that is suitable for use with future 
patients who receive an elective surgical procedure to treat proximal TAA 
disease. 
 
This study aims to achieve this goal by considering a number of aspects 
related to proximal TAAs, HRQoL and PROMs: 
 
1.  To present a clear overview of the natural history of TAA’s, the risks 
and consequences of aneurysmal disease (along with the likelihood of 
concomitant heart problems) and the current treatment options that 
are available. Also to review the history, philosophy and importance of 
monitoring HRQoL as an outcome of clinical interventions and to 
describe the adoption of PROMs as the main facilitating tool for 
collecting and analysing HRQoL information. 
 
2.  To explore the key themes of HRQoL within the proximal TAA patient 
population via detailed analysis of patient testimony. 
 
3.  To design and pilot a PROM tool based on the themes emerging from 
the lived experiences of proximal TAA patients, which can then be 
used within the prospective elective patient population. 
 
4.  To establish the feasibility of using a PROM tool in the proximal TAA 
patient population. 
 
5.  To analyse and present the results of the proximal TAA PROM pilot 
study, and to make recommendations for future development and 
study. 
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The outlined work creates an in-depth understanding of how patients 
perceive their own lived experiences of proximal TAA, and helps to generate 
important PROM information for this growing cohort of patients. This PROM 
information may then be useful to inform and advise both patients and 
clinicians when designing treatment plans and hospital services to improve 
outcomes in the future. 
 
1.4.2         Chapter outline 
The thesis contains six chapters. Following on from this introduction, Chapter 
2 provides the literature review, this is followed by the methodology (Chapter 
3), qualitative study of patients’ experiences of living with proximal TAA 
(Chapter 4), PROM tool development and pilot study (Chapter 5) and an 
overall Discussion and Conclusion (Chapter 6). The content of each of these 
chapters is discussed in more detail in the following paragraphs. 
 
Chapter 2 begins by describing and discussing the aorta and aneurysmal 
disease, including anatomy, diagnosis, causes of disease, symptoms, 
treatment options and current published outcomes, including HRQoL. The 
concept of HRQoL is then covered in detail before reviewing and presenting 
current proposed best practice with regards to developing a PROM tool 
designed for regular use. The chapter reviews reports from current PROM 
programmes to investigate how tools were built, how data was reported and 
any lessons learned. This systematic critical evaluation of the literature 
establishes current practice with regards to PROM design and reporting, 
which is applied to the proximal TAA PROM tool.  
 
Chapter 3 critiques the relevant methodology and underlying assumptions 
related to the development of PROM tools. The underlying pragmatic 
philosophy of the study is also introduced and discussed, along with a 
rationale, description and definition of the mixed methods research approach 
that was used to execute the project. 
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Chapter 4 outlines the initial qualitative research study, covering the 
exploration of key HRQoL issues for patients who have a lived experience of 
proximal TAA disease. In-depth interview data is interrogated and presented 
in the form of a thematic analysis. A final conceptual model based on the 
data is presented and described. The methods and approach to focus group 
and the role of clinician involvement are discussed. Design considerations 
and a review of options for PROM construction are also included. 
 
Chapter 5 explores the results from the pilot of the newly designed proximal 
TAA PROM. This includes detail on patient selection, the patient population 
(such as sociodemographic characteristics, co-morbidities and treatment 
history), how the tool was finally structured and delivered to the patients, 
along with evaluation of internal consistency and test-retest reliability. 
Appropriate scoring methods are given and the longitudinal comparison 
results of pre- and post-HRQoL domains are presented and discussed. 
 
A systematic critical discussion of the research presented in this thesis, as 
well as relevant conclusions is provided in Chapter 6. This discussion also 
evaluates the strength and limitations of the research presented, and 
identifies pathways for continued future validation of the proximal TAA 
PROM, along with other further areas of research. 
 
 
1.5  Contribution to knowledge 
The purpose of this thesis is to contribute to two main areas of knowledge. 
Firstly, to identify and present the key domains of HRQoL for patients with 
proximal TAA disease. This is done via in-depth one-to-one interviews with 
patients who are either under hospital surveillance for proximal TAA disease 
(awaiting potential surgery with regular, scheduled scans to monitor any 
changes in the size of their aneurysm), or patients who have already 
undergone a previous surgery for the treatment of a proximal TAA. The 
construction of a conceptual model of patients’ perceptions and experiences 
of proximal TAA disease, and the issues surrounding their care and treatment 
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contributes to existing literature as well as identifying areas where future 
research may be carried out. 
 
Secondly, the design, refinement and piloting of a specific PROM tool for 
elective, surgical proximal TAA patients contributes to the practical medical 
literature. Previous research has been done on monitoring HRQoL in similar 
patient populations, but this was done using generic tools rather than 
specifically designed questionnaires based on patient testimony and expert 
clinical agreement. One further contribution that the design of this pilot study 
makes is the delivery of not one but two post-operative PROMs. The study 
protocol specified that follow-up PROMs should be sent at both six-weeks 
and at three months after the patient had their initial operation. The details of 
this approach are expanded upon in Chapter 4, but the data gathered from 
the double delivery of post-operative PROM questionnaires will allow more 
refined conclusions and recommendations to be made regarding the effects 
of treatment on proximal TAA patient HRQoL during the initial weeks and 
months of the post-operative phase. 
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Chapter 2 
On thoracic aortic aneurysms, health-related quality of life 
and patient reported outcome measures – a review of the 
literature 
 
2.1  Introduction 
In addition to the traditional clinical indicators associated with patients, the 
practice of regularly measuring health outcomes from the perspective of the 
patient is now widespread (Dawson, 2010; Black, 2013). This chapter 
investigates in more detail the natural history, aetiology and pathological 
presentation of aortic aneurysmal disease and the concept of HRQoL. The 
literature related to patient HRQoL data via PROMs will be reviewed and 
current practice will be compared with and contrasted to prevailing 
methodologies and guidance. 
In order to sufficiently understand the position of the patient suffering from an 
aortic aneurysm, Section 2.3 includes a brief history of medical treatment for 
the condition, this is followed by an examination of current understanding on 
the causes, symptoms and consequences of the disease. In Section 2.4, an 
overview of the literature on the topic of HRQoL is presented. Section 2.5 
then evaluates the concept of PROMs, and provides the rationale for the 
creation of a disease specific tool for the collection, analysing and reporting 
of patient data. 
 
2.2   Objectives for this chapter 
This chapter aims to critically evaluate the current literature to: 
 Create a comprehensive overview of aortic aneurysms, HRQoL 
and PROMs, thus updating and adding to previous reviews 
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 Provide a rationale for the development of a new PROM tool that will 
allow HRQoL to be collected, analysed and reported in patients with 
proximal aortic aneurysmal disease 
 
2.3  Thoracic aortic aneurysms 
2.3.1  History 
In the Merriam Webster Dictionary (1999) the word aorta is said to derive 
from the ancient Greek word αόρτη (aorte), meaning “to lift” or “to raise”, 
demonstrating the anatomical nature of the aorta raising blood flow away 
from the heart. It is recorded as the term applied by Aristotle to the great 
artery of the heart, and was used earlier by Hippocrates to name the 
branches of the windpipe. Accurately pinpointing the origin of words is not 
easy, however, and there is some discussion about how the word may have 
first been coined (Albinali, 2007). 
Evidence gathered from the close examination of Egyptian mummies dating 
from 3500 years ago, revealed that atherosclerosis (see Ross, 1986) and 
arterial calcification were relatively common during those times. Also one of 
the earliest known medical writings from the Egyptian Ebers Papyrus, 
thought to have been composed circa 1550 BC, contains a passage where 
the writer seems to identify arterial aneurysms, and recommends the 
following treatment: “Treat it with a knife and burn it with a fire so that it 
bleeds not too much.” (Barker, 1992). 
Thompson (1986) provides a concise history for the medical treatment of 
aneurysms, which includes the work of the Greek writer Oribasius, who lived 
in the 4th century AD. According to Oribasius, a Greek surgeon named 
Antyllus in the 2nd century AD, left an early record of his advised therapy for 
aneurysms at that time, although these original writings have been 
destroyed. Oribasius noted Antyllus’s recommendations as follows, “We 
decline exceptionally big aneurysms, but we will operate as follows on 
aneurysms in the extremities, the limbs and the head.” Antyllus applied 
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ligatures to the arteries that entered and left the aneurysm and then cut into 
the aneurysm sac, removed the contents, and packed the cavity. Antyllus did 
not resect the aneurysm sac. He offered the following useful instruction, 
“Those who tie the artery, as I advise, at each extremity, but amputate the 
intervening dilated part, perform a dangerous operation. The violent tension 
of the arterial pneuma often displaces the ligatures.” (Crowe, 1957). 
The next noteworthy advance in aneurysmal treatment came from Ambroise 
Paré (1510-1590), who advocated the application of proximal ligature to 
aneurysms but did not believe the sac should be opened because of the 
danger of fatal bleeding. Paré also described a ruptured aneurysm of the 
thoracic aorta and wrote, “The aneurysms which happen in the internal parts 
are incurable.” (Slaney in Greenhalgh, 1990; Barker, 1992). Andreas 
Vesalius (1514-1564) was a friend of Paré and was the first to describe 
thoracic and abdominal aortic aneurysms (Garrison, 1921). 
John Hunter (1728-1793) studied the development of collateral circulation of 
occluded main arteries, which led to his method of treating aneurysms. He 
gained success by ligating the superficial femoral artery high in the thigh, in 
the area now known as Hunter’s canal. This case represented the first major 
innovation in the treatment of aneurysms since the Antyllus operation of the 
2nd century (Perry, 1993). 
Astley Cooper (1768-1841) made contributions in many fields of surgery, but 
his name is linked foremost to advances regarding the vascular system. In 
1817, he provided the first recorded case of ligation of the aorta to treat a 
leaking iliac aneurysm (Brock, 1952). 
Rudolph Matas (1860-1957) introduced endoaneurysmorrhaphy by obtaining 
proximal and distal control, incising and removing the aneurysmal clot, 
oversewing collaterals and preserving a lumen of blood flow. This technique 
successfully reduced the occurrences of gangrene and amputation that 
usually followed aneurysmal surgery and is a principle still used today 
(Matas, 1888; Elkin, 1940). 
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In between Matas’ experience and the mid-20th century several methods of 
treating aortic aneurysms were employed, such as needling, wiring, proximal 
banding, ligation, cellophane wrapping and electrothermic coagulation. 
These techniques had persistent advocates, but ultimately fell out of favour 
(Osler, 1909; Nunn, 1995; Blakemore, 1952). 
There was an advancement of diagnostic testing throughout the 20th century, 
including aortography via clinical angiography (see Wilms, 1995). Treatments 
also improved and in 1945 teams in Sweden and Boston (Crafoord, 1945; 
Gross & Hufnagel, 1945) reporting successful end-to-end anastomosis of the 
aorta to treat coarctation (or aortic narrowing, see Section 2.3.6.3 and Rao, 
2005). This progressed in the 1950’s with great steps forward in successful 
aortic aneurysm resection. Between 1951 and 1953, several landmark 
operations took place in quick succession from international teams (Schafer, 
1951; Dubost, 1952; Julian, 1953; Brock 1953; DeBakey 1953a; Bahnson 
1953). 
The legitimacy of using a homograft replacement for aneurysmal treatment 
was a considerable step forward, but obtaining suitable arteries and veins for 
this type of procedure was a significant limitation. Consequently, the 
development and use of arterial prostheses began in the early 1950’s with 
tubes of Vinyon-N being implanted into animal subjects (Voorhees Jr, 1952). 
The materials used in these prostheses quickly advanced through Nylon to 
implants constructed from Teflon and Dacron. Surgeons including DeBakey 
(1958) and Szilagyi (1966) worked closely with textile engineers to produce 
these elasticised, woven implants. Refined versions of these man-made 
devices are still in use today (Spadaccio, 2016) 
Aneurysms of the thoracic aorta have long presented a challenge to 
surgeons. Aneurysms located in the proximal aortic segments can be 
saccular, fusiform or associated with an aortic coarctation (see Figure 2.3 for 
more detail on aneurysm morphology). Surgical techniques to tackle these 
life-threatening conditions have developed from Alexander (1944) simply 
resecting the aneurysm with the coarctation and sewing the ends without 
incorporating an anastomosis or graft. Swan (1950) wrote the first report of 
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surgical removal of an aneurysm associated with a coarctation and use of a 
homograft replacement.  Then in 1951, Gross reported five cases of 
aneurysm associated with coarctation that he treated by means of resection 
and homograft. By the early 1950’s, Bahnson (1953) and Cooley (1952) had 
resected saccular aneurysms and repaired the arterial walls using lateral 
stitching. DeBakey and Cooley (1953b) reported the first case performed 
with a successful resection and graft of a fusiform thoracic aneurysm. Since 
that time, all sections of the proximal and distal thoracic aorta from the root to 
the diaphragm have been operated on successfully and replaced using a 
variety of custom made prostheses.  
 
2.3.2  The aorta 
The aorta is the largest artery in the human body. It is the blood vessel 
attached to the heart that carries oxygenated blood to all parts of the body 
through systemic circulation. The aorta is divided anatomically into the 
thoracic and abdominal components.  
The thoracic aorta, which is located above the diaphragm, is further divided 
into the proximal segments (aortic root, ascending aorta and aortic arch) and 
the distal descending aorta (see Figure 2.1).  
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Figure 2.1: The aorta and its major branches (Häggström, 2017) 
In a normal aorta, the aortic root supports the bases of the aortic valve 
leaflets. The ascending aorta, located between the aortic valve and the 
innominate artery, is approximately 5 cm long. The three sinuses of Valsalva 
are the pockets of tissue which bulge outwards at the aortic root. These allow 
the aortic valve leaflets to manoeuvre during normal heart contractions. 
Typically, there are three aortic valve leaflets which span the aortic orifice, 
during a heart contraction the valve leaflets are pushed open to allow blood 
to flow through the aorta, they then close to seal and prevent any backflow. 
The left and right coronary arteries both emerge from the sinuses of Valsalva 
and supply blood to the heart itself. The innominate, or brachiocephalic, 
artery emerges from the proximal arch and splits into the right subclavian 
and right carotid arteries which supply blood to the right arm and the right 
side of the neck and head, respectively.  Then the left carotid artery (which 
supplies blood to the left side of the neck and head) and the left subclavian 
(supplying the left arm), both subsequently emerge from the aortic arch. 
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The point where the aortic arch joins the descending aorta just distal to the 
left subclavian artery is called the aortic isthmus, the aortic arch ends at the 
level of the T4 vertebra or around the second rib. The thoracic aorta is 
relatively mobile and tears may occur at points of anatomical fixation, the 
aortic isthmus is where the aorta is attached to the chest wall by the 
ligamentum arteriosum and is particularly vulnerable to trauma. The 
descending aorta is situated distally from the left subclavian artery and 
descends to the diaphragm.  
The walls of the aorta consist of three layers (see Figure 2.2): the tunica 
(layer, or covering) intima, the tunica media, and the tunica adventitia. The 
intima is the thin, delicate inner layer that is directly in contact with the blood. 
It is lined by slender, plate-like endothelium cells which can be easily 
damaged, the production of reactive oxygen species (ROS) by these 
endothelium cells may be a contributing factor of aneurysm formation (Miller, 
2002).  
The middle, or medial, layer is composed of intertwined sheets of elastic 
tissue such as elastin, collagen type I/III, proteoglycans and vascular smooth 
muscle cells (VSMCs) (Wolinsky, 1967). These elements are arranged in a 
spiral manner that provides tensile strength and elasticity; this allows the 
vessel to comfortably respond to changes in blood pressure.  Aneurysmal 
formation will, over time, significantly reduce the integrity of these load-
bearing cells via the degradation of the elastin and the deposition of 
collagen, resulting in a stiffer, less mobile aorta. 
The adventitia is the thin outer layer containing the structural protein 
collagen, nerve fibres, fibroblasts, and vasa vasorum. It is also affected when 
aneurysms form. 
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Figure 2.2: Cross section of an arterial wall, showing the three layers of 
composition (Blausen, 2014c) 
 
2.3.3  Defining and describing aneurysms 
The word ‘aneurysm’ is derived from the Greek ἀνεύρυσμα (aneurysma), 
which means “a widening/an opening” (Antoniou, 2011; Suy, 2006). Slezac in 
Magill’s Medical Guide (2018) defines an aneurysm as “A localised dilatation 
of a blood vessel, particularly an artery, that results from a focal weakness 
and distension of the arterial wall”.  This arterial weakness can be brought 
about by atherosclerotic plaque formation which over time erodes the vessel 
wall, or by the loss of the structural fibres elastin and collagen within the 
vessel itself potentially caused by inflammatory diseases or genetic 
disorders. The enlargement of the blood vessel typically occurs gradually, 
and the weakness of the arterial wall becomes more pronounced over time 
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as the vessel shape, and consequently the flow of blood, alter (Klein, 2005). 
Congenital abnormalities, trauma and infections can all lead to the formation 
of aneurysms. 
If an aneurysm expands beyond the point where the vessel wall remains 
intact, and the artery ruptures and splits open, this is known as ‘aortic 
dissection’ and has the potential to cause massive haemorrhage and death 
(Munson, 2005).  
Aneurysms can take several different forms (see Figure 2.3).  
 
Figure 2.3: Types of aortic aneurysms (text from Munson, 2005) 
  
2.3.3.1 Aneurysm morphology 
A fusiform aneurysm develops when the arterial wall weakens around the 
whole of its circumference, this creates a symmetrical swelling along an 
extended section creating an aneurysm with the appearance of a spindle. 
Saccular aneurysm formations occur when increased pressure in the artery 
pushes out a pouch on one side of the artery, creating a unilateral bulge. 
These types of aneurysm are less common than fusiform ones, and are 
perceived as carrying a greater risk of rupture than their fusiform 
counterparts (Shang, 2013; Szilagyi, 1966). 
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A dissecting aneurysm occurs when blood is forced between the layers of the 
arterial wall, causing them to separate and creating a false lumen. 
A false aneurysm (also known as pseudoaneurysm) develops when there is 
a break in all layers of the arterial wall and blood leaks out, but is contained 
by surrounding structures. This creates a haematoma, or blood clot, which 
pushes the arterial wall outwards. These types of aneurysm usually occur 
after trauma.  
Common aneurysmal locations include: 
Thoracic aortic aneurysm – an abnormal progressive dilation of the normal 
aortic lumen involving all three layers of the vessel wall (the intima, media 
and adventitia). Occurring in one or more of the root, ascending, arch, or 
descending segments of the aorta. 
Abdominal aortic aneurysm – an abnormal progressive dilation in the arterial 
wall, generally occurring in the aorta between the renal arteries and iliac 
branches. The aorta appears to be more susceptible to aneurysms than 
other blood vessels. The reason for this is thought to be because the aorta is 
the first artery to receive blood from the heart, and it is therefore placed 
under uniquely high levels of pressure. If there are any deficiencies in the 
wall of the aorta, it is more likely that aneurysms will occur (Fogoros, 2018)  
Aneurysms can also occur in other areas of the body, for example a cerebral 
aneurysm is a localised dilation of a cerebral artery that may arise at an 
arterial junction in the circle of Willis, the circular anastomosis forming the 
major cerebral arteries at the base of the brain. 
Femoral and popliteal aneurysms (sometimes called peripheral arterial 
aneurysms) are the end result of progressive atherosclerotic plaque growth 
changes occurring in the arterial walls of these major peripheral arteries.  
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2.3.4 Personal risk factors associated with aortic 
aneurysms 
Personal risk factors for developing aortic aneurysms differ based on the age 
of the individual. In older people, atherosclerosis is likely to be a contributor 
to aneurysmal formation. Hypertension (high blood pressure), smoking and 
chronic obstructive pulmonary disease (COPD, a group of lung conditions 
that cause breathing difficulties) are all also significantly associated with an 
increased risk (Hiratzka, 2010; Fogoros, 2018). In younger patients, genetic 
or physiological variations are more common. However, there have been 
proposals dating back decades that the sole underlying cause of aortic 
aneurysms may be genetic anomalies. Kuivaniemi (1991) states that: 
“reports from several groups [have] established that aortic 
aneurysms are familial, and, therefore, strongly suggested that 
they are caused by genetic defects…The family studies did not 
contradict the general impression that the development of 
aneurysms is accelerated by atherosclerosis, hypertension, and 
other factors. In fact, the higher incidence among brothers than 
sisters of patients strongly suggested a secondary component 
such as atherosclerosis contributes to the disease. The results, 
however, strongly suggested that a genetic defect unrelated to 
any genetic defect causing atherosclerosis or hypertension is 
the underlying cause of most aortic aneurysms.” 
Studies continue to hypothesise on the fundamentally genetic nature of aortic 
aneurysms. Humphrey (2015) observes: 
“An emerging concept is that altered cell–matrix 
connections…play important roles in TAADs. Given that such 
connections are fundamental determinants of cell phenotype 
and cell survival, this hypothesis is intuitive. Based on our 
review of the mechanics and mechanobiology…we submit 
further that many of the identified genetic mutations in [aortic 
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aneurysms]…directly affect the structural integrity of the aortic 
wall.”  
Genetic syndromes with a predisposition for thoracic aortic aneurysms have 
been identified and are covered in more detail later in this chapter.  
Thoracic aortic aneurysms are also associated with bicuspid aortic valve and 
other congenital cardiovascular anomalies and inflammatory diseases. Also, 
as Kuivaniemi alludes to, some thoracic aortic aneurysms are due to an 
inheritance of a predisposition for the disease, this has been termed ‘familial 
thoracic aortic aneurysm syndrome’. Still others have an unknown origin 
(Hiratzka, 2010). 
 
2.3.4.1 Atherosclerosis 
The role of atherosclerosis, or the build-up of plaque inside an artery (see 
Figure 2.4), highlights the differences in aetiology, pathology and natural 
history of aneurysmal development in different segments of the aorta.  
 
Figure 2.4: Normal artery and artery narrowed by atherosclerotic plaque 
(Dreamstime, 2019) 
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Atherosclerosis tends to be accepted as a key risk factor for the formation of 
aneurysms in the descending and abdominal aorta. However, the effect that 
atherosclerosis has on aneurysmal formation in the thoracic aorta is 
disputed. The European Society of Cardiology Task Force Report on 
‘Diagnosis and management of aortic dissection’ (Erbal, 2001) makes the 
following generalised statement: “Atherosclerosis is the main cause of aortic 
aneurysms”. This conclusion is based solely on the findings of two autopsy 
studies. There is however, some subsequent evidence that suggests patients 
who suffer with thoracic aneurysms actually develop less systemic 
atherosclerosis than age and sex-matched controls (Achneck, 2005).  This 
finding has been supported by laboratory testing that has investigated 
enzymes linked with ascending aortic aneurysms and dissections, these 
enzymes are known as matrix metalloproteinase (MMP). It has been 
hypothesised that an increased level of MMPs could encourage the growth of 
aneurysms at the same time as disintegrating any formations of 
atherosclerotic plaques (Elefteriades, 2010; Silence, 2002). 
Isselbacher (2005) also maintains that atherosclerosis is “an infrequent 
cause of ascending thoracic aortic aneurysms”, and that plaque build-up as a 
contributing factor is more associated with descending and abdominal aortic 
aneurysms.  
Currently, it seems that the relationship between atherosclerosis and 
aneurysmal development is not fully understood. Further detailed 
investigation is required to reveal the extent of contribution towards 
aneurysmal disease, based on both the position of the aortic aneurysm in the 
vessel itself and the presence of other important factors such as MMP 
enzymes. 
 
2.3.4.2 Degenerative changes 
The underlying cause of the tissue abnormality that results in thoracic aortic 
aneurysms is the degeneration of the central (medial) layer of the blood 
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vessel. This degeneration presents as a loss of the smooth muscle cells, a 
breaking up and reduction in the numbers of the elastic tissue fibres, and an 
increase in the number of proteoglycans (Guo, 2006).  Proteoglycans are 
connective tissue proteins which are produced by smooth muscle cells. 
When the tissue is subjected to low levels of mechanical strain these 
proteins are created in greater numbers. It has been suggested that genetic 
mutations could lead to a decrease in smooth muscle cell contraction, 
leading to increased tissue strain and resulting in the cells increasing 
production of both proteoglycans and MMPs (Milewicz, 2008).  
This fragmentation of the normal cellular construction of the aorta most often 
results in a cyst-like formation in the medial layer of the vessel wall (see 
Figure 2.5). This cystic medial degeneration, also known as cystic medial 
necrosis, weakens the wall of the aorta and encourages the formation of an 
aneurysm. In a person with cystic medial degeneration, high blood pressure 
greatly accelerates the condition and makes rapidly-developing aneurysms 
much more likely (O’Rourke, 2004). As noted above, proximal thoracic aortic 
aneurysms are most often the result of these non-atherosclerotic 
degenerative changes, in contrast to descending and abdominal aortic 
aneurysms which tend to be associated with atherosclerosis. 
 
Figure 2.5: Structure of a normal and a diseased aortic wall, showing both 
elastic tissue and smooth muscle cells (adapted from van de Pol, 2017). 
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Cystic medial degeneration is usually associated with aging, but it also can 
be seen in some younger people, especially individuals who have a genetic 
disorder (Rubin, 1999, p.522; Underwood, 2000, p.278–279). The different 
types of genetic disorder which can have an effect on aneurysmal formation 
are discussed in greater detail over the following pages. 
 
2.3.5 Genetic disorders associated with aortic 
aneurysms 
The gene mutations that can lead to the formation of aortic aneurysms are in 
the early stages of being identified. To date, 30 genes have been shown to 
have an association with the development of thoracic aortic aneurysms or 
dissection (Brownstein, 2018). Genes that have been recognised as being 
important include: FBN1, TGFBR1, TGFBR2, COL3A1, ACTA2 and MYH11.  
Mutations of these genes, and the syndromes associated with these 
mutations, can cause a variety of clinical features that may contribute to 
aneurysmal development and growth. These associated genetic features 
may have consequences for patient treatment, especially if they are 
cardiovascular in nature. Or if the patient has other coexisting clinical issues 
to consider then their recovery or care may have to be adapted to take them 
into account. Some examples of these features are:  
 Bicuspid aortic valve (BAV). A normally developed aortic heart valve 
has three leaflets (known as tricuspid), which open and close when 
the heart beats. In BAV’s two of these leaflets are fused together 
when the heart is growing in the womb. This results in a disrupted 
blood flow into the aorta (McKellar, 2007). More detail on BAV is 
provided in Section 2.3.6.1. 
 
 Livedo reticularis, which presents as a mottled, purplish 
discolouration of the skin, where small blood clots have obstructed 
capillary vessels (Sneddon, 1965).   
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 Iris floccule, where tiny cysts in the eye have a constant progression 
of breaking down and building up again. This presents as wrinkled 
blobs on the margin between the iris and the pupil. Patients do not 
usually report any problems with vision (Shields, 2016).   
 
 Patent ductus arteriosus, which is a condition seen after birth when 
the ductus arteriosus fails to close. The ductus arteriosus is a blood 
vessel that connects a foetus’s main pulmonary artery to the 
proximal descending aorta, allowing oxygen-filled blood to bypass 
the lungs. In a typical birth this closes off and becomes the 
ligamentum arteriosum (see Section 2.3.2 and Zhu, 2006).  
 
 Thin, translucent skin 
 
 Arterial tortuosity, this rare disorder is characterised by elongation, 
stenosis and tortuosity (or an excessively frequent twisting) of a 
person’s arteries. This arterial dysfunction is caused by genetic 
mutation of the elastic fibres in the medial layer of the artery (see 
Section 2.3.2 and Couke, 2006).  
 
 
 
2.3.5.1 Marfan syndrome 
A French paediatrician called Antoine-Bernard Marfan was the first to 
describe the skeletal abnormalities, including an overgrown frame and soft, 
hyper-flexible joints which typify the connective tissue disorder eventually 
named after him (Marfan, 1896; Verstraeten, 2016).   
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Figure 2.6: General manifestation of Marfan syndrome (Reprinted by 
permission from Springer Nature: image originally in “Genetics and 
Dysmorphology” by Naga et al, Copyright 2015). 
Since that time, many other clinical features have been linked to the disease. 
These include several eye, skin, and cardiovascular presentations such as 
lens displacement, short-sightedness, loose skin, stretch marks, aortic 
aneurysms and floppy heart valves. The cardiovascular problems are 
understandably the major culprits for the high rates of morbidity and mortality 
in patients who have Marfan syndrome (Cook, 2015).  
The gene mutations that cause Marfan syndrome have been isolated to the 
FBN1, or fibrillin 1, gene (Dietz, 1991). FBN1 encodes a type of protein 
which is used by the body to create tissue fibres, including bone. FBN1 is 
particularly used for fibres that contain important qualities such as elasticity 
and structural support.  
Patients with Marfan syndrome are highly predisposed to thoracic aortic 
aneurysms disease or aortic dissections, virtually every patient diagnosed 
with the syndrome has evidence of aortic disease at some point during their 
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lifetime (Hiratzka, 2010). The population incidence of Marfan syndrome is 
approximately 1 in 3,300 worldwide (Arslan-Kirchner, 2010). 
 
 
2.3.5.2 Loeys-Dietz syndrome 
Loeys-Dietz syndrome is a genetic disorder with similar characteristics to 
Marfan syndrome, in that it is a genetic dysfunction which affects connective 
tissue in the body. The disorder was first observed and described by Dr’s. 
Bart Loeys and Harry Dietz at the Johns Hopkins University School of 
Medicine in 2005 (Loeys, 2005). A key defining feature of patients with the 
disease is the presence of aortic aneurysms or dissection (Loeys, 2006).  
As well as aneurysmal formation, patients with Loeys-Dietz syndrome 
typically present with three common physical abnormalities, arterial tortuosity 
(see Section 2.3.5), wide spaces between the eyes and bifid uvula or a cleft 
palate, or a palate with a wide base and prominent ridge. Other features of 
these patients include: velvety and translucent skin which can bruise easily, a 
malformed skull, jaw or lower face, a blue tint to the whites of the eyes, 
patent ductus arteriosus (see Section 2.3.5), atrial septal heart defects, 
developmental delays or learning disabilities, spine abnormalities and joint 
hyper-flexibility (MacCarrick, 2014; Hiratzka, 2010). 
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Figure 2.7: Characteristics of the Loeys–Dietz Syndrome. Panel A shows 
typical facial characteristics of patients with Loeys–Dietz syndrome type I at 
different ages. Panel B shows the facial characteristics of a patient with 
Loeys–Dietz syndrome type II. The translucency of the skin is evident, with 
visible veins and distended scars. Panel C shows a patient who had type I 
with a bifid uvula (Loeys, 2006. Reproduced with permission from the New 
England Journal of Medicine, Copyright Massachusetts Medical Society). 
As well as the aneurysmal formations and/or aortic dissections that define 
Loeys-Dietz syndrome, the gene mutations that cause the syndrome have 
been identified as occurring in the TGFBR1, TGFBR2, SMAD2, SMAD3, 
TGFB2 and TGFB3 genes (Loeys, 2018). The four TGF genes are in the 
transforming growth factor category, these types of gene are essential for 
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tissue regeneration, cellular development and immune system regulation 
(Matt, 2009). The two SMAD genes are part of the TGF genetic process, 
they are activated by the TGF gene and combine to form protein-based 
cellular building blocks for creating tissues. Mutations in these genes lead to 
the production of non-functional cells which leads to physical abnormalities in 
blood vessels, cartilage and skin development (van de Laar, 2011). The 
population incidence of Loeys-Dietz syndrome is unknown, although 
mutations affecting TGFBR1 and TGFBR2 appear to be the most common. 
 
2.3.5.3 Ehlers-Danlos syndrome 
Ehlers-Danlos syndrome (EDS) is a group of genetic disorders that are 
characterised by abnormalities of the skin, joints and connective tissues, 
particularly stretchy or hyper-elastic skin, hyper-flexible joints and 
cardiovascular malformations. Although hypermobility was first described in 
400 BC by Hippocrates (Beighton, 2011), and a comprehensive description 
of loose, fragile skin and hypermobile joints was published in late 19th 
century Russia by Tschernogobow (1892), the syndrome is named after two 
dermatologists – Edvard Ehlers and  Henri-Alexandre Danlos – one Danish 
and one French respectively, who independently published their findings in 
the early 20th century (Ehlers, 1901; Danlos, 1908). 
The system of classifying patients with EDS currently contains 13 different 
types. The type most associated with aneurysmal formation is Type IV, or 
vascular EDS. Patients who present with vascular EDS typically have very 
thin, fragile skin which bruises easily and has visible veins, they are also 
usually of short stature, have thin scalp hair and possess distinguishing facial 
features including large eyes, a small chin, sunken cheeks, thin noses and 
lips, and ears without lobes (Inokuchi, 2014). Internal arteries are particularly 
delicate and are predisposed to rupture, so surgical interventions are often 
limited to those life-threatening scenarios where aortic rupture occurs 
(Hiratzka, 2010), surgeons who have attempted arterial reconstruction in 
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these patients have found the task a formidable challenge and advise to 
carry out only the most straightforward procedures (Ascione, 2000).  
The diagnosis of vascular EDS is based on mutations to the COL3A1 gene. 
This gene provides instructions for making type III collagen, which is a 
protein that provides strength and support to many different types of bodily 
tissues (Kontusaari, 1990). 
 
Figure 2.8: Examples of skin and joint presentations of EDS from Chen 
(2014). Skin hyperextensibility (A). Joint hypermobility at fingers (B). 
(Reproduced with permission from the New England Journal of Medicine, 
Copyright Massachusetts Medical Society). 
The combined prevalence of all types of Ehlers-Danlos syndrome varies 
between 1 in 10,000 and 1 in 25,000 individuals worldwide. EDS type IV 
represents approximately 5 to 10% of cases (Germain, 2007) 
 
2.3.5.4 Turner syndrome 
Turner syndrome is a condition that occurs in females where they are 
partially or completely missing their X chromosome. It is named after Henry 
Turner, who in 1938 was the first to describe the disorder in detail (Turner, 
1938).  
As well as developmental, endocrine and reproductive problems, Turner 
syndrome also has a detrimental effect on the cardiovascular system. The 
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most serious manifestations of this are bicuspid aortic valves (between 10% 
and 25% of patients) and aortic coarctations (approximately 8% of patients, 
see Section 2.3.1). Both of these conditions carry with them an increased 
risk of aneurysmal formation and aortic dissection (Hiratzka, 2010; Bondy, 
2007). 
Some characteristics of Turner Syndrome (from Carr, 2014) include: 
 Short stature 
 Low hairline 
 Fold of skin around the neck 
 Constriction of the aorta 
 Shield-shaped thorax 
 Widely spaced nipples 
 Elbow deformity  
 Brown spots on the skin 
Early identification and regular monitoring of the cardiovascular elements of 
Turner syndrome is necessary, including blood pressure, echocardiogram 
and clinical examination by a cardiologist. When significant cardiovascular 
problems occur, the most appropriate medical or surgical repair is advised 
(Gravholt, 2002). 
Turner syndrome affects approximately one in 2500 live-born females 
(Nielsen, 1991). 
 
2.3.6 Cardiovascular conditions associated with aortic 
aneurysms 
Whether they are caused by a genetic syndrome, familial inheritance or 
developmental abnormalities, understanding how the following 
cardiovascular conditions manifest themselves, and the associated 
aneurysmal risk that they carry, is important when presenting an overview of 
aortic disease.  
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2.3.6.1 Bicuspid aortic valve 
BAVs are one of the most common congenital heart defects reported, recent 
estimates put the prevalence of the condition between 0.5% – 1.4% of the 
general population (Braverman, 2011).  
The earliest description of a BAV has been attributed to Leonardo da Vinci, 
who drew a bicuspid variant of the aortic valve in the early 16th century. The 
drawing was found amongst his numerous sketches regarding heart function 
and blood circulation, along with a note describing how the typical tricuspid 
valve has a more optimal configuration than a quadricuspid valve. (Mills, 
1978; Braverman, 2005).  
More recently BAV was referred to by Hunter in 1764, who described the 
case of a man with a BAV afflicted with severe disease and by Paget in 1844 
who noted that patients with the condition were far more likely to develop 
disease on the leaflets of their aortic valves. In 1858, Peacock recognised 
that BAVs seemed more likely to harden and so become less flexible and 
effective than tricuspid configurations, and Osler (1886) saw a greater 
tendency for these valves to become infected. By the 1950’s, clinicians 
began to appreciate how BAVs were intrinsically associated with aortic 
stenosis (where the aortic valve narrows over time), aortic regurgitation 
(where the aortic valve becomes leaky and blood begins to flow in the 
reverse direction), infection and aortic dissection (Campbell, 1953; Smith, 
1955 and Bacon, 1959), or often a combination of these pathologies.  
The leaflets of a BAV are usually of an unequal size, with a groove or ridge 
(known clinically as a raphe) noted in the larger leaflets, see Figures 2.9a 
and 2.9b, below.  This groove is an indication of where the original tri-leaflet 
valve has fused together. The edges of the two BAV leaflets are limited in 
mobility when compared to tricuspid valves, the result of this is an increase in 
the stresses and strains being put on the valve during the course of 
contraction during a heartbeat. BAVs have been seen to undergo more 
significant folding and wrinkling while the flow of blood through the valve is 
more turbulent and irregular (Robicsek, 2004).  
42 
 
 
 
Figure 2.9a: Appearance of a Bicuspid Aortic Valve (Reprinted with 
permission from the Journal of the American College of Cardiology, 
Copyright Siu, 2010).  
 
Figure 2.9b: BAV, detail (Bayne, 2016. Image reproduced with permission 
from Medscape Drugs & Diseases (https://emedicine.medscape.com/), 
Copyright 2016). 
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The first suggestion of a link between BAV and aortic aneurysms was made 
by Abbott in 1928. In the following years many studies have confirmed this 
link between BAV and aortic aneurysms, even if the BAV is functioning well 
and showing no signs clinical dysfunction (Nkomo, 2003; Morgan-Hughes, 
2004). Patients with BAV have been found by Fazel (2008) to be more likely 
to develop aneurysms in all the proximal segments of the aorta (aortic root, 
ascending aorta and aortic arch), with 73% of his sample having some 
dilation of the aortic arch. Overall, aortic dilatation is one of the most 
common findings in patients with a BAV, with reported incidence rates 
between 30% and 70% (Losenno, 2012). 
These aneurysmal formations represent a clear risk factor for aortic 
dissection, the connection of BAV with this critical outcome was highlighted 
by Larson and Edwards in 1984, who calculated a nine-fold greater risk of 
aortic dissection in BAV patients. Subsequent investigations have found that 
the rate is probably not quite so high, but individuals with a BAV are still at a 
significantly higher risk than the general population (Tzemos, 2008; 
Michelena, 2011). 
 
2.3.6.2 Aberrant right subclavian artery 
An aberrant right subclavian artery (ARSA; also known as ‘Arteria Lusoria’) is 
a physiological anomaly first described in 1735 by Hunauld. It has a reported 
incidence of between 0.5% and 2.0% in the general population (Epstein, 
2002).  
The irregular arterial structure of an individual with an ARSA is shown in 
Figure 2.4. Compared with the normal arrangement (see Figure 2.1) the 
innominate artery (also known as the brachiocephalic trunk), which appears 
closest to the aortic valve and then braches out into the right common carotid 
artery and the right subclavian artery, is missing. Instead, four arteries 
emerge directly from the aortic arch in the following order: the right common 
carotid artery, the left common carotid artery, the left subclavian artery, and 
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then finally the ARSA.  In most cases, the ARSA then crosses behind the 
esophagus (not labelled in the figure) to supply blood to the right arm. 
 
 
 
 
 
 
Figure 2.10: Aortic arterial structure with the presence of an ARSA (Polguj, 
2014) 
  
In many patients who have an ARSA, the aorta itself is also abnormal and is 
prone to aneurysm formation, dissection, and rupture (Hiratzka, 2010). It is 
possible for patients with an ARSA to have no symptoms that would indicate 
their presence, but they can also cause symptoms such as dysphagia 
(problems swallowing), shortness of breath or chest pains (Kedora, 2009). 
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2.3.6.3 Kommerell diverticulum 
A Kommerell diverticulum (KD) is a developmental error that can occur within 
a number of aortic arch structural anomalies (see Figure 2.11). KD’s can 
become aneurysmal when a weakened proximal section of an artery 
enlarges. The condition takes its name from a German radiologist, Dr. 
Buckhard F. Kommerell, who in 1936 made the first report in a living patient. 
Kommerell’s original diverticulum was from a patient who had an ARSA (see 
Figure 2.10), but KD’s are most frequently found in cases of right aortic arch 
with an aberrant left subclavian artery (van Son, 2002). 
 
 
Figure 2.11: Diagram of a Kommerell diverticulum and its relationships with 
the oesophagus, the aorta and its collateral branches (posterior view) 
(adapted from Adert, 2013) 
Kouchoukos (2007) described a surgical series of 10 KD patients over the 
course of 10 years, noting that the rarity of the condition meant that the 
natural history was not yet known with certainty. However, it has been 
observed that KD patients seem more susceptible to embolisation, internal 
compression of the trachea or oesophagus, aortic dissection and aortic 
rupture. Kouchoukos goes on to recommend a surgical technique for KD 
patients, reporting acceptable results. 
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2.3.6.4 Coarctation of the aorta 
The first reported case of coarctation of the aorta (CoA), or aortic narrowing, 
was reported by Paris in 1791. It has since been recognised as a relatively 
common genetic abnormality, with both paediatric and adult cases being 
described before surgical treatment was feasible by Abbott (1908, 1928) and 
Lewis (1933). 
CoA can occur anywhere in the aorta, but is usually found in the distal arch 
segment (see Figure 2.12). It is a relatively common abnormality that occurs 
in about 40 to 50 of every 100 000 live births, with a 2:1 ratio in males versus 
females (Hiratzka, 2010). CoA’s are normally diagnosed in early life, and 
treated surgically at that time. Adult presentations are therefore typically due 
to subsequent complications or failures of the initial treatment.  Choudhary 
(2015) reports aneurysmal formations in 15% of individuals, with the most 
common occurrences being noted in patients who had a patch aortoplasty 
procedure to treat their CoA. 
 
Figure 2.12: Coarctation of the Aorta from Robbins (1953). (Reproduced with 
permission from the New England Journal of Medicine, Copyright 
Massachusetts Medical Society).  
47 
 
2.3.7 Inflammatory diseases associated with thoracic 
aortic disease 
Inflammatory diseases of the aorta are rare compared to genetic 
malformations, atherosclerosis and degenerative changes, which are the 
most frequent causes of aortic disease. However, these diseases can quickly 
damage the aortic tissue and result in aneurysmal formations (Caspary, 
2016). Some of the most prominent diseases of this type, along with some 
introductory references, are listed below.  
 
 Takayasu arteritis (Numano, 2000; Johnston, 2002) 
 Giant cell arteritis (Evans, 1995; Salvarani, 2008) 
 Behçet’s disease (Sakane, 1999; Seyahi, 2016) 
 Ankylosing spondylitis (Haroon, 2015) 
 Cogan’s syndrome (Kessel, 2014; Angiletta, 2015) 
 Polyarteritis nodosa (De Virgilio, 2016; Guillevin, 2017) 
 Kawasaki disease (Newburger, 2016) 
 
 
 
2.3.8 Other pathologies related to aortic aneurysms 
It is common for patients with an aortic aneurysm to experience other 
problems with their heart or heart valves. The presence of these additional 
abnormalities can make surgery more complex and therefore increase the 
risk of undesirable outcomes. The most common of these pathologies are 
covered in more detail in the following sections. 
 
2.3.8.1 Aortic stenosis 
Patients with a BAV or other congenital anomalies are at a greater risk of 
suffering from aortic stenosis (see Section 2.3.6.1), but the condition more 
commonly develops during aging as calcium deposits and scarring on the 
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valve leaflets increase. These degenerative developments damage the valve 
and restrict the amount of blood that can flow through it (American Heart 
Association, 2019). Figure 2.13 shows the differences in performance 
between a normal, tricuspid heart valve and a tricuspid valve with aortic 
stenosis. 
 
 
Figure 2.13: Normal aortic valve versus stenosed aortic valve (Šušak, 2013).  
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2.3.8.2 Aortic regurgitation 
When an aortic valve is regurgitative it is because the leaflets of the valve 
are not closing properly. This causes blood to leak backward from the aorta 
into the left ventricle, as illustrated in Figure 2.14: 
 
Figure 2.14: Aortic valve regurgitation (Mayo Clinic, 2019, used with 
permission of Mayo Foundation for Medical Education and Research, all 
rights reserved). 
As the heart is not working efficiently, blood does not flow through the body 
as it should. Mild aortic regurgitation may have few symptoms, but more 
severe cases can provoke symptoms such as shortness of breath, fatigue or 
chest pain and if left untreated can lead to ventricular dysfunction and heart 
failure (Enriquez-Sarano, 2004). 
 
2.3.8.3 Ventricular dysfunction 
The left ventricle (see Figure 1.1) is the heart’s main pumping chamber. 
Ventricular dysfunction occurs when the heart is not pumping as much blood 
as it should be. A common measure of how well the left ventricle of the heart 
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is pumping blood is the left ventricular ejection fraction (LVEF); this is a 
percentage expression of how much blood in the left ventricle is pushed out 
with each heart-beat. A healthy heart has an LVEF greater than 50%, 
moderate LVEF is defined as between 31% and 50%, poor LVEF is between 
21% and 30% and very poor LVEF is 20% or less (Nashef, 2012). Patients 
with a reduced LVEF may experience shortness of breath, heart palpitations, 
fatigue, swelling in the lower extremities or a lack of appetite. 
 
 
2.3.9  Symptoms 
Thoracic aortic aneurysms can often develop without generating physical 
symptoms. Patients who have asymptomatic aneurysms are regularly 
diagnosed as a consequence of having an imaging scan (such as a chest x-
ray, an echocardiogram or a computerised tomography (CT) scan) for some 
other health problem (Isselbacher, 2005).  
Symptomatic patients, who account for between 5%–10% of cases (Sawyer, 
2017), present with pain caused by the aneurysm. This pain can be due to 
the stretching of aortic tissue, or as the aneurysm grows it may begin to 
squash against other parts of the body. 
If patients have pain, the site can indicate the location of the aneurysm, so 
proximal thoracic aortic aneurysms can cause pain in the neck and jaw, 
sternum or upper back. Aneurysms in the more distal descending aorta may 
produce pain in the left shoulder or between the shoulder blades, and 
abdominal aneurysms may trigger pain in the flanks, abdomen or lower back 
(Elefteriades, 2008).  
Examples of symptoms that are associated with internal compression are: 
voice hoarseness, when nerves in the larynx are squashed; a high-pitched 
wheezing (known as ‘stridor’) if the larynx or trachea are compressed; 
difficulty breathing, or dyspnoea, if the lungs are affected; problems 
swallowing, if the oesophagus is compressed; and if the vena cava becomes 
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compressed this can result in plethora and oedema (swelling caused by an 
excess of blood). 
Depending on how and where the aneurysm develops, it may stretch out the 
aortic valve structure and have a detrimental effect on its performance. The 
valve may become leaky or the leaflet movement may be impeded by the 
aneurysmal growth. This would then result in a heart murmur detectable 
upon examination (Hiratzka, 2010). 
 
2.3.9.1 Aortic dissection 
As mentioned in Section 2.3.3, aortic dissection often occurs as a 
consequence of an aortic aneurysm. This occurs when the aneurysm 
expands and the walls of the artery rupture, the aorta breaches and normal 
blood circulation is interrupted.  
Aortic dissections are classified as either ‘acute’, which represent life-
threatening clinical emergencies (Hagan, 2000), or ‘chronic’, which are still 
serious conditions but in these cases the arterial failure occurs more 
gradually (Beebeejaun, 2013).  
Reports of aortic dissections have been made for over 200 years (Acierno, 
2014), with one of the most famous early descriptions being made on the 
body of King George II after his death in 1760: 
“…the next day Dr Nicholls, physician to his late Majesty, found 
the pericardium [the protective sac which covers the heart] 
distended with a pint of coagulated blood, probably from an 
orifice in the right ventricle, and a transverse fissure on the 
inner side of the ascending aorta 3.75 cm long, through which 
blood had recently passed in its external coat to form a raised 
ecchymosis [bruise], this appearance being interpreted as an 
incipient aneurysm of the aorta” (Leonard, 1979) 
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Estimated incidence of aortic dissections in the UK was 3,892 in 2010, based 
on Office of National Statistics 2010 census population figures. This 
corresponds to around 4 – 7 cases per 100,000 individuals (Howard, 2014). 
It is estimated that around a third of all dissection cases are chronic (Patel, 
2014). 
Patients who suffer from an aortic dissection report an abrupt onset of sharp, 
severe chest pain. Back or abdominal pain is also reported, typically linked to 
the location of the dissection. 
 
2.3.10  Identification, diagnosis and surveillance 
The clinical presentation of an aortic aneurysm can vary and may be similar 
to other more common health problems. If thoracic aortic aneurysms are to 
be identified at an early stage then a clear medical history, appropriate 
physical examination, suitable diagnostic studies, and skilled clinical 
management is important to achieve a positive outcome (Klein, 2005).   
There are several diagnostic studies that can help to identify aortic 
aneurysms and offer useful information about size and location: 
 Chest x-rays often raise suspicions about the presence of aortic 
aneurysms. They can clearly identify abnormal arterial formations, 
but are less sensitive when more detailed information is required 
(von Kodolitsch, 2004) 
 Transthoracic echocardiography (TTE) can also provide 
suggestions of aneurysmal problems, but due to the limited 
coverage it provides it is not comprehensive enough for a full 
evaluation (Shiga, 2006). Transoesophageal echocardiography 
(TOE) has more value, especially if the aortic root and the aortic 
valve are the areas that the clinician is interested in, however it is a 
relatively invasive procedure, so is not used as a matter of routine 
(Holloway, 2011) 
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 CT scanning is currently the most widely employed technique for 
the study of the thoracic aorta (Di Cesare, 2016). The speed, 
convenience and precision of the technique give it an advantage 
over the other scanning methods. One drawback of CT scans is 
the amount of radioactive dose exposure that is involved. This 
makes repeat scanning, especially in younger people, a particular 
concern (Pearce, 2012). 
 Magnetic Resonance Imaging (MRI) scanning has a similar, or 
perhaps greater, capability to CT scanning when comparing 
sensitivity and specificity of diagnostic images. It also has less of a 
radioactivity burden, making it preferable in younger patients or 
patients who may require multiple scans. Some weaknesses of 
MRI scanning are that the patient may feel claustrophobic in the 
scanning machine, the processing times for scans is longer and 
the presence of metal artefacts, such as aortic stenting or a 
pacemaker, can result in suboptimal images (Holloway, 2011). 
Figure 2.15 shows an example of a CT scan with a large ascending aortic 
aneurysm indicated. For more details on imaging and aortic measurements 
see McComb (2016), who discusses reference values for treatment and 
normative sizes of aortic diameter. McComb found that while smoking did not 
appear to affect the diameter of an aorta, increasing age, male gender and 
increasing body surface area were all associated with a broadening of the 
artery. 
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Figure 2.15: CT scan showing a 7.5cm×8.3cm ascending thoracic aortic 
aneurysm. A indicates ascending; D, descending (Isselbacher, 2005. 
Reproduced with permission, copyright Circulation, AHA Journals 2005). 
When a patient has been diagnosed as having a thoracic aortic aneurysm, it 
may not be appropriate to treat the malformation straight away as the risks of 
a poor outcome from an invasive surgery could be larger than the risks 
posed by the aneurysm itself. Many patients who have aneurysms therefore 
do not undergo immediate surgery, but are rather put under surveillance so 
the growth rate of their aneurysm can be monitored, and appropriate medical 
treatment given (Davies, 2002). 
Size thresholds for patient monitoring and treatment vary based on various 
factors including age, body mass, ethnicity, the position of the aneurysm, 
aortic valve pathology and the presence of congenital disorders. Typically, a 
proximal thoracic aortic diameter of 3.5 cm is considered dilated and would 
require a follow up scanning regime to monitor potential growth (Wolak, 
2008).  
Current guidelines (Hiratzka, 2010) advise that in patients who have no 
genetic co-morbidities, surgical intervention should be administered for 
ascending thoracic aortic aneurysms when they reach 5.5 cm in size. In 
patients who have a genetic disorder, such as Marfan syndrome, the 
threshold for surgical intervention is set lower, at 5 cm.  These guidelines are 
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based on data showing that at these sizes the risk of complications following 
an aortic rupture increases beyond the risk of complications from the surgical 
intervention, making the surgery preferable. Figure 2.16 illustrates the risks 
of rupture or dissection for increasing size of the ascending aorta, the ‘hinge 
point’ for greatly increased risk can be seen at 6cm, supporting the current 
strategy for intervention. 
 
Figure 2.16: Illustration of hinge points for lifetime risk of rupture or 
dissection at various sizes of the ascending aorta (adapted from Coady 
(1997) in Elefteriades, 2010. Reprinted from Journal of the American College 
of Cardiology, Copyright (2010), with permission from Elsevier). 
 
2.3.11  Treatment 
2.3.11.1 Surveillance 
Patients who have been diagnosed with a thoracic aortic aneurysm, but do 
not yet meet the criteria for surgery and have been placed under surveillance 
(see Section 2.3.9), do not constitute the target population of the following 
study. However, it is instructive to note the various types of medical advice 
56 
 
which is often given to these patients, along with regular scans to monitor 
aneurysmal growth. 
Aneurysmal patients often have concomitant coronary disease, or other co-
morbidities including respiratory illnesses, high blood pressure and high 
cholesterol. The possibility of surgery at some point in the future means that 
these patients should aim to be in their optimal physical condition. If patients 
can positively modify their lifestyle to take exercise regularly, eat healthily, 
moderate alcohol intake and stop smoking (where applicable), this will 
increase their chances of having successful surgery if and when their 
aneurysm requires intervention (Smith, 2006). 
 
2.3.11.2 Surgery 
The indications for different types of surgical treatment depend on the 
location of the aneurysm and the presence of simultaneous disease in either 
the aortic valve or the arteries of the heart.  
In general terms, there are two approaches: open surgery and endovascular 
surgery. These are covered in more detail in the following sections. 
 
2.3.11.3 Open heart surgery 
Historically, open surgery has been used to treat aneurysms located in the 
root, ascending and arch segments of the aorta. This involves making an 
incision in the sternum, opening the ribcage and using medical prostheses to 
replace the dilated segments of the aorta.  
As mentioned above, patients who present with proximal thoracic aortic 
aneurysms often need secondary treatments for additional medical issues. 
Procedures that may be performed together with the aneurysm repair 
include: coronary artery bypass graft surgery (Eagle, 2004), valve 
replacement or repair (Nishimura, 2014), repair of cardiac septal defects 
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(Warnes, 2008), closure of vascular fistulas, and ablative therapy for 
arrhythmias (Calkins, 2007).  
Over the years, several different styles of operation have been popularised 
including: the Bentall procedure (Bentall, 1968), or the Cabrol procedure 
(Kourliouros, 2011) where the aortic valve, aortic root and ascending aorta 
are all replaced; aortic valve sparing treatments, where the proximal aorta is 
diseased, but the valve does not require treatment (David, 2012); and 
‘elephant trunk’ procedures (Svensson, 2004), where the aortic arch is 
replaced with a prosthesis that extends down the aorta, making it accessible 
for an either planned or probable subsequent secondary operation to repair a 
more distal aneurysm. 
 
2.3.11.4 Endovascular surgery 
Historically, endovascular surgery, or endovascular aneurysm repair (EVAR), 
has been used to treat aneurysms located in the descending and 
thoracoabdominal segments of the aorta. These procedures involve a more 
minimally invasive approach with a surgical incision through the groin. 
Catheters and guidewires are then used to deploy a prosthesis that replaces 
the affected area of the aorta (Moll, 2011).  
Recently, investigators have suggested that endovascular treatments may 
become more popular with operators treating the proximal aorta as 
techniques, materials and the understanding of aneurysmal disease continue 
to advance (Klonaris, 2016; Harky, 2018) 
 
2.3.12 Adverse treatment outcomes and post-operative 
care 
2.3.12.1 Likelihood of adverse surgical outcomes  
Patients who undergo open proximal aortic surgery have a relatively high risk 
of operative mortality. They are also at risk of life-changing complications 
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such as stroke or neurocognitive deficit, as well as other undesirable 
outcomes such as reoperations, infections, respiratory failure and changes in 
voice such as hoarseness or differences in tone (Hiratzka, 2010).  
Reported operative mortality rates rise as the invasiveness of the procedure 
increases, expected mortality rates are summarized below: 
 Patients who receive valve-sparing root replacements (‘David’ 
procedures, see Section 2.3.10.3) tend to be younger and have 
better overall health. Correspondingly, in-hospital mortality rates 
have been reported around 1% to 1.5% (David, 2007; Patel, 2008; 
Svensson, 2007a) 
 In procedures where the aortic valve is bicuspid and the ascending 
aorta is replaced, Svensson (2007a, 2007b) reports a risk of 
operative mortality of 1.5%.  
 Composite valve grafts and valve replacement with ascending aortic 
repair carry an operative mortality risk of between 1% and 5% 
(Crawford, 1989; Svensson, 2000).  
 In arch replacement operations, a risk of death between 2% and 6% 
has been reported (Kazui, 2007; Sundt III, 2008; Spielvogel, 2005) 
 Cases where the patient is returning for a reoperation on their aorta 
also carry with them some additional risk. Operative mortality rates 
for these patients are reported as being between 2% and 6% 
(Hirose, 2004). 
Factors other than how invasive the operation is are also strongly associated 
with increased operative mortality, these include emergency priority, 
advancing age, concomitant cardiac disease and patient comorbidities such 
as renal dysfunction, poor lung function or irregular heart rhythms (Bashir, 
2016).  
Although rare, it should be noted that spinal cord injuries such as paraplegia 
can occur in these patients as a result of malperfusion. Paraplegia and 
paraparesis are usually associated with aortic dissection and circulatory 
arrest, but is reported to occur in approximately 1% to 3% of thoracic aortic 
aneurysm patients (Hiratzka, 2010; Sundt, 2004). 
59 
 
Permanent stroke complications are reported as occurring in between 2% 
and 8% of cases (Svensson, 2002; Svensson, 2007a). Protecting the brain is 
a key consideration when operating with cardiopulmonary bypass or 
circulatory arrest techniques (see Section 2.3.11.2). 
Reoperation for bleeding is more common in the more difficult surgeries, this 
increased difficulty can increase the time a patient spends under 
cardiopulmonary bypass. Zehr (2004) and Motomura (2008) report rates of 
between 1% and 6% of this complication in their comprehensive series.  
Motomura (2008) also reports an incidence of superficial infections of around 
1% to 5% and a rate of less than 1% for more serious infection. 
Contamination, patient obesity or lung disease may be contributing factors. 
Respiratory failure can occur in around 5% to 15% of patients. Standard 
tests for lung function can be carried out preoperatively to alert healthcare 
providers to the risks of this happening on a patient-by-patient basis 
(Hiratzka, 2010).  
Changes to the voice can occur when the left recurrent laryngeal nerve 
(which loops under the aortic arch) is damaged during surgery. Reported 
occurrences of this complication differ, as do the length of time for healing, 
but rates could be as high as 30% in patients who undergo arch surgery 
(Ishimoto, 2002; Mulpuru, 2008) 
 
2.3.12.2 Immediate post-operative care  
The exact configuration of post-operative care will depend on the type of 
operation performed and the physical condition of the patient. All surgical 
patients would typically be admitted to an intensive care unit where their vital 
signs, peripheral pulses, urine output and neurological status (including lower 
extremity sensation and strength) can be monitored (Hiratzka, 2010).  
Patients who have undergone open surgical repair for aneurysmal disease in 
the root, ascending or arch segments of the aorta will have had a median 
sternotomy incision (a vertical surgical cut made with a scalpel down the 
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centre of the chest, that allows surgeons access to work on the heart and 
aorta, see: Julian, 1957), this will need particular attention in order to avoid 
infection.  
Cardiopulmonary bypass (CPB), where the circulation of oxygenised blood 
throughout the body is performed by a machine (Gravlee, 2008), is also a 
requirement for these procedures. The CPB technique carries with it the risk 
of patients suffering from post-operative fluid retention, electrolyte 
abnormalities, coagulopathies and hypothermia. Furthermore, patients who 
undergo repairs of their aorta that go beyond the root and ascending 
segments into the aortic arch are likely to have been subjected to a period of 
circulatory arrest and cerebral perfusion. When a patient is put into 
circulatory arrest, their body is cooled and blood flow to the brain is stopped 
whilst the surgery on the blood vessels that supply the brain takes place 
(Ziganshin, 2013; Tian, 2013). The surgical team will then continue to send 
oxygenated blood to the brain using a cerebral perfusion strategy. The 
additional cooling of the body, circulatory arrest and cerebral perfusion 
strategies in these cases can lead to postoperative brain injuries, so 
appropriate monitoring of the patient is required. 
After patients are transferred from the intensive care unit onto a general 
ward, care is based around management of pain, helping the patient from 
their bed to getting around more normally, physiotherapy and monitoring their 
surgical wounds.  
Upon discharge, patients and their families are advised on the importance of 
taking the appropriate medication, taking good care of their sternal wound 
and the need for regular outpatient follow-up. They are advised about the 
signs and symptoms of infection (redness, swelling or fever) and who to 
contact in case of any pain, unusual sensations and weakness or dizziness 
(Hiratzka, 2010). 
 
61 
 
2.3.12.3 Post-surgery lifestyle and healthcare 
Lifestyle goals for patients who have had surgery on their proximal aorta 
should include: 
 Maintaining an ideal body weight with regular low-impact aerobic 
exercise such as walking, tennis, golf or bike riding 
 Eating a low-fat and low-salt diet to keep blood pressure under 
control  
 Avoiding smoking tobacco or using stimulant drugs such as cocaine 
or amphetamines, as sudden increases in blood pressure could 
cause serious  problems in the aorta (Eagle, 2002) 
 Lifting heavy weights, or doing other forms of strenuous isometric 
exercise should be avoided for similar reasons of sudden increases 
in blood pressure (Hatzaras, 2007) 
 More ‘extreme’ sports where there is a risk of trauma or stress to the 
chest (such as rugby, skiing or mountain biking) should be avoided 
(Nataf, 2006) 
 Routinely taking prescribed medication 
These are some generalised points to consider that are further refined on an 
individual basis. Patients should be able to continue to work in most 
occupations, but in a similar way to their lifestyle choices, jobs where heavy 
lifting or hard manual labour is required may trigger serious problems with a 
diseased or prosthetic aorta (Elefteriades, 2003). Patients should try to avoid 
putting themselves at risk in this way.  
Patients who have aortic disease usually require active healthcare 
monitoring throughout the rest of their lives, regardless of what their 
treatment has been. This monitoring is a combination of treatment 
assessment, updated ideas about where the patient’s care may be heading 
in future, and scans or imaging of the patient’s aorta that can identify further 
aneurysmal growth (Erbel, 2014). 
Clinical follow-up typically occurs more frequently in the first 12 months after 
surgery, with checkups at 1 month, 6 months and 12 months post-surgery 
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(Isselbacher, 2005).  After this, if all is going well, scans and checkups may 
occur every 24 months or at the surgeon’s discretion.  
Patients who undergo aneurysmal surgery in the NHS are automatically 
invited to attend a post-operative cardiac rehabilitation course. The 
rehabilitation course is an affiliated national programme which patients can 
attend approximately 6 weeks after their operation. Patients are referred to 
their local hospital or community health centre for meetings with a 
specialised rehabilitation team who aim to help them achieve a healthy, 
active lifestyle and lower the risk of future heart problems. Many studies from 
international teams have found beneficial links for patients who attend these 
courses (Lindsay, 2003; Hedbäck, 2001; Williams, 2006). 
 
2.4  Health-related quality of life 
2.4.1  History and concept development 
2.4.1.1 Quality of life 
The term “quality of life” (QoL) has its origins in research conducted in the 
1930’s, but awareness and relevance of the term saw an increase in the 
aftermath of the Second World War (Pinto, 2017). It gained notable 
acceptance during the 1960’s and 1970’s as a socio-political goal proposed 
by policymakers for members of society to strive towards. Common usage 
began following a speech by the US President Lyndon B. Johnson in 1964 
where he contrasted the objective of wealth acquisition with what he seemed 
to consider a nobler aim, an improvement in QoL: 
“These goals cannot be measured by the size of our bank 
balance. They can only be measured in the quality of the lives 
that our people lead. [Americans] need a chance to seek 
knowledge and to touch beauty – to rejoice in achievement and 
in the closeness of family and community, and this is not an 
easy goal. It means insuring the beauty of our fields and our 
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streams and the air that we breathe. It means the education of 
the highest quality for every child in the land. It means making 
sure that machines liberate men instead of replacing them. It 
means reshaping and rebuilding our cities to make them safe, 
and make them a decent place to live. Yes, it means all of these 
things and more – much more”. (Johnson's Address at Rally in 
the Garden). 
QoL as expressed in these terms involves not only health and heathcare, but 
acknowledges a wide-ranging and diverse mixture of influences including 
politics, economics, environment, housing and architecture, employment, 
income, social networks and recreation. In more recent decades, these 
socio-environmental factors have become characterised as ‘social 
determinants of health’ and several models have been produced to illustrate 
how the organisation and distribution of economic and social resources 
influences the quality of people’s lives. One of the most widely used models 
is Dahlgren and Whitehead’s ‘rainbow model’, formulated in 1991 (see 
Figure 2.17. This model attempts to map the relationship between the 
individual, their environment and health (Dahlgren & Whitehead, 1991; 
Raphael, 2006). 
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Figure 2.17: The Dahlgren-Whitehead ‘rainbow model’ of health 
determinants (adapted from Dahlgren and Whitehead, 1991. Image 
reproduced with permission from the Institute for Future Studies). 
The extensive range of influences contained within QoL make it, at the very 
least, “a multi-level and amorphous concept” (Brown, 2004), with the result 
that there is no single accepted definition of QoL, even as its use has 
become commonplace in the last few decades throughout medical research 
and beyond (Barcaccia, 2013a). 
In some respects, QoL suffers from its own abundance of possibilities. 
Scanlon (1993) suggests three interrelated questions that may contribute to 
the understanding of the concept:  
 “What kinds of circumstances provide good conditions under which 
to live? 
 What makes a life a good one for the person who lives it? 
 What makes a life a valuable one?” 
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These questions could also be asked from a number of different 
perspectives: the individual person, an interested or caring third party, an 
official in charge of allocating resources or from a larger societal/population 
perspective. It may therefore be understandable that a clear, shared 
conception of the methods and tools required to improve or sustain the value 
of a person’s existence has not yet been reached. 
Gasper (2010) argues that QoL should be understood as an umbrella term 
that covers many different meanings, as it “refers to an evaluation (an 
evaluative judgment) about selected aspects or the entirety of a life situation 
and that it doesn’t refer to one unitary or objective entity”. Although the 
nebulous nature of QoL definitions is in part due to these “evaluative 
judgment[’s]” being individual and subjective, some researchers have argued 
that objective judgments should also be included (Meeberg, 1993; Cummins, 
2005). 
For example, QoL has been defined as ‘‘an overall general well-being that 
comprises objective descriptors and subjective evaluations of physical, 
material, social, and emotional well-being together with the extent of 
personal development and purposeful activity, all weighted by a personal set 
of values’’ (Felce, 1995). 
When such a broad range of characterisations are possible, the study, 
application and interpretation of the concept of QoL requires careful 
consideration about what the term means. It has been suggested that some 
of the confusion around defining QoL is that researchers from different 
disciplines view QoL from different perspectives (Farquhar, 1995), and 
consequently have different purposes (Anderson, 1999). Economists focus 
on how scarce resources are allocated in order to gain benefits (Grabowski, 
1990). Philosophers concern themselves with existential ideas and defining 
what may resemble a ‘good life’ (Ventegodt, 2003). Ethicists discuss how 
health-care decision-making is changing from being led by the concept of 
‘sanctity of life’ to ‘quality of life’ (Weingarten 2007), and physicians 
appropriately concentrate on the health and illness-related dimensions 
(Devlin, 2017).  So with no widely accepted single QoL definition to work 
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with, researchers should specify how they are using the concept within the 
parameters of their own investigations.  
The individual nature of QoL means that the way in which it is measured 
must also be questioned. If a standardised questionnaire is used, can it truly 
be said to reflect an individual’s outlook? Measurements must therefore be 
made using tools and techniques that are proven to be valid, discriminative, 
reliable and responsive to changes in QoL over time (Guyatt, 1993). 
Interpretability of results and reproducibility must also be considered 
(Terwee, 2007).  
Another issue to appreciate when attempting to measure QoL in an 
individual, is how a typical questionnaire will take the fundamentally 
subjective concept of QoL and assemble a series of objective criteria in order 
to assess that individual’s responses. Questionnaire tools used in this 
manner therefore need to be as customised as possible, and incorporate 
subjective experiences through the involvement of the subject group in the 
construction and development of the tool (Carr, 2001). 
The broad, unwieldy nature of the concept of QoL suggests that realising a 
shared, universal understanding of what it is will remain challenging for some 
time (Moons, 2006). However, as QoL results are being increasingly used to 
inform political and economic decisions, these questions of definition, 
measurement, objectivity / subjectivity and shared understanding are more 
than just philosophical concerns. Different situations, alternative definitions 
and diverse points of view could have significant moral and ethical 
consequences (Barcaccia, 2013a). 
 
2.4.1.2 Health status 
QoL was first mentioned in relation to the medical field by Elkington in 1966. 
He highlighted the fact that new technologies, in particular kidney dialysis 
and transplantation, raised new questions for clinicians. Elkington made 
prescient insights that still carry weight today, he understood that medical 
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care was slowly changing and would begin to “focus on patients’ lives rather 
than patients’ bodies” (Sullivan, 2003).The three main issues he raised were 
broad themes drawn from personal experience, concerned with the 
effectiveness of medical care: 
 How does a physician protect the QoL of an individual patient?  
 How can QoL be improved in other patients in the future whilst also 
giving current patients optimal care?  
 Which medical programmes should receive a greater proportion of 
society’s limited resources in order to achieve the best health and QoL 
results for all members of that society? 
Traditionally, the healthcare community was focussed on outcomes based on 
mortality and morbidity, or post-operative changes in the biological function 
that had been targeted by a treatment. Many public health strategies are 
intended to standardise practice and guide improvement projects towards 
areas that can reduce the incidence and prevalence of avoidable deaths, 
strokes, operative infections or other negative outcomes at population level. 
Whilst this approach continues to be fundamental to healthcare and 
important to patients (SCTS, 2019), measuring QoL has seen an increase in 
prominence as medical treatment improves and lives are extended. 
Straightforward measures of mortality and morbidity were no longer seen as 
broad enough in scope to evaluate changes in the health of a population, 
‘healthy life-years’ saw increasing prominence in public health policy and 
research not just ‘additional life-years’ (Bergner, 1985) 
The World Health Organisation (WHO) first defined health in their 
constitution in 1946, and the wording remains the same as of the 48th edition 
published in 2014: ‘‘a state of complete physical, mental and social well-
being, and not merely the absence of disease and infirmity’’ (Grad, 2002).  
The wording of this definition was highly influential for researchers as they 
began to develop tools that were intended to assess patient’s health. Key 
aspects of the WHO definition are the inclusion of psychosocial well-being 
and the emphasis on more than just the absence of disease signalling a 
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move away from the reductionist medical model towards the ‘social 
determinants of health’ (Larson, 1996). 
One of the first attempts to measure and value health was the Health Status 
Index (HSI), devised by Fanshel and Bush in 1970. The HSI was a generic 
measure of health rather than a disease or population-specific measure, and 
the health states it defined were evaluated on a categorical scale. This scale 
was based on value judgements rather than in terms of an economic benefit, 
which was the standard practice at that time (Karimi, 2016). The eleven 
health states that the HSI ranged through from best to worst are as follows:  
 
 Well-being  
 Dissatisfaction 
 Discomfort 
 Disability-minor 
 Disability-major 
 Disabled 
 Confined 
 Confined-bedridden 
 Isolated 
 Coma 
 Death 
 
This early attempt concentrates on describing the physical functioning of the 
body. More recent tools developed for measuring general health status 
include the Medical Outcomes Study Short Form (SF) collection of 
questionnaires (Ware, 1998) and the EuroQoL 5 Dimension (EQ-5D) 
questionnaire (Rabin, 2001). These tools are rooted in the WHO definition of 
health and as such include categories which refer to the responder’s 
psychosocial condition. 
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In 1984 Ware presented a “crude” framework for discussing disease and its 
impact upon a patient’s life (see Figure 2.18). Health status was argued to 
have the following elements, or domains: 
 
 Physiological aspects of disease  
This characteristic is at the center of the framework, because the 
focus of healthcare is curing or managing disease. It is comprised of 
the measurable physiological parameters of the disease such as 
symptoms, laboratory values and therapies.  
 Personal functioning  
This domain is defined as the performance or capacity to perform 
daily tasks, it includes self-care, mobility and other physical activities. 
 Well-being and psychological distress 
The third level of Ware’s personal health status model includes 
psychological effects of disease. This includes negative psychological 
states such as anxiety or frustration, but could also include positive 
changes and improved mental health. 
 General health perception 
This layer of the framework is intended to include how the individual 
perceives their overall health, taking into consideration the three 
previous health domains (physical functioning, personal functioning 
and psychological distress and wellbeing). 
 Social / role functioning 
The outermost layer of the model refers to an individual’s performance 
of their typical roles. This includes employment / schoolwork, ability to 
complete household tasks, or activities within the community. 
Ware presented each domain in the framework as a layer. Each domain was 
hypothesised to have a two-way interaction with the other domains. For 
example, impairments in the performance of tasks (personal functioning) 
may result in frustration or anger (well-being / psychological distress). 
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Conversely, anxiety (well-being / psychological distress) as well as limiting 
some activities such as personal functioning, may also affect an individual's 
immune system (physiological aspects of disease). 
 
Figure 2.18: Ware’s framework for discussing disease and its impact 
(adapted from Ware, 1984. Reproduced with permission from John Wiley 
and Sons). 
In the same paper, Ware attempted to further categorise health status and 
well-being within the domains he proposed. Each framework domain was 
subcategorised into three “operational definitions”, which would allow a 
healthcare professional to summarise a patient’s health status whilst also 
incorporating QoL concepts: 
 
 Diagnostic indicators 
o Blood pressure 
o Forced expiratory volume 
o Neurotic disorder 
 Physical 
o Personal functioning 
o Role functioning 
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o Disability days 
 Mental 
o General positive affect 
o Emotional ties 
o Psychological distress 
 General   
o Self-ratings of health 
o Physical symptoms 
o Psychosomatic symptoms 
 Social   
o Close friendship 
o Social contacts 
o Group activities 
 
As the literature on health status measures developed and acquired 
increased recognition, the term health-related quality of life (HRQoL) was 
introduced.  
 
2.4.1.3 Health-related quality of life 
Kaplan and Bush (1982) referred to HRQoL when introducing the concept of 
‘quality-adjusted life years’ (QALYs).  QALYs are used in NHS cost-utility 
analyses as a measure of the value of a year in full health (Rawlins, 2004). In 
the wake of this, the term HRQoL was embraced by researchers in other 
influential papers (see for example Torrance, 1987) and expanded from 
there. 
Lin (2013) notes that although QoL and HRQoL are often used 
interchangeably, the terms relate to different concepts. QoL is a broad 
concept that considers all aspects of human life, whereas HRQoL narrows 
the focus to concentrate specifically upon the effects of illnesses and the 
impact of healthcare treatments (Barcaccia, 2013b). This distinction is 
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important as it helps to separate out the elements of life that are related to 
how the individual maintains personal health and the wider socio-political 
determinants of health, such as education, home / workplace environment or 
religious / spiritual beliefs (Theofilou, 2012). Even though HRQoL can be 
seen as a subcategory of QoL it is still not an easy concept to define, 
Bowling (1995) asserts that “health-related quality of life is an equally 
nebulous concept”. This persistent difficulty in finding a straightforward 
definition of either QoL or HRQoL may be a consequence of the subjective 
nature of the terms and the wide range of determinants that contribute to 
them. The individualised judgments that underpin both QoL and HRQoL 
indicators are subjective and dynamic, meaning that defining either would 
rely on precisely characterising entities that are by their very nature 
imprecise. 
Several definitions of HRQoL can be found in the literature. Torrance in 1987 
related HRQoL directly to QoL: ‘‘quality of life is an all-inclusive concept 
incorporating all factors that impact upon an individual’s life. Health-related 
quality of life includes only those factors that are part of an individual’s 
health’’. Non-health aspects of QoL, for example economic and political 
circumstances, are therefore not included when considering HRQoL, 
although the appropriateness of these omissions is often disputed 
(Anderson, 1999; Moons 2006) 
Ebrahim’s (1995) definition similarly focuses on the aspects of QoL that are 
affected by health. For example, HRQoL is defined as ‘‘those aspects of self-
perceived well-being that are related to or affected by the presence of 
disease or treatment’’. This definition is sometimes stated in more focussed 
terms, where HRQoL ‘‘is used to identify the sub-set of the important or most 
common ways in which health or health care impact upon well-being’’ 
(Peasgood, 2014).  
A third definition of HRQoL focuses on the value of health. For example, 
HRQoL can refer to the ‘‘values assigned to different health states’’ (Gold, 
1996). These values, or utilities, are used to calculate QALYs and to 
measure the benefits of health technologies. The values used to calculate 
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the QALY are on a scale where zero is equal to dead and one is equal to full 
health. Values less than one are intended to reflect the loss of quality of life 
because of living in ill health. 
One final definition of HRQoL by Hays and Reeve in 2008 used the following 
description: ‘‘how well a person functions in their life and his or her perceived 
wellbeing in physical, mental, and social domains of health’’. “Functions” 
refers to an individual’s behaviours that can be observed by others, while 
“wellbeing” refers to an individual’s internal, subjective feelings and 
perceptions. These feelings and perceptions are not directly observable by 
others. 
 
2.4.2  Quality of life vs. Health status vs. Health-related 
quality of life 
As far back as the 1980’s there were concerns among researchers that the 
three terms were being used interchangeably, and with intentions that were 
indistinguishable from one another (Spitzer, 1987; Bergner 1989). These 
apprehensions around how the terms are defined and used persist in more 
recent publications (Moons, 2004; Karimi 2016).  
The most straightforward distinction to be made is between QoL and health 
status. Ferrans in 1990 recognised that “quality of life is more than health 
status, clinical symptoms, or functional ability… health is only one dimension 
of quality of life”. This is shown by the range of factors influencing the 
definitions that were presented in Section 2.4.1.1. QoL includes many 
elements, such as an individual’s environmental and socio-economic context, 
that are not ordinarily considered to be a part of personal health. So whilst 
QoL is affected by health status, health status only describes a smaller 
subsection of QoL (Michalos, 2004). These two terms therefore describe 
different concepts. 
Understanding and describing the differences between HRQoL and both QoL 
and health status is more of a challenge. This is because some HRQoL 
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definitions are similar to health status, and some are similar to QoL. If we 
consider HRQoL to concentrate on personal functioning and wellbeing, or 
that HRQoL is a subcategorised concept, focusing on the health properties of 
QoL, this does not seem to go significantly above and beyond the concept of 
health status. If we define HRQoL as relating to domains including physical, 
psychological, and social attributes then that is merely a description of 
‘health’, as defined by the WHO. Rather than using disease symptoms or 
biological measurements, performance and wellbeing are used (Wilson, 
1995). This makes it a determinant of health rather than QoL.  
If we view HRQoL as a component of QoL that can be affected by health, it is 
difficult to distinguish it from overall QoL. It would be hard to identify key 
aspects of QoL that are not affected by health in at least some way. It is 
therefore sensible to approach the concept of HRQoL as an indicator of QoL 
derived from the perspective of healthcare; a measurement that contains 
both health status and QoL elements. 
 
2.4.3  Measures of health-related quality of life 
Choice of the most appropriate instrument for assessing HRQoL is 
dependent on the objectives for collecting data, the environment of the 
application, and methodological and practical considerations (Patrick,1989). 
Several different types of instrument are available and a researcher should 
consider these and how they meet the particular requirements of the study in 
question (Fitzpatrick, 1998): 
 Disease-specific 
These tools have been developed to measure perceptions of a 
specific disease or health problem. A wide variety of instruments have 
been developed that are focussed on common healthcare problems. 
For example, the Arthritis Impact Measurement Scale is a self-
administered questionnaire for use in rheumatic diseases (Meenan, 
1980). It contains 45 questionnaire items covering nine dimensions: 
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dexterity, physical activity, mobility, household activities, activities of 
daily living, depression, anxiety, pain and social activities. The 
advantages of this approach are that the tools are more likely to have 
a high clinical relevance and be responsive (see Section 2.4.3.1) to 
any health changes that result from targeted interventions. Because 
the items contained within these tools are designed around diseases, 
patients are more likely to accept and complete them (also refer to 
Section 2.4.3.1) as questions are tailored and thus more relevant to 
their particular circumstances. This specialised approach does 
however have some drawbacks, as it means that aggregated health 
scores cannot be compared with the general population. Also, scores 
cannot be compared across different treatments and diseases, which 
may limit the application of these instruments when carrying out 
economic or population health evaluations. The focused nature of the 
instruments could also prove restrictive if, for example, any new or 
unforeseen side-effects appear that were not incorporated in the 
original tool. 
 Population-specific 
Population-specific instruments are designed to have an application to 
a particular demographic group, such as children or elderly people. 
For example, the Child Health and Illness Profile/CHIP is a tool 
developed for adolescents (Riley, 2004). The advantages of this 
approach are that population-specific instruments can be designed to 
have greater relevance to the group in question. For instance, in the 
case of the children’s CHIP tool, a tailored format such as the use of 
cartoon illustrations rather than text can make these measures more 
accessible. This approach could enable individuals who are not 
typically consulted directly to report on their own health independently. 
Population-specific developed instruments may also be sensitive to 
systematic differences between population groups. The drawbacks of 
this approach are similar to the disease-specific measures, as they 
cannot be compared with any general population health measures 
76 
 
thus making the judgment of treatment efficacy across population 
groups difficult. 
 Dimension-specific 
Dimension-specific instruments assess one specific aspect of health 
status. The most common type of dimension-specific measure is one 
that assesses aspects of psychological well-being such as the Beck 
Depression Inventory (see Beck, 1988). Another commonly assessed 
dimension of outcome in trials of physically ill patients is pain, The 
McGill Pain Questionnaire is an example of a dimension-specific 
instrument developed for use in this way (Melzack, 1975). The 
instrument is based around a series of lists of adjectives that describe 
pain. The patient then selects the adjectives that best describe his or 
her personal pain status, the items chosen by patients are given 
quantities and summed to produce individualised scores for four 
separate aspects of pain experience: Sensory, Affective, Evaluative 
and Miscellaneous. The advantages of tools created using a 
dimension-specific approach are that they typically provide a more 
detailed assessment of a particular dimension of health than that 
given by disease-specific or generic instruments. A further advantage 
is that many of the instruments have been used for many years and in 
a wide range of situations, so there is a large amount of data available 
for comparing and interpreting results. A potential disadvantage of 
these types of tools is that judgments on psychological health were 
often made to assess differences between patients rather than being 
used as outcome measures. Further evidence of how appropriate and 
effective these instruments are for measuring changes over time is 
required and decisions must be made carefully to ensure they are 
sensitive enough to use in the context of a prospective trial 
(Fitzpatrick, 1998). 
 Generic 
Generic HRQoL tools are designed to measure very broad aspects of 
health and are potentially suitable for a wide range of patient groups 
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and the general population. The Medical Outcomes Study Short Form 
(SF-36) questionnaire (Ware, 1992) is one of the most widely used 
generic instruments (Brazier, 1992; Lins 2016). It is a 36-item 
questionnaire that measures health across eight dimensions of 
physical functioning, social functioning, role limitations due to physical 
problems, role limitations due to emotional problems, mental health, 
vitality, pain, and general health perceptions. Patient responses to the 
36 questions are then summed to produce a ‘health profile’ of eight 
scores. The main advantage of generic tools is that they can be used 
in a wide range of healthcare situations. The results are also 
standardised, so they can be used across different patient groups in 
order to assess how effective different treatments or public health 
initiatives are. Generic tool data can be gathered from healthy 
populations in order to generate what may be considered ‘normal’ 
health state information, which can then be used as a comparator for 
different disease groups. However, the broad approach that generic 
tools take means sacrificing a level of detail which can limit their 
effectiveness in patient cohorts with specific disease problems. These 
tools would therefore be potentially less responsive to clinically 
relevant health changes. 
 Individualised 
Individualised measures are instruments in which the respondent 
selects domains that are of concern to them, but that are not 
predetermined by a list of questionnaire items (Ruta & Garratt, 1994). 
For example, the Measure Yourself Medical Outcomes Profile 
(MYMOP) is an individualised measure that allows patients to 
nominate and score two most important aspects of their lives (in the 
order of their importance) that contribute most to their overall QoL 
(Paterson, 1996; Ishaque, 2018). The advantages of this approach 
are that the concerns of the individual patient are addressed, rather 
than a researcher imposing a fixed idea of HRQoL that may not be 
applicable. This means that individualised instruments usually have a 
high content validity (see Section 2.4.3.1). Delivering these types of 
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instrument usually requires a face-to-face interview with the patient, 
and thus are resource intensive. This means that individualised 
measures are not as practical to implement as other types of 
instrument which involve, for example, a self-completed questionnaire.  
 Summary items 
Summary items are measures which ask respondents to summarise 
their HRQoL using a single question or a very small number of 
questions. Since 1974 the General Household Survey for England and 
Wales (see Thomas, 1994) has used two questions that together 
provide an assessment of chronic illness and disability: "Do you have 
any long-standing illness or disability?" and "Does this illness or 
disability limit your activities in any way?”. The advantages of 
summary items are that they are as brief as possible and make the 
least demands on a respondents’ time. This ease of item delivery 
means that it takes much less effort and resources to collect large 
comparative data samples, and regardless of how simple this type of 
measurement is, there is evidence that these items can be valid and 
reliable (Yohannes, 2011). The disadvantages of summary item 
measures are that the limited question scope and response variety 
results in crude results and limits any nuanced analysis of particular 
disease types, especially if only small differences are expected over 
time.   
 Utility measures 
The development of utility measures began in the early to mid-1990’s, 
they grew out of economic theory with the intention of providing an 
estimate of individual patients’ overall preferences for different health 
states (Drummond, 1993; Bakker, 1995). They are similar in scope to 
Generic HRQoL measures but they also incorporate evidence for the 
overall value of health states to society and can be used in cost-utility 
analysis. The EuroQol EQ-5D-5L (Herdman, 2011) consists of five 
items (5D) relating to mobility, self-care, main activity, pain/discomfort 
and anxiety/depression, with five levels of response (5L). On the basis 
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of their responses to the five items, patients are classified into a health 
state with a preference weight attached. Preferences for health states 
are derived from general population surveys using techniques such as 
the rating scale, standard gamble, and time trade-off. An advantage of 
utility measures is that they produce a single index. This helps with 
comparing alternative treatments for different health problems and 
also incorporates the idea of economic evaluation. The EuroQol EQ-
5D-5L in particular is a widely used tool which has been validated in 
many different countries, typically included with the EQ-5D-5L is the 
EQ-VAS (Visual Analogue Scale) which allows respondents to self-
rate their own health on a scale of 0 (worst imaginable health) to 100 
(best imaginable health). Disadvantages are similar to generic 
measures, in that utility measures have a broad focus which make 
focused analysis of particular disease symptoms difficult. 
 
The most useful distinction to make, and the one that is used most often in 
operational applications of HRQoL measures, is between those that are 
generic and hence widely applicable, and those that are specific to particular 
health problems or populations.  
These instruments can be used in a number of applications, including clinical 
trials, economic evaluation and routine patient care. Different forms of 
instrument administration are possible, the main forms being patient or 
researcher completion of paper based questionnaires. Choice of HRQoL 
measure should be based on a number of criteria including certain 
psychometric properties (see Section 2.4.3.1), but also more general issues 
such as the appropriateness of an instrument for a specific application or 
patient cohort. 
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2.4.3.1 Attributes of health-related quality of life 
instruments 
Following the identification of literature pertaining to instruments it is 
important that users apply the necessary criteria to select the most suitable 
instrument(s). As Fitzpatrick documented in 1998, there are eight criteria that 
should be considered in the selection of HRQoL tools: appropriateness, 
acceptability, feasibility, interpretability, precision, reliability, validity and 
responsiveness each attribute is explained in more detail below. 
 
 Appropriateness – Is the HRQoL tool appropriate to the questions 
which the study is aiming to address?  
A researcher must consider the nature of their patient study group, 
which domains of HRQoL are important and if the instruments 
available fit into those parameters (Guyatt, 1991). These 
considerations are often unique to each individual study, making 
objective recommendations about how to select a tool difficult, but 
researchers certainly need to consider how instrument items, scales 
and content will be received by responders (Ware, 1987). Deciding on 
the balance between specific and generic HRQoL instruments within 
the tool is also important. Where possible, both specific and generic 
instruments should be used to measure HRQoL (Cox, 1992; Devlin, 
2010). In this way the most immediate effects of treatment on disease 
should be captured, as well as possible consequences that are harder 
to anticipate. 
 Acceptability – Is the instrument acceptable to patients?  
Indicators of acceptability include how long the tool takes to complete, 
what the response rates are and how complete the data is (Fitzpatrick, 
1998). There are a number of factors that can influence acceptability 
including how the tool is administered, questionnaire design, and what 
the health of respondents is like at the time of completion. What type 
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of HRQoL measure is used can also influence how acceptable it is. 
For example, respondents completing individualised instruments 
usually find it more difficult than completing a pre-determined 
questionnaire (Ruta, 1999). General features of layout, appearance, 
and legibility are considered to be important influences on how 
acceptable a tool is. Language is also an important consideration, the 
instrument must be presented in a language that is familiar to 
respondents (Herdman, 1997). Acceptability issues should be 
considered at the study design stage, incorporating patients’ views 
with pre-testing of the instruments (Sprangers, 1993).  
 Feasibility – Is the instrument easy to administer and process?  
Feasibility means considering how easy the instrument is to 
administer and process. These are important considerations for staff 
and researchers who collect and process the information produced by 
HRQoL measures (Erickson, 1995). Instruments that are difficult to 
administer and process may jeopardise the conduct of research and 
disrupt clinical care. An obvious example of this is the additional 
resources required for patient interviews versus a patient self-
completing a questionnaire. The complexity and length of an 
instrument will also have implications for data collection and analysis.  
 Interpretability – How interpretable are the scores of the instrument?  
Interpretability is concerned with how meaningful the scores produced 
by an instrument are. There are three common approaches to 
interpretation in the literature. First, changes in instrument scores 
have been compared to previous scores produced by the same 
instrument (Testa, 1996). Secondly, attempts have been made to 
identify a minimal clinically important difference (MCID), which is 
presented as being the smallest change in score that is perceived as 
beneficial by patients (see for example Jones, 2005). Thirdly, 
normalised data from the general population can be used to compare 
and interpret scores (Garratt, 1994).  
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 Precision – How precise are the scores of the instrument?  
Item scales within instruments have important implications for 
precision. A binary 'yes' or 'no' is the simplest form of response, but it 
does not allow respondents to report degrees of difficulty or severity. 
The majority of instruments use Likert type scales such as: strongly 
agree, agree, uncertain, disagree, strongly disagree (Sullivan, 2013). 
Visual analogue scales appear to offer greater precision but there is 
insufficient evidence to support this and they may be less acceptable 
to respondents (Fitzpatrick, 1998). The ability to capture the full range 
of HRQoL may vary in different instruments (Gardiner, 1993). Item 
Response Theory (IRT) may be applied to further determine the 
precision of an instrument. IRT assumes that a measurement 
construct, such as physical disability, can be represented by a 
hierarchy that ranges from the minimum to maximum level of disability 
(Lord, 2012). IRT has shown that a number of instruments have items 
concentrated around the middle of the hierarchy with relatively fewer 
items positioned at the extremes (Garratt, 2003). This approach 
allows researchers to understand both the intricacies of a patients’ 
HRQoL and how precise the measurements used are. 
 Reliability – Does the instrument produce results that are 
reproducible and internally consistent?  
Reliability can be seen as the proportion of a HRQoL score that is 
signal rather than noise, or an assessment of how confident 
researchers can be in what the results of the instrument are telling 
them. As the measurement error of an instrument increases, so does 
the sample size required to obtain precise estimates of the effects of 
an intervention (Fitzpatrick, 1998).  
Reproducibility assesses whether an instrument produces the same 
results on repeated administrations when respondents attributes (e.g. 
symptoms) have not changed. This is assessed by test-retest 
reliability (Weir, 2005). There is no exact agreement about the length 
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of time between administrations but in practice it tends to be between 
2 and 14 days (Streiner, 2015). The reliability coefficient is normally 
calculated by correlating instrument scores for the two 
administrations. It is recommended that the intra-class correlation 
coefficient be used in preference to Pearson's correlation coefficient, 
which fails to take sufficient account of systematic error. Reliability 
correlations of above 0.7 and 0.9 are recommended for instruments 
that are to be used in groups and individual patients respectively 
(Fitzpatrick, 1998). 
Internal consistency is measured with a single administration of a tool 
and it assesses how well items within a scale measure a single 
underlying dimension. Internal consistency is usually evaluated using 
Cronbach's alpha, which measures the overall correlation between 
items within a scale (Tavakol, 2011).  
 Validity – Does the instrument measure what it claims to measure?  
Validity can be assessed qualitatively through an examination of 
instrument content, and quantitatively through factor analysis and 
comparisons with related variables. As with reliability, validity should 
not be seen as a fixed property and must be assessed in relation to 
the specific population and measurement objectives (Hays, 2005). 
Qualitative evidence can be obtained from considering how the 
instrument was developed. This includes the extent of involvement of 
experts with relevant clinical knowledge in instrument development 
(Guyatt, 1994). More importantly, consideration should be given to the 
extent of patient involvement (Andersen, 2009).  
Quantitative validity testing typically takes the form of construct 
validation.  Construct validity is assessed by comparing the scores 
that the instrument produces and evaluating how these scores align 
with hypotheses related to the measure. Many instruments are 
multidimensional and measure several domains, such as physical 
functioning, mental health, and social functioning. These domains 
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should be considered when assessing construct validity. Factor 
analysis and principal component analysis can provide empirical 
support for the dimensionality or internal construct validity of an 
instrument (Joliffe, 1992). These statistical techniques can be used to 
identify separate health domains within an instrument (Garratt, 2001). 
 Responsiveness – Does the instrument detect changes over time 
that matter to patients? 
Responsiveness is usually assessed by examining changes in 
instrument scores for groups of patients whose health is known to 
have changed. Alternatively, patients may be asked how their current 
health compares to some previous point in time by means of a health 
transition question. There is no single agreed method of assessing 
responsiveness and a number of statistical techniques are used for 
quantifying responsiveness (Langfitt, 2006).  
 
2.5  Patient reported outcome measures 
2.5.1  Patient-centredness 
The concept of a patient-centred approach to medical care has been 
discussed in the literature since 1969, when Balint began to explore the 
possibilities of “understanding the patient as a unique human being”. The 
idea found popularity throughout the 1970’s as healthcare treatment saw a 
shift from concentrating mainly on the biology of patients (a ‘traditional’ 
diagnosis, to use Balint’s terminology (1970)) to combining biology, 
psychology and social perspectives (an ‘overall’ diagnosis (Balint, 1970; 
Bensing, 2000).  
In 1976, Byrne and Long published a method that sought to categorise a 
medical consultation as either doctor- or patient-centred. They analysed 
1850 general practitioner (GP) patient visits and concluded that the majority 
of doctors had a biological, or traditional, style of interpretation. That meant 
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that they responded to a patient’s condition only through their own frame of 
reference. By the late 1980’s, Stewart and colleagues were developing a 
‘patient-centred clinical method’, with the aim of encouraging more effective 
patient / doctor communication and ultimately improving health outcomes 
(Stewart, 1989; 1995; 2003). 
Over recent decades, patient-centredness in medicine has found an 
increasing number of advocates. Many practical and theoretical advances 
have arisen from studies on patient / doctor communication, such as the 
influential text by Ley in 1988 which found that improved communication led 
to an increase in patient satisfaction and compliance. Mead and Bower 
(2000) attempted to define the concept, and proposed five key dimensions 
that explained how patient-centredness differed from the ‘traditional’ 
biological model. 
 
 Biopsychosocial perspective 
This dimension is a central theme of many papers concerned with 
patient-centredness. It refers to the idea of extending the 
understanding of patient illness to include social and psychological 
factors. Stewart (2003), for example, maintains that a patient-centred 
consultation needs a clinician who has a “willingness to become 
involved in the full range of difficulties patients bring to their doctors, 
and not just their biomedical problems”. According to Grol (1990), a 
patient-centred doctor is one who “feels responsible for non-medical 
aspects of problems''. So the concept of patient-centredness can be 
seen as the widening of the scope of medicine from merely an organic 
disease to a far wider range of “dysfunctional states” (Silverman, 
1987). 
 
 The ‘patient-as-person’ 
This dimension is concerned with understanding the personal 
meaning of the illness for that particular individual. For example, a 
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broken arm may not be experienced the same way by two separate 
individuals, and it is recognised that the medical treatment can be 
experienced differently too (Kaba, 2007). Mead and Bower (2000) 
suggested that this can have many dimensions, one obvious 
contributory factor being the economic instability that a period of poor 
health may produce. In order to develop a complete understanding of 
a patients’ situation, and to provide effective clinical management, a 
doctor “should strive to understand the patient as a distinctive 
personality within his or her unique context.” (Kaba, 2007). 
 
 Sharing power and responsibility  
Rather than focus on the paternalistic mode of healthcare that was 
encouraged in the 1950’s (Parsons, 1991), Mead and Bower (2000) 
suggested a more democratic, equal partnership between doctor and 
patient. This represented a definite shift from a doctor guiding and a 
patient co-operating towards mutual participation in diagnosis and 
treatment. In this way, power and responsibility are shared. Byrne and 
Long (1976) recommend “encouraging the patient to voice ideas, 
listening, reflecting, and offering collaboration”.  
 
 The therapeutic alliance 
Following on from the idea of partnership between doctor and patient, 
the alliance that is built is regarded as having its own intrinsic value. 
Treatment adherence may be increased if there is a mutual 
understanding and concordance based on friendly courteous conduct 
and a sympathetic manner (Wahl, 2005; Martin, 2000). Conversely, a 
negative relationship may produce misunderstandings or errors in 
judgment. A common understanding of the goals and requirements of 
treatment is crucial to any therapy, whether physical or psychological 
(Mead and Bower, 2000).  
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 The ‘doctor-as-person’ 
The final dimension considers the contribution that the doctor as an 
individual makes to the doctor / patient relationship. Balint (1993) 
described the traditional biological model of medical assessment as 
“one person medicine” meaning that the doctor is effectively 
undetectable when a patient’s clinical situation is described. In 
contrast to that approach, patient-centred medicine is portrayed as 
“two-person medicine”, positioning the doctor who is involved as an 
integral component of the healthcare encounter: “the doctor and 
patient are influencing each other all the time and cannot be 
considered separately”. Sensitivity and insight into the reactions of 
both parties can be used for therapeutic purposes (Mead and Bower, 
2000).  
In defining the conceptual framework of patient-centredness (see Figure 2.19 
below), Mead and Bower (2000) also hypothesised a number of variables 
which have the potential to influence the degree of patient-centredness that a 
doctor may exhibit. At the centre of the model is the doctor-patient 
relationship. This relationship is expressed in the form of how the two parties 
behave towards one another, these behaviours are closely related to the five 
key dimensions discussed above.  
The ‘Shapers’ are the external factors that shape the interaction, such as 
cultural norms or clinical experience, and may have an impact upon more 
specific elements such as gender or ethnicity. For example, cultural norms 
relating to gender may mean that it is more socially acceptable for females to 
discuss feelings and emotions than males (Chaplin, 2015). 
The specific professional context of the clinical practice may also have an 
impact on patient-centredness. For example, GP’s may have overall 
knowledge of a disease, but could lack the specific understanding of an 
unusual problem which prevents them from having personal confidence in 
their diagnosis. 
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Finally, Mead and Bower (2000) point out that consultation-level influences 
may have the most immediate impact on the propensity of doctors to be 
patient centred. For example, time or workload pressures may limit 
possibilities for a satisfactory discussion potentially meaning that a treatment 
resolution between the doctor and patient is not possible. The conceptual 
framework presented also explicitly recognises that a doctor’s tendency to be 
patient-centred will vary over time, and that the personal dimensions (i.e. the 
patient-as-person and the doctor-as-person) can require a significant period 
of time to develop. 
 
Figure 2.19: Factors influencing patient-centredness (adapted from Mead 
and Bower, 2000. Reprinted from Social Science & Medicine, Copyright 
(2000), with permission from Elsevier). 
 
2.5.1.1 Communication with healthcare professionals 
Communication skills are fundamental to the idea of a patient-centred mode 
of healthcare, at the turn of the century a consensus statement was released 
by 21 medical communication leaders with the objective of identifying the 
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‘essential elements of communication in medical encounters’ (Makoul, 2001). 
They concluded that there were seven sets of fundamental communication 
tasks that should apply during healthcare consultations: 
 Build the doctor-patient relationship 
 Open the discussion 
 Gather information 
 Understand the patient's perspective 
 Share information 
 Reach agreement on problems and plans 
 Provide closure 
 
A more recent consensus guideline for oncological treatment produced more 
detailed recommendations for doctors who care for adults with cancer 
(Gilligan, 2018). The first key point of ‘Core communication skills’ represents 
a contemporary view of how a skilled doctor may demonstrate the 
fundamental ideas of patient-centred care: 
 
“1. Core communication skills 
1.1. Clinicians should review the patient’s medical information, 
establish goals and anticipate the needs and responses of the patient 
and family.  
1.2. Clinicians should explore the patient’s understanding of their 
disease and set a collaborative agenda with the patient and their 
family 
1.3. Clinicians should use behaviours that actively foster trust, 
confidence and collaboration 
1.4. Clinicians should provide information that is timely and useful to 
the patient. Clinicians should also check that the patient understands 
this information. 
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1.5. When patients display emotion, clinicians should respond 
empathically.” 
Other key communication themes include ‘Discussing goals of care and 
prognosis’, ‘Discussing treatment options and clinical trials’, ‘Using 
communication to facilitate family involvement in care’ and ‘Communicating 
effectively when there are barriers to communication’.  
 
2.5.1.2 Improving patient satisfaction and outcomes 
There is compelling evidence that a patient-centred approach to healthcare 
can improve both patient satisfaction and outcomes. Little (2001) found that 
when GP’s adopted a positive, patient-centred approach (defined with five 
components: ‘Communication and partnership’, ‘Personal relationship’, 
‘Health promotion’, ‘Positive and clear approach to problem’ and ‘Interest in 
effect on life’) that it was significantly associated with patient satisfaction, 
patient enablement (how capable the patient felt in terms of dealing with their 
health problem), a reduction in referral rates and a reduction in symptom 
burden 1 month after their appointment. 
A systematic review of 40 patient-centred care articles (Rathert, 2013) 
reported similarly encouraging results. They reported strong evidence for 
patient-centredness increasing patient satisfaction and having a positive 
impact on patient self-management and adherence to medical instructions. 
However, the impact on clinical and long-term outcomes was more mixed, 
with some studies reporting improvements and some finding no difference. It 
was noted that observing the most important outcomes was a challenging 
task and that future studies would need to be carefully designed to fill that 
gap in knowledge (Rathert, 2013; Donabedian, 1988). 
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2.5.1.3 Patient-centredness in the United Kingdom 
In the UK, policy documents released by the NHS have also increasingly 
highlighted the importance of a patient-centred approach to clinical 
management. Beginning in 2004 with an NHS Improvement Plan subtitled 
‘Putting People at the Heart of Public Services’ (Department of Health, 2004), 
these policy white papers recognised that: “A new spirit of innovation has 
emerged, centred on improving the personal experience of patients as 
individuals, and this is now taking root in the NHS.” 
Subsequent policy documents reinforced this approach, all stating the 
intention of putting patients and their families at the centre of the NHS 
healthcare approach. The language used within these documents and the 
clear intention was to ensure that the design, delivery and evaluation of 
services become responsive to the needs and priorities of NHS users. In 
2005, another NHS policy white paper titled ‘Creating a Patient Led NHS’ 
acknowledged that patient-centredness was not merely a small adjustment to 
current practice, but “a fundamental change in our relationships with patients 
and the public… [T]o move from a service that does things to and for its 
patients to one which is patient-led, where the service works with patients to 
support them with their health needs.” 
This shift in focus, along with a continued commitment to present “An NHS 
that gives patients and the public more information and choice, works in 
partnership and has quality of care at its heart.” (Department of Health, 
2008a), positioned PROMs as a fundamental means of assessing 
effectiveness of care from the patient’s perspective: “This means 
understanding success rates from different treatments for different 
conditions. Assessing this will include clinical measures such as mortality or 
survival rates and measures of clinical improvement. Just as important 
is…the patient’s own perspective which will be measured through patient-
reported outcomes measures (PROMs)” (Department of Health, 2008b) 
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2.5.2  What are patient reported outcome measures? 
PROMs are health-related questionnaires which aim to determine patients’ 
views of their health symptoms, their functional status and their HRQoL. This 
is achieved by patients completing a PROM both before and after their 
treatment. (It is important to note that PROMs are not the same as PREMs 
(Patient Reported Experience Measures), PREMs focus on aspects of the 
humanity of care, such as being treated with dignity or being kept waiting 
(LaVela, 2014)).  
Nelson (2015) identified five types of healthcare structure or situation that 
may benefit from the use of PROMs, along with stating what those benefits 
are:  
 Type 1: A health system 
o Deliver patient-centred aspects of performance assessment 
o Determine value for money 
 Type 2: Healthcare providers 
o Benchmarking PROM performance between providers (in the 
NHS, this could indicate a utility for commissioners) 
o Can be used as a gateway to quality improvement 
 Type 3: Clinical trials 
o Screening. Identifying patients who may be at a higher risk of 
suffering post-operative complications 
o Can be used as evidence for differences in treatment outcome 
 Type 4: Clinical practice 
o Have the potential to assist medical diagnosis 
o Can be used to monitor patient progress post-treatment 
 Type 5: Information for patients or clinicians 
o Have the potential to influence choice of provider 
o Have the potential to influence choice of treatment 
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The routine use of PROMs is in keeping with the national promotion of 
patient-centredness. PROMs are a vital component in signifying the shift 
away from traditional biological health evaluations towards the 
biopsychosocial model (see Section 2.5.1). Black (2013) notes that the aim 
of most healthcare is to reduce symptoms, minimise disability and improve 
QoL, and that these are aspects which can be assessed only by patients. 
Patients often welcome being involved (Cox, 2007) (but not always, see 
Levinson 2005), and when patient do experience strong involvement, this 
has been shown to have benefits not just to patient health but also to 
healthcare institutions (Delaney, 2018). Considering patients’ views also 
increases public accountability of health services and clinicians (Black, 
2013). 
 
2.5.3  Patient reported outcome measures in practice 
Following on from the NHS policy reconfigurations detailed in Section 
2.5.1.3, the first nationwide use of PROMs took place in 2008. This took the 
form of a voluntary audit of mastectomy and breast reconstruction patients 
(Jeevan, 2014). After the delivery of this programme had been established as 
feasible, a UK programme for PROMs in four elective surgeries was 
established. From April 2009 to October 2017 it was mandatory for all NHS 
providers who treat patients undergoing hip or knee replacement, groin 
hernia repair or varicose vein surgery to invite patients to complete a PROM 
questionnaire before and after their surgery. After a review of the national 
PROM programme took place during 2016, collection of groin hernia repair 
and varicose vein PROMs ceased in October 2017 while the collection of 
PROMs for hip or knee replacements is ongoing. The invitation to participate 
in PROM research typically happens in the pre-assessment clinic or on the 
day of admission. Black (2013) describes the content and process of PROM 
delivery: 
 
“The preoperative questionnaire collects data on the patient’s 
sociodemographic characteristics, the duration of their 
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condition, their general health, any comorbidities, and whether 
they are undergoing a repeat/revision procedure. In addition, 
they are asked to complete a disease specific PROM…and a 
generic PROM...Patients who complete a preoperative 
questionnaire are mailed a postoperative questionnaire…Non-
responders receive one reminder letter. The questionnaire 
includes the same PROMs as the preoperative one plus single 
transitional items on their overall view of the result of surgery 
and the extent of any improvement. They are also asked to 
report on adverse outcomes (complications, readmission, and 
further surgery).” 
 
Initial response rates to this initiative were encouraging, with around 131 250 
eligible recruitments out of 245 220 eligible patients (54%) over the second 
year of delivery. These rates did vary from around 63% recruitment in the hip 
and knee replacement patients to around 38% for varicose vein surgery 
(Hutchings, 2014).  
For these nationally mandated PROM returns, returned patient data is linked 
to data collected from Hospital Episode Statistics (see Herbert, 2017). This 
link allows a match between the PROM data and a systematically reported 
NHS admissions dataset. The link permits a more wide-ranging analysis 
upon a set of demographic, diagnostic and procedural information. The NHS 
providers of the elective surgery in question are identified and the change in 
PROM results is adjusted for case mix (Nuttall, 2015). In this way different 
healthcare providers can be compared to each other, and assessments can 
be made at a national level to identify any outlying institutions.  
 
2.5.3.1 National PROM pilot for revascularisation 
Between November 2011 and January 2013 in 11 English hospitals 
specialising in cardiac care, a pilot study was performed to assess the 
feasibility of delivering PROM instruments to patients who had undergone 
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coronary revascularisation. The patients may have undergone either cardiac 
surgery or a percutaneous coronary intervention (PCI). The main PROM 
instrument used for collecting pre- and post-procedure HRQoL data was the 
Coronary Revascularisation Outcome Questionnaire (CROQ; Schroter, 
2004), a psychometrically validated patient based measure which as well as 
novel items contains items borrowed and modified from the Seattle Angina 
Questionnaire (Spertus, 1995), the Quality of Life after Acute Myocardial 
Infarction questionnaire (Valenti, 1996), the Angina Impact Questionnaire 
(Wilson, 1991), the SF-36 (Ware, 1992), the Menorrhagia Outcomes 
Questionnaire (Lamping, 1998a) and the Prostate Outcomes Questionnaire 
(Lamping, 1998b). 
Official documentation regarding the outcomes of this pilot remain 
unpublished, but preliminary conclusions were that patient response rates 
were comparable to the nationally mandated PROM programmes at 61%, 
although there was considerable variability between hospitals the highest 
being 87% and the lowest 41% (unpublished National Cardiac Benchmarking 
Collaborative data). Early recommendations included the need for staff to 
have specific time allocated in order to administrate the PROM. 
 
2.5.4 Experience of using patient reported outcome 
measures 
In addition to the UK PROM approach, literature has been published 
describing experiences of PROM programmes from many international 
groups including Australia, Canada, Sweden, the Netherlands and the United 
States (Meehan, 2006; Cranley, 2004; Kettis-Lindblad, 2007; Haverman, 
2011 and Crandall, 2010).  
The perceived value of PROMs data varies in different settings and 
specialities, but in broad terms healthcare professionals do find value in 
PROMs, particularly in situations where they are useful for supplementing 
the clinical decision making process (Boyce, 2014). More specifically, studies 
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which reported positive aspects of  PROMs found that they improved 
clinician’s ability to assess the severity of patient symptoms (Crane, 2007; 
Berry, 2011), informed treatment decisions (Ayers, 2015) and enabled 
tracking of both treatment outcomes and general health and wellbeing over 
time (Forsberg, 2015; Katzan, 2011).  
However, implementing PROM collection as a routine part of a healthcare 
pathway is not without challenges. Logistical concerns related to the extra 
workload placed on the staff administering the questionnaires and analysing 
and interpreting the subsequent data are often expressed (Miller, 2015; 
Franklin, 2015). Also, as technology continues to advance with service users 
beginning to expect quick, easy access to important healthcare information 
over the internet or on their mobile devices, PROM delivery needs to develop 
to meet these raised expectations (Lavallee, 2016). This prompts questions 
around the most informative and appropriate way to deliver PROM results 
(Kroenke, 2015) and the best way to tackle any legal or regulatory 
requirements in collecting and storing PROM data (Petersen, 2015). 
 
2.5.5 Health-related quality of life and patient reported 
outcome measures in aortic surgery 
A recent review of QoL papers focussed on patients undergoing surgery on 
their thoracic aorta (Jarral, 2015) found thirty relevant studies in the 
literature, however only twelve of these were focussed on the proximal aorta, 
and they included patients who had aortic dissections as well as elective 
aneurysm presentations.  
Of the twelve which concentrated on the proximal aortic segments, seven 
included patients who underwent different forms of isolated aortic root 
replacement (Akhyari, 2009; El-Hamamsy, 2010; Franke, 2010; Golczyk, 
2010; Khaladj, 2009; Lehr, 2011; Perrotta, 2010). These typically 
demonstrated a follow-up HRQoL that was comparable to healthy members 
of the general population. El-Hamamsy (2010) found an improvement in 
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physical functioning for patients who received a Ross procedure rather than 
a homograft, while Franke (2010) reported a superior HRQoL in all domains 
for patients who received a David procedure rather than a composite root 
replacement. 
Four more studies reported outcomes after a mixture of different proximal 
aortic operations and again reported an acceptable HRQoL following surgery. 
Lohse (2009) concentrated on aneurysms within the ascending aorta, 
including concomitant aortic valve replacements, David, Bentall and Cabrol 
procedures, while Oda (2004) was interested in how more elderly patients 
(>65 years) coped with the impact of aortic surgery. Song (2012) examined 
patients with Marfan’s syndrome and reported the differences in HRQoL 
between elective aneurysmal surgery and emergency type A dissections, the 
study found emergency surgery to be a significant predictor for impaired 
long-term HRQoL and reoperations. Another study by Stalder (2007), 
including both aneurysmal and dissection patients, identified the use of deep 
hypothermic circulatory arrest as a predictor of an impaired long-term deficit 
in physical functioning. 
Two further studies described HRQoL outcomes after the surgical repair of 
type A dissections. Campbell-Lloyd (2010) reported a reasonable long-term 
survival rate and a HRQoL that was similar to that of healthy individuals in 
the general population, while Nakamura (2011) reviewed a small number of 
patients with cerebral malperfusion and demonstrated an initial improvement 
in functional status after surgery along with further improvement at follow-up. 
 
2.6 Summary 
The purpose of this review was to define and describe the pathology of 
proximal TAA and related diseases, to explore the concept of HRQoL and to 
examine the role of PROM instruments in how they record and report 
patients’ experiences of treatment. The further intention of this chapter was 
to determine whether there was an existing, disease-specific, patient-based 
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questionnaire that is appropriate for measuring HRQoL and health status in 
patients undergoing surgical treatment for proximal TAA disease.  
 
While there are useful instruments that have been used in similar clinical 
settings, and general health tools that have been used in similar patient 
populations, there was no single PROM instrument found that was 
appropriate for the measurement of HRQoL in a proximal TAA population. 
Subsequent chapters therefore describe the development and pilot of a new 
instrument designed to measure patient-based outcomes in these patients. 
Where possible, items from existing questionnaires reviewed in this chapter 
were considered for inclusion. 
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Chapter 3 
Methodology 
 
3.1  Introduction 
The following chapter explores the philosophical and methodological 
framework for the development of a PROM tool aimed at patients who 
undergo elective surgical treatment for a proximal aortic aneurysm. The 
previous chapter highlighted the limited research that has been undertaken 
so far in this subject area. Considering the cost of performing major aortic 
surgery (Mishra, 2008), and the lack of evidence to date for the effectiveness 
of this surgery in terms of HRQoL and psychosocial recovery, this was 
considered an important area for further investigation. 
 
3.2   Content of this chapter  
Briefly, the main sections of this chapter will be: 
 A summary of PROM methodology and an outline of the current 
research study problem 
 An exploration of the pragmatic philosophy and theory that will 
underpin the research methodology 
 An outline of the aims of the research study 
 A rationale for gathering both quantitative and qualitative data, with 
associated research questions, descriptions of the types of data 
collected and the associated analytical approaches 
 A discussion and definition of mixed methods research, including a 
categorisation and description of the type of mixed methods design 
used 
 A research map 
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3.3   PROM methodology 
The United States Food and Drug Administration (US FDA) centre have 
provided detailed guidance for PROM development (US FDA, 2006). They 
identify four main phases that should typically occur during instrument 
development, illustrated in Figure 3.1: 
 
Figure 3.1: The PROM instrument development and modification process 
(adapted from the US FDA guidelines document, 2006) 
 
3.3.1  Identifying concepts and developing a conceptual 
framework 
An appropriate, clearly defined conceptual framework is a ‘fundamental 
consideration’ in PROM development (US FDA, 2006). Concepts and 
domains are generally chosen based mainly on patient interviews, along with 
expert opinion and literature review (see Rothman 2007 and Grady 2015 for 
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commentary and examples). It is also important at this early stage to clarify 
how the PROM is going to be applied; some PROM instruments are used to 
assess outcomes in clinical trials (Vodicka, 2015), while others evaluate 
treatment benefit (Schäfer, 2010; Nilsdotter, 2003) or monitor adverse events 
(Banerjee, 2013; Absolom, 2017). The intended patient population also 
needs to be identified, with particular considerations made towards the 
impact of the targeted disease and demographics such as age, sex, ethnicity 
and cognitive ability (Ju, 2017; McKenna, 2011).  
 
3.3.2   Creating the PROM instrument 
Items included in the PROM instrument can be generated from analysing 
interview transcripts (with patients, medical experts, family members or other 
stakeholders), reviewing the literature or focus group discussions (US FDA, 
2006). Item generation should always be undertaken with the involvement of 
appropriate patients (see Marcovitch 2017 and Kingsley 2017). The way in 
which the PROM data is to be collected also requires clarification. Any 
special considerations around instrument administration procedures (such as 
interviewer instructions, instructions for self-administration or electronic / 
web-based / IT system requirements) need to be finalised at this stage. 
Malhotra (2016) reports a successful experience of using electronically 
delivered PROM instruments, and Hewlett (2016) highlights another 
secondary issue concerning the translation of PROM items into different 
languages. 
The delivery strategy must also be reflected upon and tailored correctly. For 
example, if a patient should not expect to recover from their treatment until 
six months afterwards, sending a PROM instrument at two months would be 
incongruous. Similarly, if it is decided that more than one post-operative 
PROM is required then this must be balanced against a likely reduction in 
response rates (see Wood (2016) for a more detailed discussion on PROM 
response rates).  
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Instrument formatting, accompanying letter structure and decisions on item 
visualisation should also occur during this phase. Study resources should be 
assessed in order to ensure PROM delivery, data entry and data storage 
elements have the necessary capability. Scoring algorithms need to be 
finalised and the working version of the PROM instrument should be 
confirmed (US FDA, 2006). 
 
3.3.3   Assessing the measurement properties 
Lohr (2002) provides a detailed summary of the attributes and criteria that a 
PROM instrument should possess in order for it to be considered useful. 
PROM reliability, validity, responsiveness (or the ability to detect change) and 
interpretability (including a minimally important clinical difference) all need to 
be assessed and evaluated to determine its appropriateness for delivery. 
These attributes have already been discussed in some detail in Section 
2.4.3.1. 
For further insight into assessing PROM reliability and validity see Bolarinwa 
(2015), who provided a convenient review of the principles and approaches 
to assessing health research questionnaires, aimed particularly at 
researchers in developing countries. Responsiveness and minimally 
important change (MIC) are the focus of many papers in the literature 
including Christiansen et al (2015), who compare the performance of two 
independently designed shoulder outcome PROMs which aim to evaluate 
both pain and joint function. The paper used Receiver Operating 
Characteristic (ROC) curves to measure the ability of the scores to identify 
significant health improvements. ROC analysis was also used to identify the 
MIC for each PROM instrument. Chiarotto et al (2016) used a similar 
approach to assess how three different versions of the Pain Self-Efficacy 
Questionnaire (PSEQ) performed with regard to people suffering from 
chronic lower back pain. The original 10 item questionnaire and two newer, 
shorter versions with four items (PSEQ-4) and two items (PSEQ-2) were 
included in the comparison study. Ohanyan et al (2017) provided a short 
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report on the responsiveness and MIC characteristics of a recently 
developed PROM for people with the chronic urticaria skin condition called 
the Urticaria Control Test (UCT; Weller, 2014). The UCT results were 
compared with results from other established PROM instruments focussed 
on dermatological outcomes; the Urticaria Activity Score (UAS), the Chronic 
Urticaria Quality of Life Questionnaire (CU-Q2oL) and the Dermatology Life 
Quality Index (DLQI). These comparisons allowed the study coordinators to 
assess responsiveness and estimate the MIC for their UCT PROM 
instrument. 
Devji et al (2017) meanwhile, presented a strategy for enhancing the 
interpretability of PROMs when carrying out a meta-analysis. The motivation 
for this study is the differences in the way that PROM results which use the 
same instrument, or PROM results with a common disease focus using 
different instruments, can be reported. These differences may lead to 
difficulties with interpretation and aggregation when carrying out meta-
analyses. The paper discussed the strengths and limitations of various 
different methods of PROM result reporting, including mean differences, 
standardised mean differences, relative risks, odds ratios and MIC units. The 
ultimate aim of the research strategy is to objectively assess how PROM 
results are reported in meta-analyses, to provide recommendations for future 
PROM design methodologies and suggest a standardised approach to 
reporting PROM results. 
 
3.3.4   Modification of the instrument 
When a PROM instrument is used in a new patient population, item wording 
or appearance are changed, or PROM measurements are revised, this is 
characterised as a ‘modification’ (US FDA, 2006). Modified PROM 
instruments are considered to be different from the original, and properties 
are held to be version-specific. Additional validation is recommended to 
ensure the PROM instrument performs to an acceptable level following 
modification. 
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3.3.5  Applying a methodology to the current research 
question 
The above representation of the current approach to PROM instrument 
construction show that undertaking such a project requires both qualitative 
(interviews, observations, focus groups) and quantitative (questionnaire 
validation using factor analysis, intraclass correlation coefficients, scoring 
algorithms, identifying minimally important clinical differences) research 
methods. Neither approach, if used in isolation, would successfully tackle the 
problem. This indicates that a mixed methods approach (Johnson, 2004) 
would be the most viable methodology for PROMs researchers to employ 
(for examples, see Bravo (2015), Dür (2015) and Martin (2018)), a research 
methodology that arises from the pragmatic school of philosophy and 
explained by Biesta (2010).  
 
3.4   Pragmatic philosophy 
The obvious challenge of placing PROM construction within a single 
research philosophy is that they should reflect individual patient experiences 
(which would be characterised as interpretivism (see Myers, 2008)), but they 
also generate quantitative data summarising the instrument properties and 
ultimately a numeric score that is representative of a pre-defined HRQoL 
domain (which would be characterised as positivism (see Crossan, 2003)). 
As a consequence of this methodological duality, PROMs research studies 
are perhaps best considered as being in the pragmatic tradition (Neale, 
2015). 
The foundations of pragmatism as a philosophy date back to publications by 
Charles Sanders Peirce in the late 19th and early 20th century (Pierce 1878, 
1905). These ideas were subsequently developed by William James (1907) 
and John Dewey (Dewey developed his theories in a series of publications 
over the course of more than two decades, from 1917 to 1938) who in 
particular proposed a method of thinking called ‘inquiry-based learning’, 
where research questions are the primary driver of knowledge creation and 
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the production of knowledge flows from those beginnings. In fact, Dewey 
preferred to avoid the assumptions associated with the word “knowledge” 
and coined the term “warranted assertions” instead. Dewey maintained that 
inquiry produces outcomes, which produces warrants and that the knowing 
cannot be separated from the doing.  
“For Dewey, the knower and the known were inseparable, 
bound together in a process of inquiry, with a simultaneous 
reliance on both belief and action… At the broadest level, 
Dewey’s pragmatism as a philosophy addresses the central 
question: What is the nature of human experience? 
Refocusing on inquiry as a central form of human experience 
requires reconsidering the philosophy of knowledge by 
replacing the older emphasis on ontology [how reality is 
perceived] and epistemology [how we know what we know] 
with a concentration on inquiries about the nature of human 
experience.” (Morgan, 2014) 
This early thinking has been shaped for contemporary applications by Maxcy 
(2003), Hoshmand (2003) and Johnson (2004), among others. Unlike purely 
interpretivist or positivist research philosophies, which broadly conform to 
either subjective or objective ontologies, a pragmatic research philosophy 
accepts any relevant concept which can be used effectively to answer the 
research question at hand and effect a positive change. Pragmatics 
“recognise that there are many different ways of interpreting the world and 
undertaking research, that no single point of view can ever give the entire 
picture and that there may be multiple realities” (Saunders, 2012). 
Pragmatics also derive the meaning of ideas from their practical application. 
The essence of a pragmatic ontology could therefore be said to rely on 
actions and change (Goldkuhl, 2012).  
Pragmatists feel that their approach values common sense and experience, 
and rather than adopting an epistemology that views knowledge as a “copy” 
of reality, they seek progress through empirical inquiry and prioritising the 
utility of outcomes (Legg, 2019). 
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Kroenke (2015) applies this strand of philosophical thinking to the creation of 
PROM instruments. He notes that the early advocate of pragmatism William 
James defined “truth” as that “which works” or that which motivates action to 
affect a positive change (James, 1967). The action “which works” in the 
context of a PROM instrument is therefore how it may allow an 
understanding of and improvement to patient care. In the 1980’s, another 
pragmatic philosopher stated that “It is the vocabulary of practice rather than 
of theory, of action rather than contemplation, in which one can say 
something useful about truth.” (Rorty, 1982). Kroenke goes on to draw a 
comparison between this perception of practical ‘truth’ and the reality of 
PROM implementation. 
 
3.5   Aims and research questions of the current study 
3.5.1   Aims  
This study aims to develop a conceptual model that identifies key domains of 
HRQoL for individuals who have a thoracic aortic aneurysm. These domains 
will form the basis of a disease specific item set, which will be used to 
formulate relevant HRQoL questions. These questions will then be used in 
conjunction with preference based generic HRQoL measures (e.g. EQ-5D, 
SF-6D) to form a PROM instrument for patients who undergo surgery for a 
proximal aortic aneurysm. 
 
3.5.2   Research questions  
1. Is there an opportunity to develop a PROM instrument for patients 
undergoing surgical treatment for proximal TAA disease? 
This first question has been responded to in part by the in-depth literature 
review presented in Chapter 2, where the decision to develop a proximal TAA 
PROM was justified by establishing the requirement for, and lack of, a 
disease-specific measure in this area. 
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2. What is the lived experience of patients who undergo aortic surgery 
on the proximal aorta? 
This second question will be answered by the qualitative study phase, where 
patient interviews will be conducted, transcribed and analysed for key 
themes. The output will be a conceptual model of HRQoL in proximal TAA 
patients based on the data. 
3. What themes specific to patients suffering aneurysmal disease of the 
aorta reflect a patient’s health status / HRQoL, and how can these be 
relayed in a PROM? 
The third question forms the bridging section between the qualitative and 
quantitative study phases, where the PROM will be constructed based on the 
emerging qualitative themes. The output will be a draft PROM instrument 
that can be piloted in a population of proximal TAA patients. 
4. Is the administration of a PROM feasible in this patient population? 
The fourth question forms the subsequent section of the quantitative study 
phase, where the PROM will be piloted and patient acceptance will be 
assessed via criteria such as response rate, administrative burden and data 
completeness. 
5. Does the newly constructed PROM instrument perform well enough 
to be useful to future patients and clinicians? 
The fifth question forms the final section of the quantitative study phase, 
where the PROM pilot results will be tested for reliability, validity and 
responsiveness. Recommendations on future administration and further 
instrument testing will be made. 
 
3.6   Study rationale 
The impetus for undertaking this project was the lack of a specifically tailored 
PROM instrument for the proximal aortic aneurysm surgery population. In 
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order to maximise the impact and utility of the PROM it was decided that a 
close application of the FDA guidelines (see Section 3.3), including gathering 
and analysing both qualitative and quantitative data, would be necessary. 
There is a standard methodological reasoning behind this approach, as 
Creswell (2013) explains it was required because we “need better 
contextualised instruments, measures, or interventions to reach certain 
populations”. 
This established methodology of PROM instrument development (US FDA, 
2006) requires both qualitative and quantitative strategies to succeed. As 
described above, this method is based within the pragmatic philosophical 
paradigm, and will use a mixed methods approach to research. 
 
3.7   Mixed methods research 
Johnson and Onwuegbuzie (2004) define mixed methods research as “the 
class of research where the researcher mixes or combines quantitative and 
qualitative research techniques, methods, approaches, concepts or language 
into a single study”. It is hypothesised that where a study has both 
interpretivist and positivist elements to it, that a mixed approach can provide 
a more complete, blended understanding of the research question than 
either a qualitative or quantitative analysis in isolation could do (Creswell, 
2003). 
The concept of a mixed methods research approach emerged from what 
commentators described as the “paradigm wars” (see Howe, 2003). During 
this period of the 1980’s and early 1990’s, members of the positivist / 
quantitative research community argued that only their approaches could 
lead to robust knowledge and an understanding of objective “truth”, they also 
maintained that qualitative methods lacked rigourous scientific precision. 
Conversely, interpretative/qualitative researchers believed that results based 
solely on statistical analysis and quantitative measurement gave a blinkered, 
inadequate interpretation of events. The human element was ignored and the 
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role of motives, reason, background knowledge and cultural behaviours, 
among other things, were side-lined (Siegel, 2018). 
Rather than become entrenched in these philosophical battles, some 
researchers began to embrace a mixed methods approach (Tashakkori, 
1998). This meant that instead of being at odds with one another, the 
objective and subjective poles of research could be melded together to 
create broad, balanced, complementary results. 
This mixture of approaches should not, however, be adopted in an arbitrary, 
careless way. Proper consideration should be taken to make the correct 
methodological choices and integrate the appropriate results for the research 
question at hand (Bryman, 2006; Denscombe, 2008). It is also worth noting 
that the mixture of paradigms displayed in mixed methods research has the 
effect of diminishing the philosophical emphasis on specific ontological and 
epistemological perspectives. Of greater importance is achieving a 
consensus and producing outcomes which have practical value, as 
advocated by the underpinning pragmatic philosophy (see Section 3.4). 
There are both benefits and challenges to consider when applying a mixed 
methodology approach to research. Johnson (2004, p21) provides a concise 
table of mixed methods strengths and weaknesses. Some accepted benefits 
include: 
 
 Mixing qualitative and quantitative data can allow a greater 
understanding of the research problem and yield more complete 
evidence, in theory the investigator will gain both depth and breadth. 
“It makes intuitive sense to gather information from different sources, 
utilising different methods, which work together as an efficient design” 
(Almalki, 2016). 
 Combining both numerical and thematic data can help avoid over-
reliance on the former, and allows the researcher to acquire “soft-core 
views and experiences” (Jogulu, 2011), or the subjective factors 
necessary to help explain complex social interactions. 
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 The process of triangulation (Jick, 1979; Wilson, 2014), where the 
final results of the study may include both observations and statistical 
analyses, provides additional evidence and support for the findings. 
 The use of a mixed methods approach can also help researchers to 
develop their skills. This is particularly important for those at an early 
stage of their career (Molina-Azorín, 2016). 
 
Along with these advantages, selecting a mixed methods approach also 
presents challenges: 
 
 It is more time-consuming and resource intensive to collect both 
quantitative and qualitative data. 
 The research procedures can be complex and may be beyond the 
experience of the research team. Investigators are often trained in 
quantitative or qualitative methods and may need assistance to 
achieve good results in the alternative discipline (Brannen, 2005). 
 Methodological intent will require clear presentation when published or 
presented, so that the audience can accurately understand the 
procedures and the findings. 
 
3.7.1  Mixed methods research type 
Several different outlines for a mixed methods study exist in the literature. 
Four of the most frequently used designs are:  
 Triangulation mixed methods design 
This type of study takes the form of a single phase project, with 
simultaneous collection of qualitative and quantitative data. The results 
are then combined with the intention of merging the two separate strands 
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of data into a composite model outcome. Some examples of this type of 
study are found in Graham (2005) and Casey (2009). 
 Embedded mixed methods design 
This type of study is conceived as providing supporting or secondary 
outcome data within the context of a larger interventional research study. 
The intention is to produce an output which supports the findings of the 
larger study, thereby enhancing the impact. Some examples of this 
approach to mixed methods design are found in Houtz (1995) and Rogers 
(2003). 
 Explanatory Sequential mixed methods design 
As the name suggests, the explanatory sequential design features 
sequential data collection in a two phase project. Here, the quantitative 
phase comes first, followed by the qualitative phase, with the concept that 
data collected during the second phase will build upon what was 
uncovered in the first. The intention is to better explain the phase one 
results, or to enable purposeful participant selection to better understand 
the initial findings. Some examples of this design approach are found in 
Lalor (2013) and McCrudden (2018). 
 Exploratory Sequential mixed methods design 
Again, this type of design features sequential data collection in a two 
phase project. But in this design the timeline of the approaches swaps 
round, so the qualitative phase comes first, followed by the quantitative 
phase. The concept of this approach is also that the data collected during 
the second phase builds upon the results of the first. The intention is to 
apply qualitative data to develop an instrument, or to identify categories 
that can be applied to a quantitative measurement. Some examples of 
this design approach are found in Stoller (2009) and Berman (2017).  
The current study will employ methodological integration by gathering initial 
qualitative data, analysing it, and then using the qualitative results to build a 
new PROM instrument that will be tested quantitatively. The mixed method 
112 
 
type that seemed most appropriate for aim of study was therefore the 
exploratory sequential approach. Figure 3.2 shows the fundamental structure 
of the study plan. 
 
 
 
              
 
Figure 3.2: Exploratory sequential mixed methods design (adapted from Wu, 
2012) 
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While Figure 3.3 illustrates in greater detail the two phases of 
implementation. 
 
 
Figure 3.3: Exploratory sequential mixed methods design for the current 
study 
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Quantitative findings
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3.8   Research study flow diagram 
Figure 3.4 shows how the two phases of the exploratory sequential mixed 
methods design fit into the research study outline as a whole. 
 
 
 
Figure 3.4: Research flow diagram for the current study 
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Chapter 4 
Qualitative study 
 
4.1  Introduction 
This chapter presents the results of the qualitative study phase. This phase 
aimed to explore patient’s experiences and perceptions related to proximal 
TAA disease, which included experiences of living with the disease and their 
perceptions of the healthcare they received. In-depth, semi-structured 
interviewing and thematic analysis were used with the intention of developing 
our understanding of the patients lived experience. 
 
4.1.1  Appraisal of the current literature  
Entering “aortic aneurysm” and “interview” as search terms into the PubMed 
US National Library of Medicine, National Institute of Health webpage 
(https://www.ncbi.nlm.nih.gov/pubmed) returned 46 entries (date of search, 
10/05/2019). 10 (22%) of the published studies were only tangentially related 
to aortic aneurysms and did not include patient interviews. 24 (52%) studies 
made specific reference to abdominal aneurysms in the study title, while 8 
(17%) made reference to endovascular repair, which also indicated 
abdominal aneurysm treatment. The remaining four studies (Luehr, 2017; 
Gavazzi, 2016; Melby, 2013 and Niclauss, 2011) did include patients who 
had treatment on their proximal aorta, but two were focussed on dissection 
patients only (Melby, 2013 and Niclauss, 2011). The third included coronary 
artery bypass grafting patients and valve replacements as well as ascending 
aorta repairs (Gavazzi, 2016) and the final paper (Luehr, 2017) included 
patients who had aortic arch replacements only, with any type of pathology. 
All four of the studies that included proximal aortic patients used interviews in 
order to establish long-term treatment complications, rather than enquire 
about patients’ experiences. To date, no studies were found that explored the 
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lived experience of these patients, identifying a gap in the literature and 
making the current work an appropriate addition to current knowledge. 
 
4.2  Objectives 
The objectives of this study were: 
1. To explore the experiences of patients with proximal aortic aneurysm 
disease in order to obtain an in-depth understanding of the extent and 
nature of how that disease impacted on their health status / HRQoL  
2. To develop a conceptual model for health status / HRQoL in aortic 
aneurysm patients based on their personal experiences 
3. To develop a questionnaire aimed at addressing health status / 
HRQoL in aortic aneurysm patients 
 
4.3  Methods 
4.3.1  Ethical approval 
Ethical approval of the study was granted by the National Research Ethics 
Service Committee in Solihull on 16th February 2015 (Ref: 13/WM/0456). The 
confirmatory letter can be found in Appendix A. 
  
4.3.2  Inclusion and exclusion criteria 
The inclusion criteria for the qualitative study were: 
 Participants must be aged 18 years or over 
 Presenting specifically for previous or current proximal thoracic aortic 
aneurysm (TAA) disease 
 Outpatient attendee at LHCH 
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The exclusion criteria were: 
 Under 18 years of age  
 Unable to provide informed consent  
 Unable to read or write in English 
 
4.3.3  Recruitment 
Purposive sampling (see Robinson, 2014) was used to recruit patients 
attending routine outpatient appointments at Liverpool Heart and Chest 
Hospital (LHCH), a tertiary centre in the North West of England that treats, 
amongst other disciplines, patients with cardiac and aortic diseases. 
Recruitment was made using the following protocol: 
 Suitable patients with a scheduled upcoming outpatient attendance 
were identified from the hospital Patient Administration System (PAS). 
 An introductory letter was sent inviting the patient to take part in a 
research study (Appendix B), this included information about the 
purpose of the research, details on the interview subjects and 
structure and an incentive for participation in the form of payment for 
travelling expenses (up to a maximum of £50). 
 Enclosed with the introductory letter was a Patient Information Sheet 
(Appendix C) which gave further details on the research study, how 
patient confidentiality would be managed and what the patient should 
do if they needed more information or wished to make a complaint. 
Patients were informed that participation was voluntary, would not 
affect their care and that they could withdraw from the study at any 
time, before or after the interview had taken place.  
 A telephone call was then made to the eligible patients, to ask whether 
they would be willing to participate in the study. If the patient was 
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happy to be interviewed, they were met in the outpatient department 
and then interviews took place after their scheduled outpatient 
appointment. 
 Participants were given the option of participating in the interview 
alone or having another person present. 
 
4.3.4  Study participants and sample size 
All participants provided written informed consent (Nijhawan, 2013) before 
their participation in the study, in accordance with Health Research Authority 
protocols (Appendix D). They were also offered a reimbursement of their 
travelling expenses (up to a maximum value of £50); many international 
studies have confirmed that monetary incentives can be useful in increasing 
the willingness of potential interviewees to participate in a study of this nature 
(Edwards, 2005; Singer, 2013; Kelly, 2017). 
The patient sample size for the initial qualitative interviews was relatively 
large (n = 30) in order to ensure maximum variability. In order to support the 
patient findings, four specialist aortic surgeons (all based at LHCH) were also 
interviewed during the same period. 
In qualitative research, unlike in quantitative data collection, it is not feasible 
to objectively predict optimal sample size prior to data collection. A frequently 
used concept for determining the sample size of nonprobabilistic studies is 
“data saturation”, which indicates the point at which no new information, 
ideas or themes are emerging from the data provided by the study 
participants (Guest, 2006). The goal was to acquire a dataset that was both 
“rich” (multi-layered, detailed and intricate) and “thick” (lots of data), in order 
to facilitate in-depth and high quality analyses (Burmeister & Aitken, 2012; 
Fusch & Ness, 2015) 
The method chosen for analyses of the qualitative data was Thematic 
Analysis (see Section 4.3.6). Researchers using this method have suggested 
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that data saturation is not a useful method for determining an appropriate 
sample size, and some authors claim that this term may have little practical 
meaning (Malterud, 2016 in Braun, 2019). However, this has not discouraged 
some investigators from advising that between 6 and 12 interviews should be 
enough to achieve saturation in these types of studies (Guest, 2006; Ando, 
2014). Hennick (2017) goes further, making a distinction between “code 
saturation” (range of issues identified) and “meaning saturation” (data 
richness and textured understanding achieved), suggesting that 9 interviews 
are enough to achieve the former and between 16 and 24 interviews for the 
latter. Another attempt by academics to employ a statistical methodology 
aimed at objectively estimating sample size for studies using thematic 
analysis (Fugard and Potts, 2015) received a largely sceptical response 
(Emmel, 2015; Braun and Clarke, 2016). In addition to these considerations, 
the researchers involved did not have a vast amount of qualitative study 
experience to draw upon. Sample size and data collection was therefore 
predicated on the following: 
 A review of how many interviews had taken place in similar studies 
 A pragmatic assessment of the number of interviews that would be 
possible within the time frame 
 A continuing awareness throughout the interview process of the 
richness of the information collected and the diversity of the 
subject population, attempting along the way to broadly recognise 
how these elements would ultimately be applied to the research 
objectives 
A short review of similar studies helped to support decisions around sample 
size for the qualitative phase. McElhone (2007) developed and validated a 
disease specific HRQoL instrument for adult patients with systemic lupus 
erythematosus (the LupusQol), thematic analysis of 30 patient interviews 
took place at the qualitative stage. Welk (2013) used thematic analysis on 16 
patient interviews to conceptualise and develop a PROM for neurogenic 
bladder dysfunction. An international study which used thematic analysis to 
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develop a conceptual HRQoL model for Hepatitis C (Armstrong, 2016) 
recruited 70 patients in total for interview (30 from France, 20 from Brazil and 
20 from Australia). Forty six patients (38 from England, 8 from France) were 
interviewed in a study which aimed to define patient experiences within 
emergency care, with the intention of subsequently creating a PROM 
instrument for use in that clinical environment (Vaillancourt, 2017). Leffler 
(2017) proposed a conceptual model for the impact of coeliac disease on 
HRQoL amongst adults, also with the intention that the findings be used to 
construct a PROM; 21 patients were interviewed, with thematic analysis used 
to interpret the qualitative data. Tatlock (2017) interviewed 30 patients for a 
similar study concerning patients suffering with gout. 
Planning to interview 30 patients therefore seemed to be a reasonable goal 
based on these comparable publications, and an achievable aim with regard 
to the study timetable and the availability of suitable patients. 
 
4.3.5  Interviews 
Two interview guides were developed (one for pre-operative patients and 
one for post-operative patients), these were based on the expertise of the 
primary investigator and clinical experts, and a review of the literature 
(Appendices E1 and E2). The interview guides were dynamic and flexible 
and were continually reviewed by the interview team (primary investigator, 
clinical supervisor and interview assistants) as the study progressed. Initial 
interview questions were general, to obtain patient perspectives, and then 
were divided into broad chronological domains, from diagnosis through to 
treatment and post-operative care, with specific probes within each domain. 
The majority of the semi-structured interviews were conducted by the primary 
investigator (n = 17), and three other research team members, with 
experience of qualitative research with respect to patient experience, also 
assisted. The interviews lasted between 20 and 75 minutes. Interviews were 
audio recorded on a digital Dictaphone and transcribed verbatim using a 
denaturalised approach. The denaturalisation of interview data has been 
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suggested as being a preferable technique for thematic analysis studies 
(Neale, 2016). The interview guide was designed to probe the patient’s 
thoughts and feelings about their experience of TAA’s in a chronological way.   
For the clinician interviews, each surgeon was asked open-ended questions 
about their perspectives on caring for TAA patients. These questions followed 
a similar order to the patient interviews as shown in the interview guide in 
Appendix E1 and E2. 
 
4.3.6  Data collection 
Digital recordings of the interviews were made using a Dictaphone. After the 
interview was completed, the digital files were uploaded onto the secretarial 
dictation system at LHCH in readiness for transcription.  A hospital secretary 
familiar with the clinical terminology and experienced in typing up dictated 
recordings was employed to transcribe the interviews. 
 
4.3.7  Data entry and thematic analysis 
Interview transcripts were imported into NVivo software (QSR International 
Pty Ltd. Version 10, 2012) for qualitative data analysis.  
Thematic analysis (TA) of the transcripts took place based on the six phase 
process that Braun and Clarke introduced in 2006 and have continued to 
develop over the following years (Braun and Clarke, 2013; Braun, Clarke and 
Rance, 2015). Although their method was initially conceived within the 
discipline of psychology, it has been used widely across many areas and has 
been specifically identified as offering a robust, practical solution for 
healthcare researchers who are undertaking qualitative data analysis (Braun 
and Clarke, 2014).  
The six phase Braun and Clarke TA structure grew out of content analysis 
(see Mayring (2004) and Hsieh (2005)), and was heavily influenced by 
principles established by Boyatzis in 1998. Boyatzis was interested in how 
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qualitative data could be arranged into “codes” and “themes” so that 
pertinent sections of text in relation to the research question could be 
highlighted, collected and reported with clarity. His approach to and 
innovations with TA have been characterised as “a bridge between the 
language of qualitative research and the language of quantitative research” 
(Boyatzis, 1998), making the techniques apt for a mixed methods study 
design. Braun and Clarke then refined and popularised the TA approach to 
qualitative analysis in their landmark 2006 paper. Many well-cited 
publications covering a variety of specialities have used these techniques in 
the ensuing years, including studies relating to international entrepreneurship 
(Jones, 2011), gerontology (Wiles, 2012) and environmental psychology 
(Devine-Wright, 2010). 
Bearing in mind that the investigators were relative novices in regard to 
qualitative research, it is also worth noting that TA is recommended as a 
suitable introductory method for this type of study “as it provides core skills 
that will be useful for conducting many other forms of qualitative analysis” 
(Braun and Clarke, 2006; Maguire, 2017). This argument is substantiated by 
Holloway (2003), who recognises the principle transferable skill of 
“thematizing meanings” as applicable to many other qualitative research 
methods, such as phenomenology, ethnography or grounded theory. 
Briefly, the six phases of TA and how they were applied to the current study 
are as follows: 
 
4.3.7.1 Phase 1: Data familiarisation  
Familiarisation involves the initial immersion of the researcher in the data 
(Rabiee, 2004; Lacey, 2007). It is the process of listening to recordings, and 
then reading and re-reading the interview transcripts, and then making 
informal summaries about the information that has been gathered. This stage 
of immersion and insight was particularly important in the current study as 
the interviews were not all performed by the same researcher.  
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4.3.7.2 Phase 2: Initial code generation 
After data familiarisation, preliminary code generation began. At this point in 
the analysis, transcripts were imported into the NVivo software package and 
systematically scrutinised. This stage allows for a broad interpretation of the 
data (Terry, 2017), any data segments that were considered relevant to the 
research question were tagged and given a short, meaningful title. Tuckett 
(2005) describes the process of code assignment as being “contingent on 
asking of the data segment, ‘What is being described (event, action, 
interaction) in the data text’? and ‘How is it understood (processes) – what 
does it mean’? ‘Why?’”. This interrogative thought process was used 
throughout the preliminary coding phase.  
 
4.3.7.3 Phase 3: Identifying themes 
After a comprehensive scrutiny of the interview data in phases one and two, 
the process of constructing a thematic sequence began. This stage involved 
a detailed inspection of the identified codes and the detection of any shared 
patterns, which then allows more extensive themes to be identified and 
categorised (Terry, 2017). Themes were generated using analytic induction 
and constant comparison within and between transcripts. This can be as 
straightforward as recognising a single complex code which incorporates 
several other codes within its meaning, these codes can then be “promoted” 
into themes (Charmaz, 2000). More frequently, the identification of codes 
and the relationships between them are knotty and complicated, requiring 
careful consideration and revision as they grouped together and given 
thematic status. The researcher must identify a dominant impression, “a core 
concept or idea, a central organising concept” (Braun, 2019), that is shared 
across a range of codes. 
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4.3.7.4 Phase 4: Reviewing themes 
In this phase, the content of the identified themes was appraised and 
evaluated for coherence. Each code comprising a theme was examined and 
if they were found to be logical and consistent they were accepted. If a 
theme category or coding were found to be problematic then they were 
reworked. For example diet and alcohol began as separate sub-themes but 
upon reflection were found not to have enough variance to justify that choice, 
so they were merged into one. The results at the end of this phase were 
determined to accurately represent in a wider sense how the researcher 
viewed the data set as a whole (Braun and Clarke, 2006). 
 
4.3.7.5 Phase 5: Defining themes 
After thematic categories were identified, there was a requirement to provide 
a stronger sense of definition and meaning. The initial categorisation of 
themes focussed on broadly summarising a profusion of rich data, and then 
this step refined that approach into achieving a thematic narrative that sought 
to explain the in-depth meaning contained within the themes. “Clarity, 
cohesion, precision and quality” (Terry, 2017) were sought, with the aim of 
sharpening the thematic map produced in the previous phase. However, 
researchers must take care to ensure that the refined themes bring a more 
developed meaning to the overall data rather than oversimplifying and risk 
losing substance. 
 
4.3.7.6 Phase 6: Producing a report 
After the thematic analysis and categorisation was complete, the production 
of the report (in this case the thesis) summarised the analysis done up to this 
point. If it is possible to answer the original research questions using the 
assembled thematic structure with both illustrative and analytical precision, 
and to construct a compelling narrative that honours the complete data set, 
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then the researchers can take some reassurance from this. Braun (2019) 
also advises that adjustments to the thematic constructions and definitions 
can still be made at this stage, in order to make the final product as clear, 
consistent and representative as possible. 
 
4.4  Results 
4.4.1  Participant characteristics 
28 post-operative and 2 pre-operative TAA patients (21 males, 9 females; 
mean age 61 years (standard deviation = 12), age range 35 to 84) were 
interviewed between March and August 2015. In the 28 post-operative 
patients, time since their operation ranged from 2 months to 10.5 years. 
Patient characteristics are shown in Table 4.1, where continuous variables 
are shown as median (inter-quartile range) and categorical variables are 
shown as absolute number (%). 
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Table 4.1: Qualitative study, patient characteristics 
 
Characteristic 
TAA patients 
(n = 30) 
Age at interview 62 (53, 68) 
Female gender 9 (30.0) 
Ethnicity   
     White - British 30 (100) 
Marital status   
     Married 22 (73.3) 
     Divorced / separated / widowed 5 (16.7) 
     Single 3 (10.0) 
Index of multiple deprivation quintile   
     1 (most deprived) 5 (16.7) 
     2 5 (16.7) 
     3 5 (16.7) 
     4 8 (26.7) 
     5 (least deprived) 7 (23.3) 
Pre-operative, 'watch and wait' patients 2 (6.7) 
  
Post-operative patients 
n = 28 
Body-mass index (kg/m2) 27.1 (25.0, 31.3) 
Canadian Cardiovascular Society (CCS) angina 
classification 
  
     Asymptomatic 23 (82.1) 
     I 1 (3.6) 
     II 4 (14.3) 
New York Heart Association (NYHA) functional 
classification 
  
     I 10 (35.7) 
     II 15 (53.8) 
     III 3 (10.7) 
Previous myocardial infarction 1 (3.6) 
Diabetes 2 (7.1) 
Hypertension 15 (53.6) 
Ex-smoker 10 (35.7) 
Peripheral vascular disease 2 (7.1) 
Left ventricular ejection fraction between 30% and 50% 6 (21.4) 
Logistic EuroSCORE 6.9 (6.4, 16.6) 
Aortic segments operated on   
     Root 22 (78.6) 
     Ascending 26 (92.9) 
     Arch 8 (28.6) 
Concomitant cardiac surgery   
     Aortic valve replacement 26 (92.9) 
     Coronary artery bypass graft 2 (7.1) 
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As seen in Table 4.1, the CCS Angina Grading Scale is a well-established 
method for the classification of angina severity. It was first published by 
Campeau in 1976 and has since been adopted and used in a wide range of 
international healthcare institutions and studies. It consists of four grades of 
increasing magnitude, described in Table 4.2: 
 
Table 4.2: The CCS grading of angina pectoris 
CCS 
Grade 
Description 
I 
Ordinary physical activity does not cause angina, such as 
walking and climbing stairs. Angina with strenuous or rapid or 
prolonged exertion at work or recreation. 
II 
Slight limitation of ordinary activity. Walking or climbing stairs 
rapidly, walking uphill, walking or stair climbing after meals, or 
in cold, or in wind, or under emotional stress, or only during the 
few hours after awakening. Walking more than two blocks on 
the level and climbing more than one flight of ordinary stairs at 
a normal pace and in normal conditions. 
III 
Marked limitation of ordinary physical activity. Walking one or 
two blocks on the level and climbing one flight of stairs in 
normal conditions and at normal pace. 
IV 
Inability to carry on any physical activity without discomfort, 
anginal syndrome may be present at rest 
 
Also seen in Table 4.1, The NYHA functional classification of heart failure 
was proposed in 1928 and has been revised several times since, most 
recently in 1994 (Criteria Committee of the NYHA). It places patients in one 
of four categories based on how much they are limited during physical 
activity. In a similar way to the CCS classification, it consists of four grades of 
increasing magnitude which are described in Table 4.3: 
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Table 4.3: The NYHA functional classification of heart failure 
 
NYHA 
Grade 
Description 
I 
Patients have cardiac disease but without the resulting 
limitations of physical activity. Ordinary physical activity does 
not cause undue fatigue, palpitation, dyspnoea (shortness of 
breath) or anginal pain. 
II 
Patients have cardiac disease resulting in slight limitation of 
physical activity. They are comfortable at rest. Ordinary 
physical activity results in fatigue, palpitation, dyspnoea 
(shortness of breath) or anginal pain. 
III 
Patients have cardiac disease resulting in marked limitation of 
physical activity. They are comfortable at rest. Less than 
ordinary physical activity causes fatigue, palpitation, dyspnoea 
(shortness of breath) or anginal pain. 
IV 
Patients have cardiac disease resulting in inability to carry on 
any physical activity without discomfort. Symptoms of cardiac 
insufficiency or of the anginal syndrome may be present even 
at rest. If any physical activity is undertaken, discomfort is 
increased 
 
 
The third and final characteristic from Table 4.1 which may need additional 
explanation is the logistic EuroSCORE. EuroSCORE stands for the 
EUROpean System for Cardiac Operative Risk Evaluation, and was 
originally published by Roques et al in 2003. It is a widely used method of 
predicting the chance of an individual patient suffering in-hospital mortality 
after undergoing heart surgery, including patients who undergo surgery on 
the thoracic aorta. The logistic model produces a risk score for each patient 
based on their personal risk factors ranging from 0.9% (even in the fittest 
patients, cardiac surgery still carries some risk) to 100%. 
 
4.4.2  Identification of qualitative themes 
The interviews with TAA patients resulted in powerful accounts about how 
having TAA affected their daily lives across the 3 HRQoL domains of 
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physical, mental and social. Three main themes related to the effect of TAA 
on HRQoL emerged  
1) Effect of disease and treatment (symptoms, personal adjustment 
to recovery and treatment satisfaction) on everyday life 
2) Attitudes of and towards friends and family 
3) Continued diagnostic monitoring for aneurysmal disease. 
 
4.4.3  Effect of disease and treatment 
4.4.3.1 Symptoms 
All of the study participants explained how they experienced a range of 
symptoms, from having no symptoms whatsoever up to debilitating chest 
pain and blacking out into unconsciousness. Participants also discussed how 
their physical symptoms affected their emotional state and their 
psychological response and reaction to their illness. 
 
4.4.3.1.1 Asymptomatic 
The majority of participants (n = 18) recalled expressing surprise and 
disbelief when they were informed they had a serious health issue that would 
require surgical treatment as they had experienced no symptoms up to that 
point, for example: 
"I didn’t have any symptoms or nothing.  Even now I wouldn’t know I have an 
aneurysm because I have absolutely no pain." – P01 
"No, I was never ever, there was never any symptoms as such like a 
shortage of breath or even under stress or under, I never felt any symptoms." 
– P12 
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Asymptomatic participants reported being incredulous when told about the 
seriousness of their condition, which may indicate the presence of a larger 
psychological burden when coping with aneurysmal disease, instead of the 
clear physical burdens which come with pain or discomfort. These 
participants exhibited a tendency towards disbelief of what they were being 
told by the doctors: 
"They tell you that you have got a heart condition and you think what the hell 
are they talking about here?" – P18 
"I said the crazy thing about it I feel great…I cannot understand why I am 
going to have this operation when I feel so good" – P21 
Naturally, this situation led to individuals reporting surprise and at times 
shock, suggesting again that there is a psychological toll that these patients 
endure that is not reflected with typical physical symptoms: 
"nothing at all like that,[shortness of breath],  he just told me about it and I 
said “bloody hell”, shock" – P28 
 
4.4.3.1.2 Fatigue and collapse 
Eight participants recalled that they were becoming tired and fatigued more 
easily. This was sometimes reported as being something they were aware of 
at the time:   
"It was making me feel tired a lot as well" – P20 
Another participant however identified their increased exhaustion only in 
retrospect: 
"looking back now I probably had the symptoms from about then, where I 
was becoming more tired and lethargic" – P09 
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Two participants reported suffering a sudden collapse, one in the course of 
their normal activities and the other when exerting themselves on a 
demanding bike ride: 
"I just collapsed and I think that it when it all stemmed from, that is where it 
all came from" – P19 
"then the worst bit was cycling up a big hill in Maldon where I work I got the 
top then I collapsed in a ditch" – P25 
These patients then in due course consulted their GP, which led to the 
discovery of the aneurysm and the subsequent procedure. 
 
4.4.3.1.3 Angina 
Several participants identified chest pain, or angina, as being a factor during 
their pre-operative experience and as an indicator that they would have to 
seek some medical attention, for example: 
"when I was in my 30’s I knew it was getting worse because I was having a 
lot of chest pain really," – P20 
This was often described as happening when taking light exercise: 
"probably up to about 18 months beforehand I started to get pains in my 
chest…and couldn’t walk really far could not do all the things I used to do" – 
P05 
"Yes I was … getting a pain in my chest that’s it, if I was walking somewhere 
maybe after 10 minutes I had to stop, stop and rest and try and carry on 
again" – P05 
"Initially I had a slight tightness in the chest, I was exercising and particularly 
when I was out walking the dogs I would get just occasionally a slight 
tightness…I thought I probably ought to get this checked out. So I was 
diagnosed with angina" – P07 
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Angina does not always originate in the chest, but can also radiate through 
the arms, neck or jaw, as articulated by this participant: 
"I was getting pains in the jaw line and a bit down my neck did not know what 
it was" – P03 
As with the earlier identified symptoms of exaggerated tiredness or collapse, 
these unusual pains led to a GP attendance and ultimately the diagnosis of 
the individual’s aneurysm. 
 
4.4.3.1.4 Shortness of breath 
All of the symptomatic participants (n = 12) spoke of experiencing shortness 
of breath, or dyspnoea, in the months to years before getting their 
aneurysmal diagnosis.  
"I was getting out breath quite easily you know which was unusual for me" – 
P21 
"yes I think I did slow down I don’t think I realised it but my husband says 
now you were slowing down and you know getting a bit out of breath" – P30 
This was again particularly felt during or after exercise or normal exertion.  
"I can’t even walk up the street.  I get out of breath" – P02 
"I was short of breath as well and you know I could not do much" – P20 
Participants noted how their physical abilities were diminishing compared to 
what they were previously used to. The dyspnoea was described as ‘getting 
puffed’ by more than one participant, and was sometimes described together 
with the chest pain symptom.  
"my quality of life was good although I was getting very puffed out which was 
starting to slightly puzzle me why and where that was coming from" – P08 
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4.4.3.1.5 Dizziness 
One participant mentioned that they became dizzy during this pre-operative 
period, and that experience was the impetus for them to visit their GP: 
"I had a dizzy spell went to my Doctor and he pressured me into having 
some tests" – P08 
This quote also demonstrates the gap between relatively mild symptoms 
contrasting with the potential for catastrophic health outcomes. It is possible 
that the patient visited their GP dutifully, seeking reassurance rather than an 
extended course of treatment for an unexpected health problem. That their 
doctor had to then “pressure” the patient into having more tests suggests that 
their perception of risk was low and they were not anticipating a lengthy 
course of action. 
 
4.4.3.1.6 High blood pressure 
Three participants explained how the diagnostic tests for their known high 
blood pressure, or hypertension, led to the discovery of their aneurysm 
"he said to me well your blood pressure is sky high…he offered me a chest 
X-ray and the X-ray showed that I had a slightly enlarged heart " – P03 
"I had intermittent hypertension where I would go for an echo and they would 
say that my blood pressure was reading high" – P09 
"my blood pressure was high and they sent me for an MRI scan" – P23 
These quotes exhibit a category of patient who already appear within the 
healthcare system for one fairly common condition, high blood pressure, who 
then move to a more serious stage of diagnosis. High blood pressure is 
reasonably well understood condition, and patients will be aware of the risks. 
The difference between the previous ‘Dizziness’ patient being “pressured” 
into more tests and the hypertension patient taking up the “offer” of a chest 
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X-ray may reveal a gap in attitude between individuals who do not expect 
their symptoms to be an indication of a more serious condition, and those 
who do. 
 
4.4.3.1.7 Psychological 
The psychological effects of dealing with an aneurysmal diagnosis were 
discussed by many of the participants.   
A feeling of having a life-threatening condition that could only be cured by a 
significant operation, not without its own risks, weighed heavily on the minds 
of many participants. The awareness that their aortic aneurysm could be 
growing without their knowledge and ultimately had the potential to dissect 
and cause disaster led to a range of significant negative emotions. 
Everything from anxiety and stress through to anger, horror, fear and 
depression were mentioned.  
Feelings of impending doom were related by the following two participants, 
describing the potential for dissection as their aorta “bursting” or “popping”. 
These quotes go some way towards highlighting the powerlessness that 
these individuals feel over the aneurysmal disease: 
"perhaps it’s because I know it can burst so I go to bed at night thinking am I 
going to wake up in the morning…It stresses me to think that I could die at 
any time….you think Christ what if I die tomorrow, what about my poor 
husband." – P02 
"and it’s all horrible isn’t it you don’t expect to be told you have got this bulge 
that is going to pop and again if you feel absolutely fine and you cannot really 
see the point of the operation apart from stopping you dropping dead in the 
street" – P26 
Fear was a common theme, and participants spoke of difficulties with coming 
to terms with their situation. One participant who was a health professional 
explained how having knowledge of the condition exacerbated her fear: 
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“Petrified, I was petrified and annoyed I had an aneurysm because I did not 
know how big it was, I am a nurse by profession so…I understood…the 
implications of it,  I have done many a fast track to theatre you know blue 
lighting with patients that I know had aneurysm’s and to find that I was in that 
position myself was [a] very, very scary and lonely time because the people 
around me kind of didn’t understand the full implications of it, I probably knew 
too much about it and that was a really hard place to be…so I was very 
frightened sort of put my life on hold frightened of moving because I did not 
know what I was dealing with, did not know how big it was" – P09 
This knowledge was seen as a disadvantage and also made the participant 
feel isolated, as people close to her did not share that understanding. 
Many participants were worried about surviving the operation: 
"you only know that you know you have got this major operation in front of 
you your head's swimming and you just think oh my god how am I going to 
cope with all this and what is going to happen am I going to come through it" 
– P13 
Some participants had experience of losing a relative to the same condition 
which compounded their distress: 
"it was scary really I was worried because then, that was what my dad died 
with an aneurysm…and I thought “Oh God, blimey”, I thought, is that going to 
be me now. " – P14 
One participant expressed their extreme emotional reaction to living with the 
aneurysm, as they experienced depression and suicidal thoughts:  
"it’s depressing more than anything it’s a condition really it attacks you so 
hard some days that you just feel that you want to end it all" – P27 
The experience of psychological distress was common and significant for 
most of the participants, which corresponds with previous research findings 
in this area. 
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4.4.3.2 Personal adjustment to recovery 
After the patients had undergone surgery, several themes emerged from 
their recovery period. These ranged from managing expectations of healing 
times and lifestyle changes, to coping with how the surgery had affected and 
altered their bodies. 
 
4.4.3.2.1 Expectation of recovery time 
Participants articulated how they felt differently after their operation, both 
physically and psychologically. These two participants mentioned how they 
had to readjust their expectations of how quickly they would recover from 
their operation: 
"I was surprised it took me so long to recover I just thought I would bounce 
straight back." – P04 
"I can say it can take you 10 months after the operation I started feeling close 
to being back to normal." – P05 
Another participant spoke of the profound differences they experienced 
within themselves after their operation, beyond physical symptoms and 
abilities they felt that their personality had changed and were having to adjust 
to a ‘new normal’. 
"I didn’t prepare myself for how difficult it would be…I don’t think I was 
prepared for that. To not be the same person after it…I was very introverted." 
– P16  
This account reflects a significant impact on personal wellbeing but also on 
the psyche and sense of self which goes beyond physical symptoms. 
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4.4.3.2.2 Unexpected replacement valve noise 
Two of the participants who had received a mechanical aortic valve 
replacement spoke about their experiences of the prosthesis making noises 
that they were unaccustomed to: 
"I was never prepared for the noise of your heart beating … even though I 
was told about it … so when you are lying there when you get to hear the 
valve, okay and when I am lying there I can hear, it is funny. But the worst 
and funniest thing is that I was on the golf team and you know it’s very quiet 
and I was standing next to this bloke and I held my breath and he said what’s 
that beating noise and I goes it my valve, he would go its spooky that it, put 
him off" – P25 
"because I think as well having had the two valve replacements I can hear it 
is so loud you know the whole family..." – P30 
These quotes seem to oscillate between making light of the situation – “put 
him off” – and having an understanding that the “spooky” heart sound makes 
people regard them in perhaps a negative or at the least an unfamiliar way. 
The replacement valve noise therefore has an effect on social interactions, 
possibly causing negative feelings for the patient such as embarrassment or 
shame. The contrast between describing the noise as “the worst and funniest 
thing” is interesting, the valve noise is perhaps a constant reminder both of a 
patient’s mortality and of their resilience and ability to overcome such 
invasive surgery and approach the unusualness of their situation with 
humour, or at least how strange the noise may seem to others. 
 
4.4.3.2.3 Limiting activities 
Participants reported limiting their activities in different ways. One individual 
was obviously keen to begin doing the things they were used to doing, but 
they restricted themselves as they did not want to produce any setbacks in 
their recovery:  
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"I have not yet lifted heavy objects yet because I do not know quite when I 
can do that …. they say 12 weeks but I think I could probably do it now but 
you know rather than risk it" – P12 
Another participant reported limitations in their activities due to how they felt 
after their procedure, another example of the personal differences that can 
be brought about by the surgery: 
"I am not as active now not even close, and I couldn’t be" – P19 
These differences in ability to recover could be caused by a variety of 
factors. The age of the patient and the extent of the operation performed may 
have an effect, and the capacity of the patient to adjust to a new post-
operative sense of self may dictate how much activity they feel capable of. 
 
4.4.3.2.4 Diet and alcohol 
Two participants reported differences in their outlook towards their diet and to 
alcohol consumption. These comments may demonstrate the influence upon 
lifestyles that having a shocking health-related diagnosis and then a 
significant operation such as aneurysmal repair can have on a person’s 
lifestyle.  
"the only sort of things that we would do we changed our diet because we 
used to pig out we were foodies … and I thought you know get rid of a 
couple of stone it has to help" – P29 
"I am not drinking as much as I used to which is another good thing, I like to 
have a drink now and again but obviously not too many" – P20 
These comments seem to reflect an increased attention to personal health 
and a mindfulness of how moderating food and alcohol can have a positive 
effect on mood and outlook. Losing weight “help[s]” and not drinking so much 
is a “good thing”. Although patients had little influence over the growth of 
their TAA and the necessity for the ensuing operation, they do have a certain 
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amount of control over their own lifestyles. Exerting this control in what they 
feel is a constructive way may allow them to feel more optimistic about their 
health in the future. 
 
4.4.3.2.5 Back to wellness and ‘normality’ 
In contrast to the participants who reported feeling less capable and having 
to adjust to a reduced capacity for activity, or even changes in their 
personality, this participant felt that after a period of time they were back to a 
normal state: 
"After the operation after 12 months everything is fantastic and I am feeling 
fine now… probably 12 to 18 months after surgery before you knew it, I 
suppose I felt no discomfort in my chest, I could feel a sort of change that 
week in myself, I could put on a shirt, it was getting comfortable." – P05 
These participants even reported feeling better than ever, with improvements 
in both physical and emotional wellbeing: 
"I am better now than I was, even before I was getting loss of breath at the 
start I am a lot better, I am not as narky " – P22 
"you know I was healthy before the operation … so I felt really good, it’s as 
good as that now if not better, I feel as physically better as I did you know in 
my late 20’s" – P05 
"it was only after about 6 months ... I felt wonderful I felt like I was 16 again I 
felt, my heart felt, I had energy, ready to go out, I was walking and I felt 
absolutely brilliant." – P09 
These comments are interesting as they touch on a range of physical, 
symptomatic and psychological aspects that patients clearly associate with 
their TAA disease and treatment. A routine action that would have previously 
been carried out automatically, such as putting on a shirt with no discomfort, 
is now a physical milestone on the road to recovery. Overcoming 
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symptomatic problems such as shortness of breath are conventional 
indicators of a good health outcome, but being less frustrated, bad-tempered 
or “narky” are the sort of psychological issues that a PROM is specifically 
designed to detect changes in, and that traditional indicators cannot. Two of 
these quotes also refer to the patient feeling young again, which could be 
interpreted as a new lease of life. This may display a perspective of how a 
successful recovery from debilitating disease and invasive treatments can 
rejuvenate people, living under the shadow of conditions like TAA disease 
and then coping with healing and renewal after intensive surgical treatment 
would take a toll on most people’s mental and physical strength. Once 
patients have come through this period, they unsurprisingly feel revitalised, 
full of “energy” and “as good as…if not better” than before their operation. 
 
4.4.3.2.6 Negative body image 
One female participant mentioned how they suffered from a negative body 
image coming from their sternotomy scar. This may be another way in which 
the course of treatment for aneurysmal disease affects patients 
psychologically as well as physically: 
"the body image was really hard at first I could not look at myself, let alone 
anybody else look at me" – P09 
"I get really up tight when somebody says when they see my scar, I don’t 
often, I usually shy away from the camera" – P09 
The presence of a sternotomy scar following cardiac surgery has been 
previously identified as a source of distress for women in particular. King 
(2009) found that although women appreciated that the presence of their 
scar was part of the trade-off between achieving better health and recovery 
from a life-threatening disease, they also found it an upsetting reminder of 
the health scare they experienced and the challenging surgery they had 
been through. Their scar made them feel less attractive and they perceived 
that they were being judged by others when it was visible in public. The 
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quotes above seem to reinforce these conclusions, and support the 
suggestion that patients could be both better prepared for the presence of a 
surgical scar in pre-operative meetings and better assisted to cope with the 
potential for a negative body image in post-operative rehabilitation or 
counselling. 
 
4.4.3.2.7 Determination 
As well as the pessimistic feelings that came with disease diagnosis, 
treatment and recovery.  There were several participants who made a point 
to continue being positive, being determined to overcome their personal 
difficulties and not accepting the intrusion of negative thoughts: 
"you know you got to get on with life…I can’t stand negative … like this lady 
… she is sitting there like an 80 year old and you know I am thinking, you 
only get one life live it.  That’s what it’s all about" – P14 
A stoical, philosophical attitude was also in evidence, with a resolve to rise 
above their situation and not wallow in hopelessness: 
"sometimes your dealt a rough hand aren’t you but there is no point 
complaining and crying and moaning all the time just get on with it and enjoy 
what life you have got, none of us know what is going to happen." – P26 
The substance of these quotes shifts the focus away from an introspective 
characterisation of personal events towards what appears to be an 
instinctive, broader understanding of how a positive approach to objectively 
undesirable situations produces optimism and possibly a smoother road to 
recovery. Rather than focussing on previous bad luck or subsequent 
hardships, making the most of their present situation may be the best way 
these patients know how to make sense of their experience. 
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4.4.3.3 Attitudes of and towards friends and family 
The families and friends of participants unsurprisingly had a significant role to 
play when they were discussing their reactions to their experiences, and their 
support and attitudes towards the participants made deep impressions on 
how they lived through the events surrounding their aneurysmal treatment. 
 
4.4.3.3.1 Understanding the disease 
Several participants reported that when they tried to discuss their situation 
with their loved ones, they found that they did not have much knowledge of 
what aneurysms and their associated risks were, or the differences between 
aortic disease and cardiovascular disease: 
"I don’t think people realise what it is you know " – P14 
"sometimes that you don’t tell people because they instantly think you have 
had a heart attack." – P25 
Even with family members who had no particular preconceived ideas about 
the problems that the participants were facing, there was sometimes a gap in 
understanding: 
"they have just sort of been the same as me really not been able to sort of 
get their heads around it'" – P12 
This participant experienced a wide divergence between what they 
understood to be the risk of their aneurysm, and how their son seemed to be 
processing the information: 
"in terms of family, a lot of people did not understand…my son, no didn’t 
even register with him at all, I don’t think he understood the severity, I did try 
and speak to him but then I thought well maybe … apart from force it down 
their throats and say 'do you realise what this means?!'" – P09 
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This disparity in understanding and difficulty with enabling others to 
comprehend the significance of their situation may contribute to negative 
thoughts and feelings, patients may experience a cognitive tension between 
wanting people to appreciate the seriousness and potential consequences of 
TAA disease but also not want to worry their loved ones too much. 
 
4.4.3.3.2 Support 
Conversely, other participants were keen to express how supportive the 
people closest to them had been: 
"Relationships were fine the wife was supportive" – P20 
Relying on the strength of these cherished relationships was clearly 
something that these two participants felt was a comfort to them throughout 
their experience: 
"I had good support from my husband…[he]’s really good and I do talk to him 
about it … we have got a good relationship and we are open and we are 
honest with each other....I would not have got through it without him, he has 
just been wonderful" – P09 
"but luckily I had family that were very strong you know" – P27 
It is possible that patients who do not have reliable and sympathetic support 
from their family or friends will encounter a more difficult recovery period. 
Having access to some loving reassurance, being able to share 
responsibilities and knowing that there is someone present who can care for 
and assist you if there are difficulties would clearly be a comfort to patients 
both before and after TAA surgery.   
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4.4.3.3.3 Not informing people 
Two participants reported another reaction to the news of their diagnosis. 
Although their nearest friends and family were involved, they did not 
necessarily tell people in their extended social and family network about their 
condition. This first quote shows that they are trying to protect these others, 
as the participant does not want them to experience any negative emotion or 
anxiety by being concerned about their situation: 
"I just did not bother telling them so no big deal, I didn’t need them to worry" 
– P25 
This reluctance to speak about their health and not want others to react may 
be part of a coping mechanism, minimising the effects of their problems 
externally so that they do not see them as insurmountable internally. 
"to be quite honest with you we never talked about it, I come back and I 
didn’t say nothing" – P28 
These patients offer fairly blunt responses, which may be a further indication 
of how they have socially managed their experience of TAA disease and 
treatment. By not engaging in communication and preventing others 
involvement, they may be protecting themselves from unwelcome reactions. 
“No big deal” for the patient either way; if the reaction of their extended family 
and social network had been less than they might have anticipated, then they 
do not feel slighted. If the reaction made it obvious that they had placed extra 
concern and anxiety on these people, then they are protected from carrying 
that with them also. 
 
4.4.3.3.4 Preparing for the worst 
With the potential outcomes of their surgery including the possibility of death, 
some participants realised that they should prepare financially for that 
possibility. It is likely that these two individuals found some peace of mind in 
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knowing they had taken care of their family to the best of their ability, in case 
the treatment outcome had been a poor one: 
"I just prepared that at least I’m getting an income coming in the family would 
get money if they needed to depending on what happened with me…I did put 
things in place just in case for my family" – P09 
"I was more worried about me being the main bread winner and that was a 
concern for checking all life insurance policies and we were covered which 
was lucky so we would be ok if the worst happened so that helped me a little 
bit but that’s all I thought about trying to get through the normal stuff just in 
case the worst happened." – P16 
These comments highlight the unusually intense situation of knowing that 
treatment to resolve TAA disease carries with it the risk of death. They are a 
reminder that the strategy of surveillance, or ‘watch-and-wait’, exists because 
an invasive treatment for TAA disease can involve a greater threat of 
mortality. Patients naturally find reassurance in their situation by 
concentrating on “normal” personal administration tasks and relieving some 
amount of anxiety. 
 
4.4.3.4 Continued diagnostic monitoring for aneurysmal 
disease 
Patients who have surgery for aneurysmal disease are often genetically 
predisposed to the condition (see Chapter 2.3.4). This means that all patients 
are routinely offered follow-up monitoring to identify any further aneurysms 
which may occur. Interview participants were recruited from these follow-up 
monitoring clinics, so they had unique and current insights into how these 
made them feel. 
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4.4.3.4.1 Reassurance 
This participant reported being reassured by these clinic visits, seeing them 
as check-ups and not letting negativity about what may be found affect them: 
"I am doing more in some ways because I am not thinking about the problem 
I had, it’s been fixed I just get checked up now" – P03 
Another participant said that they appreciated getting their annual check-up: 
"it is nice to know that we come back every year and get the MOT" – P21 
The “MOT” terminology that this participant uses is striking, as it relates to 
the annual UK Ministry of Transport motor vehicle roadworthiness test. The 
patient is perhaps intending to defuse the threat of recurrent TAA disease by 
humorously minimising its importance and maybe slightly dehumanising 
themselves. Alternatively they are using this language to ‘other’ their disease. 
As TAA disease in isolation rarely has symptoms this disassociation makes 
sense, because even if there was a large TAA with a high risk of aortic 
rupture the patient may be oblivious. Patients with TAA disease are reliant on 
clinical experts to let them know if they have a problem with their own bodies, 
just as most car owners would not be aware if their car required a new oil 
filter or an exhaust fitting, they rely on garage mechanics to inform them 
whether their car is fit for travel or not. 
 
4.4.3.4.2 Apprehension about reoccurrence 
However, the same participant as in that last quote went on to admit that 
there was also apprehension and nervousness about the results of the 
annual check-up. This suggests that patients do not take for granted their 
‘aneurysm-free’ status and may have underlying concerns about the 
possibility of further operations: 
"you feel a bit conscious when you come back after you have had your scan 
and you think, oh, you know what are they going to find" – P21 
147 
 
The check-ups themselves, although necessary, are understandably a 
source of anxiety and trepidation. They are a reminder that although their 
TAA disease has been successfully diagnosed and treated in the past, there 
may be no physical symptoms or warning signs to let the patient know that 
they have a current problem.  
 
4.4.4  Physical HRQoL  
The physical element of participant’s post-operative experience was 
discussed by all participants. This ranged from a brief outline of how they felt 
in themselves, to more complex, personal observations about their bodies 
capabilities and the changes that their health and healthcare had made. 
 
4.4.4.1 Exercise 
Several participants discussed how their activity capabilities and exercise 
regimes had developed and changed after their aortic aneurysm surgery. In a 
similar way to the activities item and the diet and alcohol item, this individual 
recognised that maintaining a healthier lifestyle was important in light of their 
treatment: 
"I like physical work and I think it is probably good to keep in shape after 
something like this." – P08 
Another patient highlighted the differences in what they felt capable of, and 
their mindfulness of what their limitations may be: 
"I do small jobs, if it’s a big job I will get somebody in to help" – P10 
This quote is useful in emphasising how returning to exercise allowed this 
individual to feel like they were getting back to their normal state: 
"I am back running now jogging, doing exercise, so yes I feel fine" – P12 
148 
 
These statements from patients reinforce the idea that TAA disease 
treatment represented a step-change in their awareness of personal health 
and how their own understanding of their physical capabilities seem to act as 
a yardstick both for recovery and for adjusting to a ‘new normal’. 
 
4.4.4.2 Lying in bed / sleep 
This participant mentioned that sleeping could be challenging immediately 
after surgery. Their chest wound would understandably prevent them from 
making their normal movements and lying down in their usual manner when 
they were in bed. 
"I have to get out of bed to turn over because I cannot do it any other way" – 
P13 
These two patients also report that getting enough quality sleep in the initial 
weeks following surgery can be a challenge: 
"when you come out of hospital and you go to sleep on your back, sleeping 
on your back propped up is just the most awful thing " – P25 
"I did not sleep well for about two weeks" – P26 
Not being able to get a good night’s sleep may also restrict post-operative 
healing and generate a low mood. Redeker (2004) studied the sleep habits 
of patients after cardiac surgery and found an association between sleep 
patterns and changes in physical function and emotional wellbeing.  
 
4.4.4.3 Intimacy 
Participants also spoke about their reactions to others in terms of intimacy. 
This ranged from individual to individual from cuddling, kissing to sexual 
contact. This participant highlights the difficulties and breadth of feeling when 
becoming intimate with their partner: 
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"Some weeks, sometimes it is a bit of a roller-coaster, one minute were okay 
and then other times I will shy away from it" – P09 
This patient emphasises the way in which pain dictated how much intimacy 
they felt comfortable with: 
"the first couple of weeks there was no cuddles for anybody I can tell you 
that, because [of] the pain" – P25 
Other studies have shown adverse effects on sexual activity in patients who 
underwent cardiac surgery. In the early post-operative period Foruzan-Nia 
(2011) found a significant increase in male impotance and premature 
ejaculation along with a decrease in libido, while females may experience 
unusual sensations in their breasts such as pain, numbness, tingling, 
burning, or heaviness (Steinke, 2013). Coupled with this is some evidence of 
a reluctance from healthcare professionals to discuss these issues with 
patients, with several studies demonstrating the reluctance of nurses to 
councal patients with heart disease about their sexual health concerns 
(Hoekstra, 2012; Barnason, 2013 and Wang, 2019). 
 
4.4.5  Psychological HRQoL 
The psychological element of participant’s post-operative experience was 
characterised by both negative and positive emotions.  Even though their 
health problem had been treated successfully, there was still some discourse 
about how they were not necessarily content. However, this trepidation was 
also counterbalanced by individual’s drive to not be overwhelmed by events. 
 
4.4.5.1 Low mood / negative thoughts 
After their operation, this patient reports feeling negative emotions. Thinking 
about “everything” suggests that they were stunned and exhausted by the 
treatment:    
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"you just think about everything and probably a lot of it was negative " – P19 
This participant reports being scared and feeling lonely: 
"then you go home and you think I am on my own, I am on my own what am I 
going to do and its frightening" – P27 
Being discharged from a hospital full of health professionals back to a 
patient’s home can clearly feel like a big step if they do not feel properly 
supported or able to take care of themselves. 
 
4.4.5.2 Overcoming adversity 
Although participants had in many cases been through a life-altering health 
situation, in a similar way to the determination item exhibited pre-operatively, 
they refused to be laid low by their circumstances.  
"I would not, not do anything I would find a way" – P09 
This participant endured through their aneurysmal treatment, and finds 
intrinsic value in that alone:  
"Never mind, I am still here to tell the tale" – P14 
These statements show the participants finding strength in their 
perseverance and survival. 
 
4.4.5.3 Vulnerability 
One participant reported feeling emotionally vulnerable when confronted with 
the prospect of being physically challenged: 
"we walked past the shops and there were a gang of lads there and I felt 
really nervous and felt dead vulnerable" – P16 
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This quote highlights a potential link between a perceived possibility of either 
verbal abuse or physical threat from the group of youngsters, leading the 
patient to consider their own reduced physical effectiveness in such a 
situation in the aftermath of TAA surgery, the further consequence being a 
negative emotional response. It would not be hard to conceive a situation 
where post-operative TAA patients chose to avoid unpredictable scenarios 
such as this, maybe leading to their normal activities or social life being 
restricted. 
 
4.4.6  Social HRQoL  
The social element of participant’s post-operative experience was also 
shown to have been affected by their health condition. 
 
4.4.6.1 Work 
This individual reports that they took 10 weeks to return to work at a reduced 
rate. Moreover they identify boredom as being a motivating factor for getting 
them back into a routine: 
"I think I was back in work after 10 weeks, obviously not doing as much as I 
used to…I suppose I was getting bored at home, probably just wanted to get 
back into a routine" – P20 
This participant quote demonstrates the challenge of returning to work, and 
the slow, structured way in which they had to build up their return in order to 
cope with the additional activity: 
"I started work by doing 1 day, 2 days, 3 days, 4 days and I eased myself 
back in " – P25 
Effective self-management and an innate understanding from the patients 
themselves of what will improve their psychological wellbeing, without 
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disturbing their physical and emotional recovery are suggested in these 
quotes. 
 
4.4.6.2 Relationships 
One particular participant spoke about struggling both with the regularity of 
people asking for information on their recovery: 
"and in the end I just said when anything gets sorted I will let you know stop 
phoning up!" – P27 
And also with their inevitable limitations and weaknesses during the recovery 
period: 
"and my best friend ever, I kept saying to her I am a rubbish friend,  why are 
you a rubbish friend,  because I had to call you and make you come down" – 
P27 
These quotes illustrate the emotional confusion that patients can feel during 
this post-operative period, and the negative thoughts and feelings that can 
occur when an individual’s body has an invasive surgery and is placed in an 
unfamiliar state of recuperation. 
 
4.4.6.2 Leisure time 
Participants were also proud of themselves for getting over their operation 
and achieving noteworthy accomplishments after their TAA surgery. It seems 
clear that this participant feels satisfied and uplifted by what he has managed 
to achieve in his leisure time: 
"they do not believe you could do the 35k having had, you know, the open 
heart surgery in January and that was quite a hard bike ride to do let me tell 
you some big bloody hills in that but so some people must feel a bit shocked 
that you can recover so quickly" – P25 
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They also seem gratified by the speed of their recovery and how they have 
managed to get back to doing what they enjoy in spite of what others may 
have thought.  
 
4.4.7  Conceptual framework 
Conceptual models are graphical representations that organise concepts and 
establish possible relationships among the concepts. Figure 4.1 summarises 
the results of the qualitative study, suggesting a conceptual model on TAA 
and HRQoL that links perceptions of receiving a diagnosis of TAA and 
undergoing subsequent surgical treatment, to satisfaction towards that 
treatment, attitudes of and towards friends and family and perceptions 
regarding the value of continued clinical monitoring of the TAA disease based 
on the data. The findings are then mapped onto the physical, psychological, 
and social HRQoL domains outlined in Sections 4.4.4, 4.4.5 and 4.4.6. The 
extent of the aneurysmal disease along with any associated heart disease 
may also influence the perceptions and experience of the disease, treatment 
and HRQoL. 
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Figure 4.1: Conceptual model 
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4.4.8 Perceptions of TAA patient QoL amongst health 
care professionals 
A separate series of four interviews were conducted with aortic surgeons in 
order to identify their views on the impact of TAA disease on their patients’ 
daily lives.  They were asked how, in their opinion, patients responded to 
their diagnosis of TAA disease, how patients experienced TAA disease in 
their daily lives and how surgical treatment affected patients day-to-day 
activities, with particular regard to any physical and psychological changes. 
They were asked to describe changes patients might notice in the short- and 
long-term in relation to symptoms, physical, psychological and cognitive 
functioning, and any complications. Their responses were used to support 
the conceptual model of proximal TAA disease derived from the patient 
interviews and their insight into patient behaviours was used to further tailor 
the questionnaire items to the target cohort.  
Discussion with the consultants also suggested a requirement for three 
separate PROM deliveries. A pre-operative PROM (Q1) and two post-
operative PROMs (Q2 and Q3). Q1 would be delivered pre-operatively, Q2 at 
6 weeks post-operation and Q3 at 3 months post-operation. The surgeons 
felt that the recovery from the surgery could be arduous, so patients may 
actually feel worse at 6 weeks post-operatively than they did beforehand. 
Then after 3 months the feeling was that although there may be some 
residual discomfort, patients should be returning to normal activities. 
 
4.5  Questionnaire construction 
The results of the qualitative research phase and the literature review formed 
the basis for construction of the proximal TAA PROM. Essential components 
identified for inclusion in the disease specific section of the PROM included: 
symptoms (or lack thereof), restrictions in physical activities, psychosocial 
function (anxiety, fear of death and / or pain, low mood, uncertainty, self-
efficacy, frustration and avoidance of activities, impact of TAA disease on 
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family and friends, independence, interference with social activities) and 
cognitive function (reasoning, memory, attention and concentration). The 
general health measure included in the PROM was the EuroQol EQ-5D-5L 
(see Section 2.4.3 and Herdman, 2011) and the EuroQol EQ-VAS (Rabin, 
2001). Permission for using these instruments for the purposes of this study 
was sought from and granted by the EuroQol Research Foundation.  
Additional post-operative items identified for inclusion included physical and 
psychological complications, treatment satisfaction (including information 
received, expectations about the impact of the operation and the strategy for 
follow-up TAA monitoring) and a single ‘Friends and Family Test (FFT)’ 
question. The FFT is a commonly used patient experience tool that has been 
used in a variety of settings within the NHS, it has produced over 65 million 
pieces of feedback so far (NHS England, 2019) and was considered to be a 
concise and potentially valuable inclusion. 
All 3 versions of the proximal TAA PROM include the four disease specific 
domains: Symptoms, Physical Function, Psychosocial Function and 
Cognitive Function. They also include the EQ-5D-5L and the EQ-VAS 
general health measures.  
The Q1 pre-operative PROM includes 3 items not found in the post-operative 
Q2 and Q3 PROMs, these relate to time since diagnosis, previous operations 
for heart conditions and a list of co-morbidities.  
The Q2 and Q3 post-operative PROMs are identical, apart from an 
introductory wording change from “six weeks” to “three months”. They 
include 17 items not found on the Q1 PROM which relate to post-operative 
complications, treatment satisfaction follow-up hospital care and the FFT. 
 
4.5.1  Item generation 
Items were generated for each specified domain. Items were either borrowed 
or modified from the CROQ (Schroter, 2004), or newly created. The 
157 
 
Symptom domain includes 12 items: 3 items were borrowed from the CROQ, 
1 item was an amalgamation of 2 CROQ items and 8 items were newly 
created. The Physical domain includes 9 items: 7 items were borrowed from 
the CROQ and 2 items were created as a result of splitting a single further 
CROQ item into 2. The Psychosocial domain includes 16 items: 13 items 
were borrowed from the CROQ, 1 was a modified CROQ item and 1 item 
was newly created. The Cognitive domain includes 3 items: 1 item was 
borrowed from the CROQ and 2 were modified CROQ items. 
The items associated with these domains can be found in Table 4.4. 
Where possible items were borrowed from the CROQ, which in fact sourced 
nearly half of its own items from other well-validated, psychometrically sound 
questionnaires. The language of each item was altered slightly to shift the 
focus towards the patient’s “aortic aneurysm”. However, some of the 
necessary items, especially in the Symptoms domain, were not well covered 
by the CROQ. New items were constructed where the necessary subjects 
were not adequately covered by the CROQ or other existing questionnaires. 
Interview themes and the relevant literature were consulted in order to 
identify further items for inclusion.  
Particular effort was made to construct simple and specific questions. 
Unusual or ambiguous phrases (Schwarz, 1999), and double-barrelled 
questions (Streiner, 2015) were avoided. Attempts were made to keep the 
text of the items as short as possible, as longer items have been shown to 
have poorer validity (Holden, 1985). All items included required a response, 
as Fayers (2013) contends that including questions which are not applicable 
to a subset of respondents can have the consequence of increased missing 
data. Underlining and the use of bold font were used to emphasise the time 
of reference along with the terms “heart condition or aortic aneurysm” 
(Ringash, 2016). This was done to help the patient focus on the specific 
problem and the impact of their aortic aneurysm / surgical treatment on their 
day-to-day life.     
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Table 4.4: Items associated with PROM domains                          
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4.5.2  Focus group 
The appropriateness and acceptability of the proximal TAA PROM instrument 
was evaluated by a focus group discussion. Focus groups have been widely 
used in health research to explore the patient perspective (Carr, 2003; Côté‐
Arsenault, 2005). They are often included in mixed-methods studies to 
gather information on the suitability of questionnaire construction or to help 
interpret results (Creswell, 2017; Kroll, 2005). Tausch (2016) notes that the 
intention of having a group process is to help people recognise and clearly 
explain their views, this is considered to be a significant benefit that focus 
groups have over individual interviews. Tausch goes on to say: 
“The group functions as a promoter of synergy and spontaneity 
by encouraging the participants to comment, explain, disagree, 
and share their views. Thus, experiences are shared and 
opinions voiced that might not surface during individual 
interviews.” 
72 patients with a history of proximal TAA disease were identified from the 
LHCH clinical database. They were each telephoned and invited to attend a 
2 hour focus group to discuss the structure, content and clarity of the PROM 
questionnaire. As an incentive for attendance, they would be given £10 
towards their travelling expenses. 
21 patients said that they would be interested in attending, they were sent an 
invitation letter in the post along with a copy of the pre-operative PROM (Q1) 
and one of the post-operative PROMs (Q3). They were asked to scrutinise 
these 2 questionnaires and consider: 
- Is there anything that could be added or altered that would improve 
them? 
- Are there any questions or terms that do not make sense, or are 
difficult to understand? 
- Is any of the wording or the layout incorrect or inappropriate? 
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8 patients ultimately attended on the day itself. Those patients were arranged 
into 2 groups of 4, each with a member of the research team who guided the 
discussions and recorded their findings using a pen and paper. 
Patient responses to the PROM instrument were generally positive:  
 They were pleased that they would have the opportunity to report their 
own experiences. 
 They felt that the questions covered the range of experience they had 
encountered. 
 The length, layout and font were acceptable. 
 Completing 2 post-operative PROM questionnaires was also 
acceptable. 
However, patients did suggest some changes to the draft PROM instrument 
that were incorporated into the items listed in Table 4.4: 
 The order of the items in the physical domain should be from easy to 
difficult, rather than difficult to easy. 
 Another item in the Physical domain that related to “Bathing and 
dressing yourself” should be split into 2 separate questions. 
 The item regarding “Depression” in the Psychosocial domain should 
be expanded to “Depression, or in a low mood”, as patients felt that 
the original term may be confusing. It was suggested that respondents 
may believe the question is relating to clinically diagnosed depression 
only, so less severe depressions may be missed. 
 In the Cognitive domain, it was suggested that the first 2 items (“Have 
difficulty reasoning and solving problems” and “Forget things”) would 
benefit from examples of what was meant by this, in a similar way to 
some of the questions in the Symptoms domain. 
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4.6  Summary 
These findings develop understanding of the complicated relationships 
between TAA disease, surgical treatment, treatment satisfaction, symptoms, 
patients’ adjustment to recovery, TAA patient’s attitudes of and towards family 
and friends, continued diagnostic monitoring for aneurysmal disease and 
HRQoL. The data outline perceptions of the disease and treatment in the 
context of a patient’s everyday life.    
The early post-diagnosis phase is characterised by physical and 
psychological components. Psychological reactions included shock, stress 
and anxiety, and occasionally depression and suicidal thoughts. Physical 
symptoms included overwhelming tiredness, sometimes resulting in collapse. 
Patients diagnosed with concomitant heart disease also suffered with 
shortness of breath, chest pains and dizziness. Attitudes towards the surgical 
operation itself were typified by acceptance and apprehensiveness. Post-
operatively, participants described a period of adjustment related to physical 
condition, improvement in diet, awareness of their body’s limits and 
weaknesses, challenges with sleep and intimacy, anxiety, depression, 
vulnerability and a negative body image. Also firmly present was a stoic 
determination to overcome these concerns, by drawing strength and 
motivation from family, friends and fellow patients. Where a heart problem 
had also been treated, participants tended to report a reduction in physical 
symptoms. 
The conceptual model of proximal TAA disease is proposed based on an 
extensive literature review, in-depth patient interviews and agreement of 
importance of concepts by aortic surgeons.  
Patient-based focus group discussions found the resultant PROM based on 
items derived from the conceptual model to be appropriate and acceptable, 
with minor changes to clarity and layout. 
The subsequent chapter describes the methods and results of the pilot field 
test undertaken to evaluate the reliability, validity, responsiveness to change 
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and clinically important differences of the newly constructed proximal TAA 
PROM.  
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Chapter 5 
Quantitative study 
 
5.1  Introduction 
This chapter presents the results of the quantitative study phase, this phase 
aimed to pilot the proximal TAA PROM. Preliminary field testing was 
undertaken to perform an initial evaluation of the PROM instrument. 
Standard quantitative assessments for questionnaires, including 
acceptability, feasibility, interpretability, precision, reliability, validity and 
responsiveness were addressed in the context of this newly proposed 
PROM. 
 
5.2  Objectives 
The objectives of this study were to: 
 Plan and implement a practical approach to how TAA PROMs are 
administered  
 Collect and store the data received from the completed TAA PROMs 
appropriately 
 Carry out statistical analysis to assess the reliability and validity of the 
TAA PROM, including: 
o Assessing the internal consistency of the TAA PROM scores  
o Assessing the test-retest reliability of the individual items of the 
TAA PROM 
 Present the results of the TAA PROM pilot study, and measure any 
changes in domain scores before and after aneurysmal surgery 
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5.3  Methods 
5.3.1  Inclusion and exclusion criteria 
All patients included in the study were inpatients at LHCH between October 
2017 and March 2019. In order to be invited to participate, patients had to 
comply with the following inclusion and exclusion criteria: 
The inclusion criteria for the quantitative study were: 
 Participants must be age 18 years or over 
 Presenting electively for surgery on proximal thoracic aortic aneurysm 
(TAA) disease 
 Inpatient at LHCH 
The exclusion criteria were: 
 Under 18 years of age  
 Unable to provide informed consent  
 Recorded diagnosis of more acute aortic syndromes, such as aortic 
dissection, trauma, intramural haematoma or penetrating 
atherosclerotic ulcer 
 
5.3.2  Pilot study recruitment and approach 
Potential participants were identified from the consultant aortic surgeon’s 
electronically networked theatre diaries. Proximal TAA cases were identified 
based on the theatre session listing within a Microsoft Outlook diary entry 
and confirmed by visual inspection of relevant letters (such as letters to the 
patient’s GP about an outpatient attendance) and diagnostic documentation 
(such as typed results of CT scans confirming the aneurysm size) on the 
LHCH electronic patient record system.  
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Patients meeting the inclusion and exclusion criteria were sent an 
introductory letter in the post inviting them to take part in the study (see 
Appendix F1) along with a copy of the pre-operative PROM instrument (Q1; 
Appendix F2) and an envelope to return the completed questionnaire with a 
freepost sticker attached. This was scheduled to happen approximately two 
weeks before they were due to have their proximal TAA operation. 
Patients who returned the Q1 PROM then routinely received a further letter 
and post-operative PROM at both 6 weeks (the letter can be seen in 
Appendix G1 and the questionnaire (Q2) in Appendix G2) and 3 months (the 
letter can be seen in Appendix H1 and the questionnaire (Q3) in Appendix 
H2) after their operation. Patients received both questionnaires regardless of 
whether they completed and returned the Q2 PROM.  
If the Q1 PROM was not returned, the patient was considered to have 
declined the opportunity to take part in the study and the follow-up 
questionnaires were not sent. 
 
5.3.3  Data collection and analysis  
Mailing and response data were collected using customised Excel 
spreadsheets. Categorical variables are presented as absolute number and 
%, associations were investigated using chi-squared tests or Fisher’s exact 
tests as appropriate. For continuous variables, firstly distributive normality 
was established using the Kolmogorov-Smirnov test and by visual inspect of 
frequency distributions. Then in the case of normally distributed variables, 
figures are presented as mean ± standard deviations and comparisons are 
made using the Students t-test. In the case of non-normally distributed 
variables, figures are presented as medians (inter-quartile range) and 
comparisons are made using Mann Whitney U-tests. 
Interpretability was measured using the technique described in Morris 
(2013), the precision of individual scores was calculated at the 90% 
confidence interval level by multiplying the standard error of measurement 
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(SEM) by the two-tailed z value at 90%. This approach was used as an 
attempt to identify potentially minimal important changes (MIC) within the 
PROM domains, the EQ-5D index and the EQ-VAS. These MIC calculations 
demonstrate the differences between both the disease specific domains and 
the general health measures from baseline to 6 weeks and 3 months. 
Differences from baseline are displayed in cumulative distribution frequency 
(CDF) charts. 
Item response theory (IRT) (see Embretson, 2013), as described with 
application to health outcomes and health status measures by Hays (2000) 
and McHorney (2000), is a technique used to assess the precision of 
measurement tools such as questionnaires. The approach has overtaken 
what was traditionally achieved with classical test theory (CTT) methods 
such as item-total correlation analysis, stepwise regression and factor 
analysis (Coste 1997). A variation of IRT known as the Rasch model is 
increasingly applied as the ‘gold standard’ of questionnaire development, this 
method aims to ensure more accurate, efficient and reliable items. 
The Rasch model generates a linear metric scale in logit-units, representing 
the construct being measured, on which both the questionnaire items and 
respondents persons are located (Prieto, 2003). Then, the probability of any 
particular item response by any particular individual is given by a logistic 
function of the difference between the item location and person location (for 
an example, see Tennant, 2007). Items and respondents are then judged for 
model conformity using fit statistics.  
Sample size is an important consideration when undertaking psychometric 
evaluations, so the development of CTT, IRT or Rasch modelling falls outside 
of the scope of this pilot study. Recommended minimum sample sizes for 
relatively straightforward models begin at 100 (Linacre, 1994), but others 
suggest that at least 200 (Orlando, 2002) or 500 cases (Tsutakawa, 1990) 
are required before these types of analyses can be considered useful and 
informative. 
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Internal consistency of the proximal TAA PROM was calculated using 
Cronbach’s alpha (see Tavakol, 2011). Cronbach’s alpha measures the 
internal consistency of a question or scale, in practice this means that it 
provides an estimate that represents the degree to which a group of 
questions (or ‘items’), within a questionnaire domain, produce similar scores 
or appraise the same concept. 
Cronbach’s alpha is presented as a number between 0 and 1. Acceptable 
values have been suggested to lie between 0.70 and 0.95, a low score 
indicates that items may have poor inter-relatedness or perhaps have been 
assembled in an unrelated manner (Bland and Altman, 1997). Whereas if the 
score is too high, it may suggest that some items are redundant as they are 
testing the same concept using an altered form of words.  
The reproducibility of questionnaire results is assessed by carrying out a 
test-retest analysis. Suitable patients are given the questionnaire and asked 
to complete it twice within a relatively short time frame, usually no more than 
two weeks. 
The output of a test-retest study is known as the intraclass correlation 
coefficient (ICC). It gives an indication of the extent to which measurements 
can be replicated, not only the degree of correlation but also the level of 
agreement between results from Phase 1 and Phase 2 responses. As with 
Cronbach’s alpha, the values range from 0 to 1 with values closer to 1 
representing a stronger reliability. ICC values less than 0.5 indicate poor 
reliability, between 0.5 and 0.75 moderate reliability, between 0.75 and 0.9 
good reliability and greater than 0.9 excellent reliability (Koo, 2016). 
Changes in the reported PROM scores between the baseline Q1 
measurement and both the 6 week Q2 measurement and the 3 month Q3 
measurement are presented as box and whisker charts (McGill, 1978). 
These charts show the median and the IQR in the ‘box’ and the range in the 
‘whiskers’, the mean value is represented with a blue dot. Comparisons of 
scores have been made using the Wilcoxon signed rank test for continuous, 
non-parametric, paired results (Chan, 2003).  
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Statistical analyses were conducted using SAS for Windows v9.3 (SAS 
Institute, Cary, NC), in all cases a P value < 0.05 was considered statistically 
significant. 
 
5.4  Results 
5.4.1  Study participants and sample size 
A total of 125 patients were found to be eligible to receive a proximal TAA 
PROM. In the pilot period 58 patients returned a completed copy of the Q1 
PROM instrument, giving a response rate of 46.4%. The final number of 
patients who returned completed Q1, Q2 and Q3 PROM instruments and 
were therefore included in the main pilot analysis was 30 (response rate of 
24% of original sample).  
The cohort diagram in Figure 5.1 below clarifies the responses and reasons 
for attrition during the study period. 
 
Figure 5.1: Cohort diagram showing pilot study response rates and attrition 
categories 
 
125 patients eligible to be sent a pre-operative PROM questionnaire (Q1)
67 (53.6%) patients did not return the Q1 questionnaire
58 (46.4%) patients returned a completed Q1 PROM questionnaire
4 (3.2%) patients died before 6 weeks post-operation
3 (2.4%) patients did not recieve aneurysmal surgery
3 (2.4%) patients returned the Q1 PROM post-operatively
1 (0.9%) patient was still in hospital at 6 weeks post-operation
47 (37.6%) patients eligible for a 6 week (Q2) + 3 month (Q3) post-operative PROMs
8 (6.4%) patients did not return the Q2 questionnaire
9 (7.2%) patients did not return the Q3 questionnaire
30 (24.0%) patients included in the Q1, Q2 and Q3 post-operative PROM analysis
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5.4.2  PROM pilot patient characteristics 
5.4.2.1 Respondent pre-operative characteristics (n=58) 
Respondents’ ages ranged from 27 to 88 years old at the time of their 
operation, with the majority (n = 36, 62.1%) being 60 or older. Nineteen 
(32.8%) of the respondents were female. Patient socio-demographic 
characteristics and co-morbidities are presented in Tables 5.1a and 5.1b. 
In addition to the characteristics of the overall cohort, a statistical comparison 
was made between study responders and non-responders. It was found that 
patients who responded to the invitation to participate in the PROM pilot 
were more likely to be older (median age of 64 years (IQR = 54 to 72) vs. 
median age of 56 years (IQR = 43 to 67); Mann Whitney U p = 0.01).  
Two other characteristics that may also have influenced response rates had 
p-values < 0.05, although small numbers mean these findings should be 
treated with caution due to low statistical power. Patients who had suffered a 
previous myocardial infarction were more likely to respond than those who 
had not (6 / 58 (10.3%) vs. 1 / 67 (1.5%); Fisher’s exact p = 0.049). Also 
perhaps understandably, patients who had not suffered a previous stroke 
were more likely to respond than those who had (2 / 58 (3.5%) vs. 9 / 67 
(13.4%); Fisher’s exact p = 0.049). 
There were no other statistically significant differences between the 
responders and non-responders on a range of clinical and demographic 
variables, as shown in Tables 5.1a and 5.1b. This shows that apart from 
some potential age bias, the invitation to the study was reasonably 
acceptable to patients across a range of different presentations. 
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Table 5.1a: Eligible patients’ socio-demographic characteristics and pre-
operative co-morbidities 
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Table 5.1b: Eligible patients’ socio-demographic characteristics and pre-
operative co-morbidities (cont.) 
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5.4.2.2 Respondent intra-operative characteristics 
Eligible patient’s intra-operative characteristics are shown in Table 5.2. This 
data includes the types of operation carried out on the patient, including any 
coronary revascularisation and valvular replacements or repairs, along with 
information on the segments of the aorta that were operated on, the 
operative times and an anonymised breakdown of responsible consultant. 
One consultant operated on over half of the eligible patients included in the 
pilot study (n = 64; 51.2%), with a second consultant accounting for a further 
21.6% (n = 27). The remaining 34 patients were split fairly evenly between 
another three consultant surgeons. This data shows that over a range of 
clinical procedure variables, there were no statistically significant differences 
between responders and non-responders. 
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Table 5.2: Eligible patients’ intra-operative characteristics 
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5.4.2.3 Respondent post-operative characteristics 
Eligible patient’s post-operative outcomes are shown in Table 5.3. This data 
includes in-hospital mortality (n = 3, 2.4%, across the entire cohort), along 
with major morbidity (strokes, paraparesis (partial paralysis of the lower 
limbs), renal failure and reoperation) and lengths of stay for these patients in 
intensive care, post-operatively and as a whole. Again the data and the 
statistical analyses shows no statistically significant differences in post-
operative characteristics between the responders and non-responders. 
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Table 5.3: Eligible patients’ post-operative in-hospital outcomes 
                                                  
  
A
ll
 p
a
ti
e
n
ts
 e
li
g
ib
le
 f
o
r 
P
R
O
M
R
e
s
p
o
n
d
e
rs
N
o
n
-r
e
s
p
o
n
d
e
rs
(n
 =
 1
2
5
)
(n
 =
 5
8
)
(n
 =
 6
7
)
In
-h
o
s
p
it
a
l 
m
o
rt
a
lit
y
3
 (
2
.4
)
2
 (
3
.5
)
1
 (
1
.5
)
0
.6
0
P
e
rm
a
n
e
n
t 
s
tr
o
k
e
2
 (
1
.6
)
1
 (
1
.7
)
1
 (
1
.5
)
>
0
.9
9
T
ra
n
s
ie
n
t 
s
tr
o
k
e
1
 (
0
.8
)
0
 (
0
)
1
 (
1
.5
)
>
0
.9
9
P
a
ra
p
a
re
s
is
1
 (
0
.8
)
1
 (
1
.7
)
0
 (
0
)
0
.4
6
R
e
tu
rn
 t
o
 t
h
e
a
tr
e
 f
o
r 
re
o
p
e
ra
ti
o
n
9
 (
7
.2
)
4
 (
6
.9
)
5
 (
7
.5
)
>
0
.9
9
A
c
u
te
 r
e
n
a
l 
fa
ilu
re
2
 (
1
.6
)
0
 (
0
)
2
 (
3
.0
)
>
0
.9
9
D
e
e
p
 s
te
rn
a
l 
w
o
u
n
d
 i
n
fe
c
ti
o
n
0
 (
0
)
0
 (
0
)
0
 (
0
)
-
In
te
n
s
iv
e
 c
a
re
 L
O
S
 (
d
a
y
s
)
3
 (
2
, 
6
)
3
 (
2
, 
7
)
3
 (
2
, 
6
)
0
.1
9
P
o
s
t-
o
p
e
ra
ti
ve
 L
O
S
 (
d
a
y
s
)
8
 (
6
, 
1
3
)
8
 (
6
, 
1
3
)
8
 (
5
, 
1
3
)
0
.9
9
T
o
ta
l 
h
o
s
p
it
a
l 
L
O
S
 (
d
a
y
s
)
1
0
 (
7
, 
1
5
)
1
0
 (
7
, 
1
5
)
1
0
 (
7
, 
1
6
)
0
.7
8
P
 
v
a
lu
e
176 
 
5.4.2.4 Analytical cohort characteristics 
In order to establish the suitability of the analytical cohort (i.e. the 30 
participants who completed the PROM at all 3 time periods, see Figure 5.1) 
to accurately represent the characteristics of the proximal TAA patient 
population as a whole, it was necessary to repeat the pre-, intra- and post-
operative analysis, this time comparing those patients in the analytical cohort 
(n = 30) with the remaining eligible patients who did not respond (n=95). The 
data on demographic and clinical differences is presented below in Tables 
5.4a, 5.4b, 5.5 and 5.6. The 30 Q3 PROM responders did appear older, and 
a higher proportion were female compared to non-responders, but this was 
not statistically significant. 
There were no statistically significant differences between the patients in the 
analytical cohort and the other eligible patients identified, suggesting that 
there was no identifiable bias involved and that the results in the analytical 
cohort (n=30) could be reasonably extrapolated to the wider patient 
population (n=125). Nevertheless, the small sample size should be noted 
and any findings should be treated with a degree of caution. 
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Table 5.4a: Socio-demographic characteristics and pre-operative co-
morbidities, stratified by analytical cohort 
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Table 5.4b: Socio-demographic characteristics and pre-operative co-
morbidities, stratified by analytical cohort (cont.) 
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Table 5.5: Intra-operative characteristics, stratified by analytical cohort 
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Table 5.6: Post-operative in-hospital outcomes, stratified by analytical cohort 
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5.4.3  Acceptability 
5.4.3.1 Response rates 
A total of 125 Q1 PROM questionnaires were posted out to patients awaiting 
proximal TAA surgery. Of those, 58 (46.4%) were initially returned and 
usable. Of those patients who returned Q1, 30 were also able to return Q2 
and Q3 giving an internal overall response rate of 63.8%. Looked at in the 
wider context of the overall eligible patient population, the analytical cohort of 
30 / 125 produces a response rate of 24%. 
Rates of response and attrition in the four original treatments which were 
allocated a nationally mandated PROM were published in a “Special Topic” 
document in 2016 (Health and Social Care Information Centre, 2016), data 
from the report is included in Figure 5.2: 
 
Figure 5.2: Attrition rate: Percentage of participants at each stage during the 
proximal TAA PROM pilot, including a comparison of national PROMs 
2013/14 data (Contains information from NHS Digital, licenced under the 
current version of the Open Government Licence). 
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Figure 5.2 shows the Q1 response rate along with the attrition rates at Q2 
and Q3 for the proximal TAA PROM pilot. Even though the delivery strategy 
for the current study included an additional post-operative PROM delivery, 
the pattern of response falls between the groin hernia PROM and varicose 
vein PROM response configuration for 2013/14. 
 
5.4.3.2 Missing data 
In the analytical group of 30 patients, the rates of missing data per 
questionnaire item were small in most cases. For the Q1 questionnaire, all 
items had a missing data rate < 10% (n missing < 3). For the Q2 
questionnaire, 6 items had a rate of missing data > 10% (3 items had 13.3% 
missing data (n missing = 4) and 3 had 16.7% (n missing = 5) missing data). 
For the Q3 questionnaire, no items had a rate of missing data > 10%. 
Overall, across the three Q1, Q2 and Q3 PROM questionnaires, 191 key 
items were identified. Multiplied by 30, that results in 5730 individual items of 
data. Out of these there were 123 items of data missing in the analytical 
cohort dataset, or 2.1%. 
 
5.4.4  Feasibility 
5.4.4.1 Respondent feasibility 
The reasonable response rates reported above go some way towards 
demonstrating the feasibility of the PROM pilot in this patient population. One 
of the unique elements of this study was the requirement for patients to 
respond at both 6 weeks and 3 months post-operatively. This makes it 
difficult to compare response rates with previous PROM programmes, which 
typically included a single follow-up survey. However, the reality is that the 
response and attrition rates appear to be at the lower end of what was 
experienced in the national programme, although strategies to improve this – 
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such as exploring how feasible it would be to deliver the Q1 PROM at a pre-
operative clinic, or testing Q2 and Q3 deliveries at different post-operative 
time points – could be adopted. 
 
 
5.4.4.2 Administrative staff feasibility 
The PROM pilot was administered by a single investigator in addition to their 
usual employment tasks. Document printing, patient identification, mailing 
and data input were all manageable with the rate of eligible proximal TAA 
patients admitted to a single aortic surgery provider. If the numbers of eligible 
patients were to increase, or the delivery of the PROM was to change in any 
significant way, the administrative burden may become more challenging. 
 
  
5.4.5  Interpretability 
Interpretability was measured using the following CDF charts, allowing the 
MIC90 thresholds to be identified.  
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Figures 5.3a and 5.3b show the MIC90 for the Symptoms domain at 6 weeks 
and 3 months, respectively. At 6 weeks the MIC90 was 5.4 and at 3 months it 
was 8.7 
 
Figure 5.3a: CDF chart showing the MIC90 (dotted orange lines) for the 
Symptoms domain at 6 weeks 
 
Figure 5.3b: CDF chart showing the MIC90 (dotted orange lines) for the 
Symptoms domain at 3 months 
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Figures 5.4a and 5.4b show the MIC90 for the Physical domain at 6 weeks 
and 3 months, respectively. At 6 weeks the MIC90 was 5.9 and at 3 months it 
was 8.1 
 
Figure 5.4a: CDF chart showing the MIC90 (dotted orange lines) for the 
Physical domain at 6 weeks 
 
Figure 5.4b: CDF chart showing the MIC90 (dotted orange lines) for the 
Physical domain at 3 months 
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Figures 5.5a and 5.5b show the MIC90 for the Psychosocial domain at 6 
weeks and 3 months, respectively. At 6 weeks the MIC90 was 5.3 and at 3 
months it was 6.2 
 
Figure 5.5a: CDF chart showing the MIC90 (dotted orange lines) for the 
Psychosocial domain at 6 weeks 
 
Figure 5.5b: CDF chart showing the MIC90 (dotted orange lines) for the 
Psychosocial domain at 3 months 
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Figures 5.6a and 5.6b show the MIC90 for the Cognitive domain at 6 weeks 
and 3 months, respectively. At 6 weeks the MIC90 was 7.4 and at 3 months it 
was 9.4 
 
Figure 5.6a: CDF chart showing the MIC90 (dotted orange lines) for the 
Cognitive domain at 6 weeks 
 
Figure 5.6b: CDF chart showing the MIC90 (dotted orange lines) for the 
Cognitive domain at 3 months 
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Figures 5.7a and 5.7b show the MIC90 for the EQ-5D Index at 6 weeks and 3 
months, respectively. At 6 weeks the MIC90 was 0.09 and at 3 months it was 
0.11 
 
Figure 5.7a: CDF chart showing the MIC90 (dotted orange lines) for the EQ-
5D Index domain at 6 weeks 
 
Figure 5.7b: CDF chart showing the MIC90 (dotted orange lines) for the EQ-
5D Index domain at 3 months 
189 
 
Figures 5.8a and 5.8b show the MIC90 for the EQ-VAS domain at 6 weeks 
and 3 months, respectively. At 6 weeks the MIC90 was 7.4 and at 3 months it 
was 8.1 
 
Figure 5.8a: CDF chart showing the MIC90 (dotted orange lines) for the EQ-
VAS domain at 6 weeks 
 
Figure 5.8b: CDF chart showing the MIC90 (dotted orange lines) for the EQ-
VAS domain at 3 months 
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5.4.6  Reliability 
5.4.6.1 Internal consistency 
Table 5.7 shows the Cronbach’s alpha scores for the four PROM domains, 
based on the baseline Q1 responses. 
 
Table 5.7: Cronbach’s alpha scores for PROM domains 
  Symptoms Physical Psychosocial Cognitive 
Item 1 0.896 0.933 0.955 0.811 
Item 2 0.907 0.935 0.952 0.824 
Item 3 0.900 0.934 0.952 0.759 
Item 4 0.902 0.934 0.951 
 
Item 5 0.909 0.941 0.956 
 
Item 6 0.912 0.939 0.950 
 
Item 7 0.899 0.933 0.950 
 
Item 8 0.901 0.950 0.957 
 
Item 9 0.900 0.952 0.950 
 
Item 10 0.907 
 
0.952 
 
Item 11 0.911 
 
0.954 
 
Item 12 0.902 
 
0.951 
 
Item 13 
  
0.952 
 
Item 14 
  
0.949 
 
Item 15 
  
0.948 
 
Item 16 
  
0.950 
 
     
Overall 0.911 0.946 0.955 0.855 
 
In the main, the alpha scores show a very high level of internal consistency 
as they are all >0.70. Although some perhaps demonstrate that there are 
redundant items present, as it has been suggested that alpha scores >0.90 
indicate questions that are testing the same response only in a different 
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guise (Streiner, 2003). This is especially true in the Psychosocial domain. 
Future work would need to repeat the analysis with a larger cohort in order to 
confirm these results. 
 
5.4.6.2 Test-retest reliability 
60 patients independent of the main analytical cohort were invited to take 
part in the test-retest study, 29 (48.3%) patients responded to both 
questionnaires and were included in the analysis. Figure 5.9 shows the 
cohort diagram, clarifying the response rates and reasons for attrition in the 
test-retest study. 
 
 
Figure 5.9: Cohort diagram showing test-retest response rates and attrition 
categories 
 
 
 
 
 
 
60 active monitoring patients selected to be sent a Phase 1 test-retest PROM questionnaire
1 (1.7%) patient had died
1 (1.7%) patient was currently an inpatient at their local hospital
24 (40.0%) further patients did not return the Phase 1 questionnaire
34 (56.7%) patients returned a completed Phase 1 questionnaire and were sent Phase 2
29 (48.3%) patients included in the test-retest analysis
5 (8.3%) patients did not return the Phase 2 questionnaire
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Table 5.8 shows the test-retest ICC values for the four PROM domains. 
 
Table 5.8: Test-retest ICC scores for PROM domains 
  Symptoms Physical Psychosocial Cognitive 
Item 1 1.000 0.907 0.910 0.785 
Item 2 0.840 0.960 0.696 0.934 
Item 3 0.966 0.874 0.974 0.856 
Item 4 0.790 0.721 0.899 
 
Item 5 0.726 0.711 0.747 
 
Item 6 0.573 0.922 0.935 
 
Item 7 0.956 0.811 0.931 
 
Item 8 0.937 0.841 0.890 
 
Item 9 0.801 1.000 0.628 
 
Item 10 0.973 
 
0.812 
 
Item 11 0.875 
 
0.857 
 
Item 12 0.671 
 
0.609 
 
Item 13 
  
0.838 
 
Item 14 
  
0.664 
 
Item 15 
  
0.799 
 
Item 16 
  
0.926 
 
     
Overall 0.919 0.910 0.875 0.923 
 
Most items and all domains show a good or excellent ICC result, indicating 
useful reproducibility and agreement. Item 6 in the Symptom domain 
(“Feeling unsteady or uncoordinated”) is notably low however, suggesting 
only a moderate degree of measurement agreement with other items in that 
domain (Koo, 2016). Further work with greater sample sizes would be 
required to confirm that finding. 
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5.4.7  Responsiveness 
Box and whisker charts showing the responsiveness in the reported PROM 
scores between the baseline Q1 measurement and both the 6 week Q2 
measurement and the 3 month Q3 measurement are presented below.   
 
 
Figure 5.10: Box plot showing PROM domain scores and statistical 
comparisons at Q1, Q2 and Q3 
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Figure 5.11: Box plot showing EQ-5D index scores and statistical 
comparisons at Q1, Q2 and Q3 
 
Figure 5.12: Box plot showing EQ-VAS scores and statistical comparisons at 
Q1, Q2 and Q3 
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5.4.7.1  Alternative presentation of results  
Perhaps a more relevant way of presenting the data is by plotting the 
differences between baseline Q1 scores and scores at Q2 and Q3. The 
following charts retain the box plot presentation but report the values as 
differences from Q1. 
 
 
 
Figure 5.13: Box plot showing PROM domain score differences from Q1 at 
Q2 and Q3  
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Figure 5.14: Box plot showing EQ-5D Index score differences from Q1 at Q2 
and Q3  
 
Figure 5.15: Box plot showing EQ-VAS score differences from Q1 at Q2 and 
Q3  
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For the NHS PROM program (see https://digital.nhs.uk/data-and-
information/data-tools-and-services/data-services/patient-reported-outcome-
measures-proms), the results have been presented in the following way, 
which simplifies the output into patients who reported HRQoL improvements, 
patients who reported a deterioration in HRQoL and patients who stayed the 
same. The first chart analysis specified that any increase or decrease in 
domain or EQ-5D score indicated an improvement or deterioration, the 
second utilised the MIC90 boundaries described in Section 5.3.3. 
 
 
Figure 5.16: PROM results, NHS format (all differences considered relevant)  
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Figure 5.17: PROM results, NHS format (MIC90 differences considered 
relevant) 
 
5.5  Summary 
In summary, the quantitative findings presented in in this chapter suggest 
that the new proximal TAA PROM tool could be a practical and scientifically 
valid measure for patient based HRQoL reporting. Although the sample size 
in the pilot was relatively small, the results show the PROM instrument 
returning reliable, interpretable and responsive data in this patient 
population. 
The questionnaire is broadly acceptable to patients. Although response rates 
in this pilot did not reach those seen in the national Knee and Hip 
Replacement PROM studies, they are comparable to those reported in both 
Groin Hernia and Varicose Vein procedures – that comparable response rate 
occurred despite the inclusion of an additional follow-up questionnaire. 
Reliability was shown through the high level of internal consistency (with 
Cronbach’s alpha results for the PROM domains ranging from 0.855 to 
0.955), and result replication (with ICC results for the PROM domains 
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ranging from 0.875 to 0.923). These high levels off reliability compare well 
with those reported in the CROQ validation (Schroter, 2004), where every 
domain had a Cronbach’s alpha score and an ICC score > 0.80 (item level 
results were not published).  
Interpretability was demonstrated by estimating the minimally important 
clinical differences at the 90% level, for each domain at both 6 weeks and 3 
months. This approach facilitates a more inferential analysis by clinical staff, 
and perhaps helps to identify subgroups of patients who would benefit from 
additional resources – for example surgical prehabilitation or psychological 
counselling.  
Responsiveness was shown using three different approaches: 
 The first approach (Figures 5.10, 5.11 and 5.12) uses box and whisker 
plots to show the range of results and any statistically significant 
differences between the baseline PROM score and the follow-up 
scores at 6 weeks and 3 months.  
 
 The second approach (Figures 5.13, 5.14 and 5.15) again uses box 
and whisker plots, but the unit of measurement in this analysis is the 
difference between the two sets of follow-up scores and the baseline 
score. Therefore only the differences at 6 weeks and 3 months need 
to be shown.  
 
 The third approach (Figures 5.16 and 5.17) is the one currently used 
by the NHS, which is a simplified view on a single scale. The unit of 
measurement is again the differences between results at 6 weeks and 
3 months when compared to the baseline. 
These different approaches each have strengths and weaknesses, and the 
intention was to give a range of visualisations that may find favour with 
different audiences. The first approach may appeal to academics or 
clinicians, as it uses p-values and attempts to paint a more complete picture 
of results. However it may not be suitable for the layperson as p-values and 
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box and whisker plots would require specialist knowledge to interpret. The 
second approach is a simplification of the first, concentrating on the follow-up 
results as compared to baseline. This removes the p-values and includes a 
“0” line to indicate the pre-operative scores, which is perhaps more intuitive. 
However, the box and whisker plots still require some specialist knowledge to 
decipher upon first glance. The third approach is the most simple, and has 
the appeal of presenting all the results on a single chart. It is similar to the 
second approach in that it shows the differences from baseline rather than all 
the scores, but this shows a percentage difference rather than using the units 
of measurement which are particular to each domain. Deciding on the 
appropriate way to present PROM results for particular audiences could be 
explored in future studies.  
To conclude, these results give encouragement that the TAA PROM tool is a 
useful instrument in this population. Furthermore, they offer some initial, 
novel evidence that the majority of patients may experience an improvement 
in their physical and psychosocial HRQoL at 3 months post-operatively, 
based on pilot data MIC90 calculations. However, further quantitative analysis 
with a larger sample size and including Rasch modelling (see Section 5.3.3) 
and psychometric work will be needed to give robust confirmation of the 
precision and validity of the instrument. Also, careful evaluation of population 
and procedural differences would have to be made before this PROM was 
used in other settings. 
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Chapter 6 
Discussion and conclusions 
 
6.1  Introduction 
The following final thesis chapter presents a summary of the research 
findings. The implications and limitations of the work are discussed, along 
with the scope and generalisability of the findings. Finally, possible directions 
for future research projects are outlined. 
 
6.2  Overview of findings 
This thesis began by reviewing the history, development and contemporary 
understanding of aortic aneurysms, HRQoL and PROMs (Chapter 2). This 
review provided evidence of a knowledge gap around suitable PROM tools 
that could be used for patients being surgically treated for proximal TAA. 
Several areas for improvement were identified, including the lack of a robust 
conceptual model or theoretical framework that reflects these patients’ lived 
experience of TAA, a derived item set of suitable questions or a feasible, 
evaluated PROM tool which could be routinely used to measure HRQoL in 
these individuals. 
The most appropriate methodology for answering these questions was 
presented in Chapter 3. This included a summary of the underlying 
pragmatic philosophical approach, a discussion of PROM development 
techniques and a rationale for including both qualitative and quantitative 
results in an exploratory sequential mixed methods research strategy. 
Chapter 4 included the design, analysis and results of the qualitative phase 
of the study.  This comprised a short appraisal of the current literature 
regarding qualitative investigations into this patient population, then a 
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discussion of the recruitment strategy, descriptive statistics for the study 
participants and a justification of sample size. The interview and data 
collection plans were also described, along with an exploration of Thematic 
Analysis – the chosen approach to qualitative data investigation. A detailed 
presentation of the key results from the qualitative analysis was then 
included which provided in-depth information about patients’ thoughts and 
feelings concerning their experiences with TAA and the healthcare services, 
these themes were then collected into the established physical, 
psychological and social HRQoL domains along with the emerging concepts 
of how TAA effects HRQoL: the effect of disease and treatment, attitudes of 
and towards friends and family and the continued diagnostic monitoring for 
aneurysmal disease. These were then summarised in a conceptual model, 
showing the interconnectedness of TAA disease, diagnosis, treatment and 
HRQoL. Item identification, questionnaire construction and findings from the 
focus group evaluation were also presented. 
The results of the TAA PROM pilot were shown in Chapter 5. These included 
the approach to recruitment, delivery and data collection along with 
descriptions of how representative of the overall population the respondent 
cohort was. Response rates and missing data values were also presented. 
The standard PROM evaluation criteria were explored, including tool 
feasibility, interpretability, precision, reliability, validity and responsiveness. 
Minimally important changes were estimated for each domain, along with 
Cronbach’s alpha and intraclass correlation coefficients for each 
questionnaire item. Post-operative questionnaire results within each separate 
domain were compared to their pre-operative baseline measures using 
paired statistical tests to identify any significant differences. 
 
6.3  Implications of this research 
6.3.1  Contribution to knowledge 
This thesis has contributed to the currently published knowledge as follows: 
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1. By establishing the need for a TAA PROM by means of an in-
depth literature review 
2. By generating a conceptual model of patient HRQoL in patients 
who suffer from TAA disease 
3. By developing and piloting a PROM for patients who undergo 
surgical treatment for TAA disease 
4. By demonstrating the feasibility of delivering a PROM tool to 
this patient population, at 2 separate post-operative time 
intervals 
5. By presenting the differences that surgical treatment of 
proximal TAA disease made to each PROM domain 
It is hoped that these results may be of some potential use to future patients 
who are scheduled to undergo surgery for proximal TAA disease, either by 
supporting their understanding of what to expect from their treatment or 
allowing them to express opinions that may otherwise go unobserved. It is 
further possible that the PROM results could influence the delivery of 
healthcare, especially for patient information documentation, post-operative 
rehab strategies, or pre-operative support clinics for ‘watch-and-wait’ 
patients. 
 
6.3.2  Generalisability of findings 
The main barrier to how generalisable the findings of this study are is the 
small sample size, especially in the quantitative phase of the study. Small 
sample sizes in this cohort are explained somewhat by the relatively low 
incidence of surgical treatment for proximal TAA disease, especially when 
compared to the nationally mandated hip and knee replacement PROM 
populations, or the revascularisation population targeted in the recent pilot 
study (see Section 2.5.6.1). 
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6.4  Limitations 
This study contains several limitations. There is an element of selection bias, 
as all patients were recruited from a single tertiary hospital in the North West 
of England. This bias would extend to environmental factors, treatment 
similarities and demographic characteristics such as ethnicity. 
The lack of qualitative research experience that the primary investigator had 
should also be acknowledged as a limitation. It is possible that a more 
experienced qualitative researcher would have been able to elicit richer, 
more detailed results by using the skills and expertise which would be 
developed when carrying out multiple qualitative studies.  
The primary researcher’s employment at the hospital which hosted the study 
should also be considered. There would exist the potential for an 
unconscious degree of impartiality or a level of preconception about hospital 
care and treatment that should be taken into account when assessing the 
results of this research. 
The TA approach to the qualitative phase of the study was considered to be 
appropriate based on TA output being conducive to PROM construction and 
the straightforward, introductory techniques of the method appealing to the 
novice qualitative researchers. It may be however, that a qualitative 
approach which produces a narrative output, such as an ethnography or 
phenomenology, could be used to extract a richer set of results from the 
data. Ethnographies are a more time consuming approach to qualitative 
research and they can be limited in how generalisable the findings are and in 
how subjective the analysis can be (Goodson, 2011). But in general, a 
deeper, thicker descriptive understanding of the research question under 
consideration can be achieved. Nanton (2016) used an ethnographic method 
to construct a narrative around how patients’ personal identities can be 
compromised when suffering from serious or advanced illnesses, while Perry 
(2006) developed a feminist ethnography to report the experiences of how 
families respond to caregiving, with particular reference to the management 
of vulnerability.   
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It is possible that a phenomonological approach could also provide more 
involved results. Phenomonologies recognise that an individual’s lived 
experience involves emotion, memory, thought and perception and each of 
these contain an ‘intentionality’ as the individual focuses on a specific entity 
or event (Rodriguez, 2018). Phenomonologies have been used in healthcare 
with some success, Kirkengen (2007) presented an integrated perspective 
on complex diseases such as cancer and autoimmune disorders which 
attempted to go beyond biomedical models such as aetiology, treatment and 
prognosis. Angner (2009) studied the relationship between health and 
happiness in 383 older adults living in community accommodation, the 
findings suggested that subjective measures of health may be better 
predictors of happiness than objective measures, and Finley (2003) 
published a phenomenological analysis of a single individual recently 
diagnosed with multiple sclerosis, focussing on diminished possibilities, the 
relationship between disease, activities and relationships, and the change in 
relationship the patient experienced with their body. 
 
6.5  Future research 
There are several possible avenues for future research studies in this area of 
proximal TAA PROM development. These are reviewed in the following 
sections. 
 
6.5.1  Further PROM testing and development 
The current proximal TAA PROM instrument requires more extensive 
psychometric testing. Greater patient numbers from other high-activity aortic 
surgery units are required to perform accurate Rasch tests and to allow a 
more robust evaluation of the questionnaire items, including any redundancy. 
Future plans for PROM collection should include detailed exploration into 
alternative methods of delivery. Campbell (2015) offers encouragement to 
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the more widespread use of electronic PROM versions as his studies have 
found these methods of delivery to be equivalent to paper versions. However 
these innovations would have to be carefully planned and resourced before 
they could be put into practice. 
Translation of the tool into different languages is another development that 
has the potential to be valuable. Wild (2005) and Sousa (2011) offer 
recommendations as to how this may be achieved, but caution that PROM 
translation is time-consuming and requires both intense planning and a 
rigorous methodological approach. 
The questions asked at 6 weeks and 3 months in the current pilot are 
identical. Now that this study has shown some feasibility for the strategy of 
collecting results at 2 stages of the post-operative period, further work could 
be done to refine the questions asked at these two time points. For example, 
the question referring to post-operative attendance at a rehabilitation course 
may only need asking at the 3 month stage. 
Some recognised layout / question construction issues need to be resolved. 
For example, the direction of the responses to the FFT question in the Q2 
and Q3 instruments follow the national template and are presented from 
positive to negative, whereas all the previous domain question responses are 
presented from negative to positive. This switch in direction could confuse 
patients who have become accustomed to the previous layout, or result in 
unintended responses if they are ticking boxes ‘on autopilot’. This 
conditioning effect could be particularly evident as the FFT question appears 
towards the end of the PROM. 
The most acceptable way to account for the nature of aortic disease should 
be determined. Theoretically, the approach was taken that proximal TAA 
disease was distinct from problems with the aortic valve. In practice however, 
the overwhelming majority (94.4%) of these patients present with aortic 
valves which require surgical replacement. The causes and effects of 
valvular disease and aneurysmal disease are likely to be closely linked, the 
treatment the patients typically receive is a single operation for both 
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disorders, so it follows that any QoL questionnaire should be worded in a 
way that will account for this disease duality. The current questionnaires 
(Appendices F2, G2 and H2) are worded in keeping with treating TAA 
disease as a separate entity. It may be that patient comprehension and 
overall accuracy could be improved by using an approach which combined 
the two disease types. 
 
6.5.2  Value of QoL information in high risk operations 
Additional investigation into how patients perceive the value of QoL 
information in respect to more life-threatening diagnoses and treatments 
should be undertaken. While PROMs for life-threatening conditions have 
been encouraged (Insight & Feedback Team, 2017) if the condition is ‘life or 
death’ rather than functional, such as hip and knee replacements, then 
PROM results are likely to be of secondary interest at best. Patients who are 
candidates for surgical treatments understand that if their TAA continues to 
grow it will inevitably rupture and cause catastrophic injury. In a similar way, 
cancer patients recognise that if they do not receive treatment then the 
prognosis is bleak. So what value are HRQoL or PROM results to patients 
who have a high likelihood of death if their condition goes untreated? As 
PROM agendas extend into more complex pathologies, this type of question 
will become more relevant. It may be that the resources which are used for 
PROM construction, validation and administration would be better distributed 
on improving vital outcomes rather than on questionnaires. 
Kotronoulas (2014) performed a systematic review into the value of cancer 
PROMs, and found some positive associations including an increase in the 
frequency of discussions regarding patient outcomes. Some studies included 
in the review also reported an increase in supportive care measures, patient 
satisfaction and improved symptom control. However, Kotronoulas concluded 
that more research would be required to support the cost-benefit of PROM 
implementation, including additional resources to handle the administrative 
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burden as well as additional support for clinicians to respond to patient 
concerns and issues. 
 
6.5.3 Finding the most effective way to present PROM 
results 
Testing and assessment of the most effective and informative way to present 
PROM results to both patients and clinicians is important. Research into the 
most informative, valuable way of delivering the results to stakeholders 
should include ease of interpretability, time required to assess performance 
and recommended levels of detail. 
 
6.5.4  Utilise full extent of EQ-5D information 
With results from more patients in a larger trial of the PROM, the EQ-5D 
results could be used to estimate QALY’s (Gusi, 2010; Ogden, 2017), which 
could be used to inform national guidelines on the costs and benefits of 
proximal TAA disease and treatment. 
 
6.5.5 QoL in surveillance patients, including possible 
interventions  
Some future consideration should be given to the situation of individuals who 
have been diagnosed with an aortic aneurysm, but do not yet meet the size 
criteria for surgery – “watch-and-wait”, or surveillance patients. As can be 
seen from the results of the pilot study, the most significant health 
improvements for this patient population appear to be within the psychosocial 
domain. It follows that patients who are under indefinite surveillance for a 
potentially life-threatening disease may be suffering a greater burden of 
stress, anxiety or social preclusion than the general population. Some recent 
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work focussing on AAA’s has been published around this subject, with 
thoughtful conclusions made about the difficulties in balancing the 
advantages and disadvantages of a surveillance program (Ericsson, 2019). 
UK AAA screening programs will in future have a QoL component for 
patients, with data collected online via the Screening Management and 
Referrals Tracking (SMaRT) IT system (Meecham, 2016; Public Health 
England, 2017). Earnshaw (2019) recognises that small QoL changes may 
seem inconsequential in light of the mortality risk that large aneurysms carry, 
but stresses that an understanding of the impact surveillance has upon 
patients is essential to how screening programs are designed and funded.  
Similar work, directed towards the proximal TAA patient population, could be 
carried out in the future. Initiatives such as counselling or psychological 
prehabilitation (as Tsimopoulou (2015) describes regarding patients awaiting 
cancer treatment) may have a positive effect, but an appreciation of the costs 
and benefits of such proposals needs to be fully comprehended before 
recommendations can be made. 
 
6.6  Conclusions 
Following on from the stated aims of this study, information about the 
experiences of patients suffering from proximal TAA disease has been 
gathered, with particular reference to subsequent surgical treatment. This 
took the form of both in-depth patient interviews and the delivery of PROM 
questionnaires. The findings substantiated some of the conclusions already 
suggested by the existing literature in this area, regarding the improvements 
that surgical treatment can have on these patients’ HRQoL. They also shed 
new light on specific issues that this patient population face. The information 
gathered from the qualitative study phase was used to develop a PROM tool 
that was designed to assess HRQoL and health status in these individuals. 
The evaluation properties of this new instrument were found to be 
acceptable, which unlocks the potential for this PROM to be used within 
routine clinical practice as part of patient support and outcomes assessment. 
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It is hoped that the findings described here will improve the experiences of 
these patients, for although they are not the largest pathological group, the 
effects of TAA disease upon HRQoL can be significant. The patient’s family, 
friends and healthcare professionals may also find the results useful in order 
to better understand, or improve upon, the day-to-day experiences and 
medical management of this population. 
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Appendix B. Recruitment letter, interviews 
 
 
 
Mr/s P Patient 
Addr 1 
Addr 2 
Addr 3 
PP1  1XX 
1st January 20XX 
Dear Mr/s Patient, 
I am writing to invite you to take part in a research study we are undertaking at 
Liverpool Heart and Chest Hospital which will look at quality of life in aortic 
aneurysm patients. You are being contacted because you have had aortic surgery in 
the past, or are due to have surgery soon. 
The study involves a single one-to-one interview with a researcher at Liverpool 
Heart and Chest Hospital. The interview will last about one hour and take place in a 
private room within the hospital. All information given will be kept confidential. If 
you decide to participate, all of your travelling expenses and car parking charges 
will be reimbursed by the research team (up to a maximum of £50). 
Your participation in the study would not alter your treatment in any way. 
Please find enclosed a copy of the Patient Information Sheet which gives all the 
information regarding this study, I would be grateful if you would take the time to 
read it and decide whether you would be willing to be interviewed. It may be useful 
to discuss it with your family and friends or your GP or the Patient and Family 
Support Team at Liverpool Heart and Chest Hospital. The Patient and Family 
Support Team can be contacted on 0151 600 1517. 
A member of the research team will call you in a few days. If you decide to 
participate we will discuss what will happen next. If you decide not to participate, 
the quality of your care at Liverpool Heart and Chest Hospital will not be affected in 
any way. In the meantime, if you  have any questions or would like any further 
information then please contact Matthew Shaw, a member of  the research team 
on 0151 600 1487. 
Yours sincerely, 
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Mr Mark L Field 
Consultant Cardiac Surgeon 
Liverpool Heart and Chest Hospital 
Thomas Drive 
Liverpool 
L14 3PE 
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Appendix C. Patient information sheet, interviews 
 
   
   
Information Sheet for Participants 
01/01/20XX 
 
Development and validation of a Patient Reported Outcome 
Measure (PROM) for patients undergoing Aortic Surgery 
 
Dear Mr/s Patient, 
 
You are being invited to take part in a research study which will examine the 
experiences of patients undergoing Aortic Surgery by means of an interview. 
This research is part of a PhD thesis being undertaken at Liverpool 
University. Before you make a decision, it is important for you to understand 
why this research is being done and what it will involve.  Please take time to 
read the following information carefully and discuss it with your friends, 
relatives and your GP if you wish. Please do not hesitate to ask if there is 
anything that is not clear or if you would like more information. You may 
contact the study investigators whose details are given below. Take time to 
decide whether or not you wish to take part. 
 
 
What is the purpose of the study? 
During hospital visits many patients are often asked to complete 
questionnaires to assess their overall health and wellbeing. This information 
is useful for informing the hospital about the quality of services it provides. 
However, recent research has shown that many of them may not be 
acceptable to some people because some of the questions may be 
inappropriate. For example, the questionnaire may not mention some issues 
that are important to the patient. 
 
We are inviting patients to participate in interviews to discuss and give their 
opinions on their aortic aneurysm disease before and after surgery. We 
would record the discussion and, with your permission, we may quote your 
comments but they would be anonymised. Information from the interviews 
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will inform the design of the next generation of questionnaires that we hope 
will be more meaningful to future patients. 
 
Why have I been chosen? 
You have been contacted because you have an aortic condition. You are due 
to have an aortic operation/intervention, or have had an aortic operation in 
the past, and are therefore eligible to take part in this study. 
 
Do I have to take part? 
You do not have to take part in this study. If you do decide to take part, you 
will be asked to sign a consent form and we will give you a copy of this 
information sheet and the consent form to keep. If after deciding to take part 
in the study you change your mind you are free to withdraw at any time, 
without giving a reason, and without your medical care or legal rights being 
affected.   
 
What will happen to me if I take part? 
If you agree, we will ask you to take part in a one to one interview with a 
student researcher in our hospital research unit. This interview will take place 
after your forthcoming outpatient appointment. We expect the interview to 
take no longer than 1 hour. All travelling expenses and any additional fees 
(e.g. car parking) up to a maximum of £50 will be covered by the hospital. 
 
 
Will my taking part in this study be kept confidential? 
Yes. If you decide to take part, all information that is collected about you 
during the course of the study will be kept strictly confidential and will only be 
accessed by members of the research team. Names will not be written on 
any of the transcripts, or reports of this research study. You will not be able 
to be identified from any report that is published from this study. With your 
permission, your GP will be informed that you are taking part in the study. 
 
What will happen to the results of the interviews? 
The results of this study will not be known for some time after the last person 
taking part in the study has completed their interview.  At the end of the study 
a report on the findings of the interviews will be produced in collaboration 
with the patient’s representatives/Service User’s Research Endeavour 
(SURE) group at the Liverpool Heart and Chest Hospital. The results may 
also be published in medical journals and presented at research seminars 
and conferences.  If you would like us to send you a copy of any published 
papers, please let us know. 
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Who is organising and funding this study? 
The principle investigator for this study is Mr Matthew Shaw. The study is 
being supervised by Mr Mark Field of the Aortic Surgery Team at Liverpool 
Heart and Chest Hospital and Dr Alan Haycox of the Management School 
department at the University of Liverpool. The study is funded by the Aortic 
Surgery Team at Liverpool Heart and Chest Hospital. Researchers are not 
receiving any extra payments other than their usual salaries. 
 
Who has reviewed this study? 
The study was given a favourable ethical opinion for conduct in the NHS by 
the Solihull Research Ethics Committee – West Midlands. In addition, a 
patient representative of the Liverpool Heart and Chest Hospital Service 
Users Research Endeavour (SURE) group and the local research group 
have given their approval. 
Contact for further information 
If you have any other questions about the study, please contact Matthew 
Shaw at:  
 
Research Unit 
Liverpool Heart and Chest Hospital NHS Foundation Trust 
Thomas Lane 
Liverpool 
L14 3PE 
 
Tel: 0151 600 1487    
E-mail: matthew.shaw@lhch.nhs.uk 
 
What do I do now? 
A member of the research team will get in touch via telephone in the next few 
days. In the meantime, please think about whether you would like to 
participate in the study or not. 
 
What if there is a problem? 
If you have a concern about any aspect of this study, you should ask to 
speak with any of the principal researchers listed above who will do their best 
to answer your questions. If you have concerns about any aspect of the way 
you have been approached or treated during the course of the study, you 
may wish to contact the hospital’s Patient Advice and Liaison Service (PALS) 
now known as “Customer Care Team” on telephone number: 0151 600 1275 
or 0151 600 1517 
 
If you wish to make a formal complaint, please write to:  
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Chief Executive 
Liverpool Heart and Chest Hospital NHS Trust 
Thomas Drive,  
Liverpool,  
L14 3PE 
 
or telephone the Patient Complaints Manager on 0151 600 1257 
 
 
 
Thank you very much for considering taking part in our 
research.  
Please discuss this information with your family and friends 
if you wish. 
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Appendix D. Patient consent form, interviews 
 
Patient Consent Form 
 
Patient Identification Number for this study: __ __ __  
Principal Investigator:  Matthew Shaw 
LHCH Research Study No: 1023 
Title of Project:      Development and validation of a Patient 
Reported Outcome Measure (PROM) for 
patients undergoing Aortic Surgery 
Please initial boxes and sign at the bottom of the sheet 
 
1 I have read and understand the patient information sheet provided to me 
and I have been given a copy to keep. I have had all my questions 
answered to my satisfaction, and I voluntarily agree to participate in this 
study. 
2 I understand that my participation in this research project is voluntary. I 
understand that I am free to withdraw myself or my information from the 
research project at any time, without giving a reason and without my 
medical treatment or legal rights being affected. 
3 I understand that participation involves being interviewed by a researcher 
from Liverpool Heart and Chest Hospital. The interview will last 
approximately 1 hour. The interview will be recorded. 
4 I understand that the researcher will not identify me in any reports using 
information obtained from this interview, and that my confidentiality as a 
participant in this study will remain secure. Subsequent uses of records 
and data will be subject to standard data use policies which protect the 
anonymity of individuals and institutions. 
5 I understand that information from this study may be used in scientific 
publications. My identity will be protected at all times. 
 
6  I have been given a copy of this consent form. 
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……………………………  ………………………….      
…………………………… 
Name of patient  Date    Signature 
 
……………………………  ………………………….      
…………………………… 
Name of researcher  Date    Signature 
  
277 
 
Appendix E. Interview guides 
E.1  Pre-operative interview guide 
Semi-structured interview questions (Pre-op) 
 
1. Demographics: age, gender, educational level, employment or 
former employment, post code 
 
2.  Can you explain the details of how you were diagnosed with the 
aortic aneurysm? 
 
3. Did/do you have any other health problems? 
 
4.  What was your quality of life like before being diagnosed? Any 
restrictions on your activities? Did you feel unwell? 
 
5. How did you feel when you were diagnosed? (surprised, worried, 
anxious, scared?)  
 
6. Did you restrict any of your daily activities once you were 
diagnosed? 
 
7. How did your friends and family react? 
 
8. How long did you have to wait until your operation? 
 
9. What are/were your thoughts about how the surgery would 
affect your quality of life e.g. independence, mobility, ability to 
work, pain, time in hospital, complications? 
 
10. Has the diagnosis affected intimacy in any way? 
 
11. Anything else to do with your condition that you’d like to 
comment on? 
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E.2  Post-operative interview guide 
 
Semi-structured interview questions 
 
1. Demographics: educational level, employment or former 
employment 
 
2. Can you explain the details of how you were diagnosed with the 
aortic aneurysm? 
 
3. Did/do you have any other health problems? 
 
4. What was your quality of life like before being diagnosed? Any 
restrictions on your activities? Did you feel unwell? 
 
5. How did you feel when you were diagnosed? (surprised, worried, 
anxious, scared?)  
 
6. Did you restrict any of your daily activities once you were 
diagnosed? 
 
7. How did your friends and family react? 
 
8. How long did you have to wait until your operation? 
 
9. Did you think that the information you were given by clinicians 
was consistent? 
 
10. What are/were your thoughts about how the surgery would 
affect your quality of life e.g. independence, mobility, ability to 
work, pain, time in hospital, complications? 
 
11. How did the surgery go? 
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12. Were there any post-operative complications? 
 
13. Where there any immediate or permanent side effects to the 
surgery? 
 
14. Were there any other post-operative health problems? 
 
15. How long do you feel it took to recuperate after the surgery? 
 
16. Has your lifestyle/daily activities been any different since 
recovering after the surgery? In what way? What can’t you do 
now that you could before the operation? 
 
17.  Has the surgery affected intimacy in any way? 
 
18. Despite any infirmities / side effects of the operation, how do you 
feel in yourself now? 
 
19. Anything else to do with your condition that you’d like to 
comment on? 
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Appendix F. Pre-operative patient mailing 
F.1  Pre-operative PROM letter 
 
 
 
January 20XX 
 
Dear Xx Xxxxxx, 
 
Patient reported outcome measures for elective surgery 
 
We would like your help with a survey that aims to evaluate the outcomes of 
heart surgery at Liverpool Heart and Chest Hospital, where you are 
scheduled to undergo an operation.  
 
We will use the results of the survey to see which areas of our care are good, 
or which need to improve. This questionnaire is also being sent to other 
people who are having similar operations, to ask them about their 
experiences too.  
Your feedback is very important to help us understand your health both 
before and after the operation.  
 
It should only take about 15 minutes to complete the survey. You can do this 
on your own or ask a friend or somebody in your family to help. The doctors 
or nurses who treat you will not know that you have taken part in the survey 
and all your answers are completely confidential. This survey is voluntary, 
so if you don’t want to take part, this will not affect your care and you don’t 
need to give a reason if you choose not to be involved. You also have the 
right to withdraw from the survey at any point in the future without giving a 
reason. 
 
If you do decide to take part, please complete and return the questionnaire in 
the FREEPOST envelope enclosed (you do not need a stamp). You will then 
be sent a second survey about 6 weeks after your operation, and a third 
survey about 3 months after your operation.  The responses from these 
follow-up surveys will help us understand the how the operation has affected 
your health. 
 
If you do not want to take part, you do not need to take any further action. 
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This survey is part of a research study run by Liverpool Heart and Chest 
Hospital. If you would like more information about the survey or need help to 
answer the questions, please call our Project Co-ordinator, Matthew Shaw 
on 0151 600 1487 and he will do his best to help. 
 
Thank you 
Yours sincerely, 
 
 
Mr ML Field 
 
Consultant Cardiac Surgeon & Clinical Lead for Aortic Surgery,  
Liverpool Heart and Chest Hospital 
 
Some questions and answers 
 
What is the ‘patient reported outcome measures’ study about? 
This study aims to assess how effective the operation you have is at improving your 
health.  During hospital visits many patients are often asked to complete 
questionnaires to assess their overall health and wellbeing. This information is 
useful for informing the hospital about the quality of services it provides. However, 
recent research has shown that many of them may not be so useful as some of the 
questions asked may be inappropriate. For example, the questionnaire may not 
mention some issues that are important to the patient. The enclosed questionnaire 
has been designed to be more focussed on specific aspects of health that are 
related to aortic conditions.  
 
Why have I been chosen? 
You have been sent this letter because you have an aortic condition. You are due to 
have an aortic operation and are therefore eligible to take part in this study. 
 
Do I have to take part? 
You do not have to take part in this survey. If after deciding to take part you change 
your mind you are free to withdraw at any time, without giving a reason, and without 
your medical care or legal rights being affected.   
 
How are my details being used? 
If you decide to take part, all information that is collected about you will be kept 
strictly confidential and will only be accessed by members of the research team. 
Names or addresses will not be written on any of the transcripts or reports resulting 
from this research study. You will not be able to be identified from any report or 
analysis that is published from this study.  
 
Can a relative or friend of the patient complete this questionnaire for them?  
Yes, but the answers to the questions should be the views of the person who the 
questionnaire was sent to. 
 
I can’t answer one of the questions – what should I do?  
If you can’t answer a question just leave it blank and move onto the next one. 
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Why is the NHS spending money on a survey?  
It is important for the NHS to ask people what they think about its services, as their 
views help to improve care. This survey has been specially developed to make sure 
that it asks questions about issues that really matter to people.  
 
What will happen to the results of the questionnaires? 
At the end of the study a report on the findings of the questionnaires will be 
produced in collaboration with the patient’s representatives / Service User’s 
Research Endeavour (SURE) group at the Liverpool Heart and Chest Hospital. The 
results may also be published in medical journals and presented at research 
seminars and conferences. Names or addresses will not be made public at any 
point. If you would like us to send you a copy of any published papers, please let us 
know. 
 
Who do I contact for further information? 
If you have any other questions about the study, please contact Matthew Shaw at:  
 
Research Unit 
Liverpool Heart and Chest Hospital NHS Foundation Trust 
Thomas Lane 
Liverpool 
L14 3PE 
 
Tel: 0151 600 1487    
E-mail: matthew.shaw@lhch.nhs.uk 
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F.2  Pre-operative PROM questionnaire (Q1) 
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Appendix G. 6 week post-operative patient mailing 
G.1  6 week post-operative PROM letter 
 
 
 
January 20XX 
 
Dear Xx Xxxxxx, 
 
Patient reported outcome measures for elective surgery 
 
Before your operation about 6 weeks ago you completed a questionnaire for 
the patient reported outcome measure study. As you might remember, the 
study involves you completing questionnaires at three separate times.  We 
are now sending you the second questionnaire.  Completing the 
questionnaire three times allows us to find out how your health and quality of 
life has changed.  
 
We hope you will be able to continue to participate, as your answers will help 
us to improve services for other patients. 
 
Your feedback is very important to help us understand your health after 
the operation.  
 
It should only take about 15 minutes to complete the survey. You can do this 
on your own or ask a friend or somebody in your family to help. The doctors 
or nurses who treat you will not know that you have taken part in the survey 
and all your answers are completely confidential. This survey is voluntary, 
so if you don’t want to take part, this will not affect your care and you don’t 
need to give a reason if you choose not to be involved. You also have the 
right to withdraw from the survey at any point in the future without giving a 
reason. 
 
Please return the questionnaire in the FREEPOST envelope enclosed (you 
don’t need a stamp). If you do not want to take part, please either return the 
blank questionnaire or call the helpline number below. 
 
This survey is part of a research study run by Liverpool Heart and Chest 
Hospital. If you would like more information about the survey or need help to 
answer the questions, please call our Project Co-ordinator, Matthew Shaw 
on 0151 600 1487 and he will do his best to help. 
 
Thank you 
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Yours sincerely, 
 
 
Mr ML Field 
 
Consultant Cardiac Surgeon & Clinical Lead for Aortic Surgery,  
Liverpool Heart and Chest Hospital 
 
Some questions and answers 
 
What is the ‘patient reported outcome measures’ study about? 
This study aims to assess how effective the operation you had is at improving your 
health.  During hospital visits many patients are often asked to complete 
questionnaires to assess their overall health and wellbeing. This information is 
useful for informing the hospital about the quality of services it provides. However, 
recent research has shown that many of them may not be so useful as some of the 
questions may be inappropriate. For example, the questionnaire may not mention 
some issues that are important to the patient. The enclosed questionnaire has been 
designed to be more focussed on specific aspects of health that are related to aortic 
conditions.  
 
Do I have to take part? 
You do not have to take part in this survey. If after deciding to take part you change 
your mind you are free to withdraw at any time, without giving a reason, and without 
your medical care or legal rights being affected.   
 
How are my details being used? 
All information that is collected about you survey will be kept strictly confidential and 
will only be accessed by members of the research team. Names or addresses will 
not be written on any of the transcripts, or reports of this research study. You will not 
be able to be identified from any report or analysis that is published from this study. 
 
Can a relative or friend of the patient complete this questionnaire for them?  
Yes, but the answers to the questions should be the views of the person who the 
questionnaire was sent to. 
 
I can’t answer one of the questions – what should I do?  
If you can’t answer a question just leave it blank and move to the next. 
 
Why is the NHS spending money on a survey?  
It is important for the NHS to ask people what they think about its services, as their 
views help to improve care. This survey has been specially developed to make sure 
that it asks questions about issues that really matter to people.  
 
What will happen to the results of the questionnaires? 
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At the end of the study a report on the findings of the questionnaires will be 
produced in collaboration with the patient’s representatives / Service User’s 
Research Endeavour (SURE) group at the Liverpool Heart and Chest Hospital. The 
results may also be published in medical journals and presented at research 
seminars and conferences. Names or addresses will not be made public at any 
point. If you would like us to send you a copy of any published papers, please let us 
know. 
 
Who do I contact for further information? 
If you have any other questions about the study, please contact Matthew Shaw at:  
 
Research Unit 
Liverpool Heart and Chest Hospital NHS Foundation Trust 
Thomas Lane 
Liverpool 
L14 3PE 
 
Tel: 0151 600 1487    
E-mail: matthew.shaw@lhch.nhs.uk 
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G.2  6 week post-operative PROM questionnaire (Q2) 
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Appendix H. 3 month post-operative patient mailing 
H.1  3 month post-operative PROM letter 
 
 
 
January 20XX 
 
Dear Xx Xxxxxx, 
 
Patient reported outcome measures for elective surgery 
 
Before your operation about 3 months ago you completed a questionnaire for 
the patient reported outcome measure study. As you might remember, the 
study involves you completing questionnaires at three separate times.  We 
are now sending you the third questionnaire.  Completing the questionnaire 
three times allows us to find out how your health and quality of life has 
changed.  
 
We hope you will be able to continue to participate, as your answers will help 
us to improve services for other patients. 
 
Your feedback is very important to help us understand your health after 
the operation.  
 
It should only take about 15 minutes to complete the survey. You can do this 
on your own or ask a friend or somebody in your family to help. The doctors 
or nurses who treat you will not know that you have taken part in the survey 
and all your answers are completely confidential. This survey is voluntary, 
so if you don’t want to take part, this will not affect your care and you don’t 
need to give a reason if you choose not to be involved. You also have the 
right to withdraw from the survey at any point in the future without giving a 
reason. 
 
Please return the questionnaire in the FREEPOST envelope enclosed (you 
don’t need a stamp). If you do not want to take part, please either return the 
blank questionnaire or call the helpline number below. 
 
This survey is part of a research study run by Liverpool Heart and Chest 
Hospital. If you would like more information about the survey or need help to 
answer the questions, please call our Project Co-ordinator, Matthew Shaw 
on 0151 600 1487 and he will do his best to help. 
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Thank you 
 
Yours sincerely, 
 
 
Mr ML Field 
 
Consultant Cardiac Surgeon & Clinical Lead for Aortic Surgery,  
Liverpool Heart and Chest Hospital 
 
Some questions and answers 
 
What is the ‘patient reported outcome measures’ study about? 
This study aims to assess how effective the operation you had is at improving your 
health.  During hospital visits many patients are often asked to complete 
questionnaires to assess their overall health and wellbeing. This information is 
useful for informing the hospital about the quality of services it provides. However, 
recent research has shown that many of them may not be so useful as some of the 
questions may be inappropriate. For example, the questionnaire may not mention 
some issues that are important to the patient. The enclosed questionnaire has been 
designed to be more focussed on specific aspects of health that are related to aortic 
conditions.  
 
Do I have to take part? 
You do not have to take part in this survey. If after deciding to take part you change 
your mind you are free to withdraw at any time, without giving a reason, and without 
your medical care or legal rights being affected.   
 
How are my details being used? 
All information that is collected about you survey will be kept strictly confidential and 
will only be accessed by members of the research team. Names or addresses will 
not be written on any of the transcripts, or reports of this research study. You will not 
be able to be identified from any report or analysis that is published from this study. 
 
Can a relative or friend of the patient complete this questionnaire for them?  
Yes, but the answers to the questions should be the views of the person who the 
questionnaire was sent to. 
 
I can’t answer one of the questions – what should I do?  
If you can’t answer a question just leave it blank and move to the next. 
 
Why is the NHS spending money on a survey?  
It is important for the NHS to ask people what they think about its services, as their 
views help to improve care. This survey has been specially developed to make sure 
that it asks questions about issues that really matter to people.  
 
What will happen to the results of the questionnaires? 
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At the end of the study a report on the findings of the questionnaires will be 
produced in collaboration with the patient’s representatives / Service User’s 
Research Endeavour (SURE) group at the Liverpool Heart and Chest Hospital. The 
results may also be published in medical journals and presented at research 
seminars and conferences. Names or addresses will not be made public at any 
point. If you would like us to send you a copy of any published papers, please let us 
know. 
 
Who do I contact for further information? 
If you have any other questions about the study, please contact Matthew Shaw at:  
 
Research Unit 
Liverpool Heart and Chest Hospital NHS Foundation Trust 
Thomas Lane 
Liverpool 
L14 3PE 
 
Tel: 0151 600 1487    
E-mail: matthew.shaw@lhch.nhs.uk 
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H.2  3 month post-operative PROM questionnaire (Q3) 
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